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The non-catalytic region of tyrosine kinase (NCK) proteins belongs to a 
group of src homology (SH) domain-containing adaptors that include Crk, Grap, 
Grb2, Grb10 and SLAP. The NCK family of proteins consists of two gene 
products, NCK1 and NCK2. Both NCK proteins are made up of three N-terminal 
SH3 domains that interact with proline-rich/polybasic motifs and a C-terminal 
SH2 domain that binds phosphotyrosine resides. Hence NCK serve to recruit 
proline-rich effectors to tyrosine-phosphorylated kinases or their substrates. While 
many interacting partners have been identified, the lack of a catalytic domain 
means that the functional impact of individual specific interactions is unclear. 
Genetic ablation strategies reveal that NCK play important roles in the modulation 
of the actin cytoskeleton, cell migration and axonal guidance in the nervous 
system. However, the spatiotemporal regulation of NCK activity is still poorly 
understood. 
I have identified G-protein-coupled receptor (GPCR)-kinase interacting 
protein-1 (GIT1) as a critical regulator of NCK1 localization and activity in the 
cell. Although NCK1 primarily interacts with a conserved phosphotyrosine 
residue (Y392) in GIT1 through its SH2 domain, I also describe a novel 
interaction between sequences in the GIT1 synaptic localisation domain (SLD) 
and the NCK1 SH3-2/SH3-3 linker region. There is strong evidence for the role of 
GIT1 in the adhesion recruitment of NCK1: inhibition of PAK activity enhanced 
adhesion targeting of both proteins; NCK1 interacts stably with endogenous PAK-
PIX-GIT complexes in vivo; NCK1 only co-immunoprecipitates with paxillin in 
the presence of GIT1, and knockdown of GIT1 abrogates adhesion localization of 
NCK1. The adhesion localization of NCK1 can be blocked by a dominant-
viii 
inhibitory NCK1-SH2 construct, leading to the inhibition of the migration-
promoting activity of endogenous NCK. I also demonstrate that NCK proteins can 
potentially oligomerize through the SH3-1 domain, while the NCK1 SH3-2 and 
SH3-3 domains regulate the cytoplasmic retention of NCK1. 
I also demonstrate NCK1’s role in regulating the GAP activity of !2-
chimaerin. The NCK1-chimaerin interaction requires the NCK1 SH3-3 domain, 
and N-terminal chimaerin sequences preceding the SH2 domain as well as part of 
the SH2-C1 domain “linker” region. The NCK1 SH2 domain modulates 
phosphotyrosine-independent binding of both NCK1 and !2-chimaerin to EphA4 
receptors, although more work is needed to work out the exact mechanism. !2-
chimaerin was also found to interact with NCK1 that is bound to the PAK-PIX-
GIT complex, with PAK enhancing the binding in a kinase-independent manner, 
probably through the allosteric modulation of GIT1. NCK1 binding in conjunction 
with phorbol ester engagement of the C1 domain, was also found to induce 
tyrosine-phosphorylation of the Y143 residue by Fyn, leading to the synergistic 
activation of !2-chimaerin’s Rac-GAP activity in vivo as measured by a cell 
spreading assay. 
In conclusion, I have demonstrated the mechanism of NCK1 recruitment 
and function at focal adhesions, novel interactions with regions of unknown 
function in GIT1 and !2-chimaerin, and that full activation of !2-chimaerin GAP 
activity requires coincidental signals from NCK1, phorbol ester binding and Fyn 
phosphorylation. Further work to establish how the potential oligomerization of 
NCK affects the specificity and affinity of its interactions, as well as the potential 
interplay between the adhesion-localized GIT complex and chimaerin will help to 
develop a more complete understanding of NCK function in the cell. 
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Chapter 1 Introduction 
 
1.1 Research objectives 
Since its discovery in 1990, the non-catalytic region of tyrosine kinase 
(NCK) adaptors have been shown to be important integrators of tyrosine kinase 
signaling through the recruitment of downstream proline-rich effector molecules. 
In particular, there is a wealth of data that indicates that the NCK proteins are key 
modulators of cytoskeletal dynamics that impinges on cell functions like actin 
polymerization, lamellipodial extension, cell migration, foot process formation 
and axon guidance. While a great multitude of NCK interacting partners have 
been identified and the biochemical basis of SH-domain mediated binding is well 
studied, there is still much to learn about the modulation of NCK activity in time 
and space. The ability of NCK adaptors to mediate the dynamic local assembly of 
multi-protein complexes through its multiple SH-domains means that deciphering 
clear-cut signaling outcomes is likely to be problematic. This is probably why 
despite the strong genetic evidence of NCK’s key role in important cellular 
processes like axon guidance (Hing et al., 1999; Fawcett et al., 2007), the 
underlying molecular mechanisms remain sketchy. Therefore, deciphering the 
spatiotemporal regulation of NCK interaction with downstream effectors of Rho 
GTPases is of critical importance for a deeper understanding of signaling events 
leading to higher-level functions of the cell. 
The main approach of this study involves the identification of NCK 
binding partners, characterizing the biochemical basis of such interactions, and 
observing their downstream functional impact on cell migration, in order to 
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delineate the signaling network modulated by NCK. Hence, my research aims to 
study the spatiotemporal regulation of NCK and defining the key signaling events 
emanating from the tangled web of its interactions, primarily focusing on the 
interplay between NCK, GIT and chimaerin.  
The GIT proteins have been shown to associate with NCK at focal 
adhesions (Brown et al., 2005) as well as key modulators of Rho GTPase activity 
like Arf6 (Nishiya et al., 2005) and !PIX-PAK (Loo et al., 2004). It has been 
suggested that GIT proteins actively regulate cytoskeletal dynamics during cell 
spreading and migration (Brown et al., 2005; West et al., 2001). Hence, it is 
plausible that GIT may modulate cell spreading and protrusion by targeting NCK 
to adhesion structures in the cell, although direct evidence of NCK’s recruitment 
mechanism and function is still lacking.  
Chimaerins are Rac-specific GTPase activating proteins (GAP) that can 
also bind the lipid second messenger diacylglycerol (DAG) and phorbol esters 
(Caloca et al., 1997). "2-chimaerin is particularly interesting as there is strong 
genetic evidence that it is functionally linked to NCK and EphA4 signaling 
networks to modulate axonal guidance in vivo (Wegmeyer et al., 2007). It was 
then suggested that growth cone collapse downstream of EphA4 receptor 
stimulation require the Rac-GAP activity of "2-chimaerin (Beg et al., 2007), 
which can be regulated by interacting NCK adaptors, However, the molecular 
basis of such regulation is still unclear. 
The literature indicates that the Rho GTPases are master regulators of the 
actin cytoskeleton (Etienne-Manneville and Hall, 2002; Heasman and Ridley, 
2008). Hence, the NCK adaptors are inevitably linked with Rho protein signaling 
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networks in the cell and it would be interesting to study how NCK modulates the 
activity of small Rho GTPases and their effector molecules.  
 
1.2 Small GTP-binding protein superfamily 
Small GTP-binding proteins (G-proteins) are monomeric GTPases with 
molecular masses of 20–40 kDa. The superfamily numbers over 150 human 
members that are divided into 5 families according to functional and sequence 
similarities: Ras, Rho, Rab, Ran and Arf (Wennerberg et al., 2005). The Ras 
oncogene was the founding member of the superfamily when its transforming 
capability was first discovered in mouse fibroblasts (Der et al., 1982).  
Small G-proteins function biochemically as binary molecular switches, 
constantly cycling between active GTP-bound states and inactive GDP-bound 
conformations (Jaffe and Hall, 2005) (Fig 1.1). The intrinsic GTPase function of 
the small G-proteins, which hydrolyses GTP into GDP and leads to inactivation, 
are enhanced by interactions with GTPase activating proteins (GAPs). Guanine 
nucleotide disassociation inhibitors (GDIs) can also inhibit G-protein (Rho and 
Rab) function via sequestration that impedes effective membrane localisation or 
nucleotide exchange. On the other hand, interactions with guanine nucleotide 
exchange factors (GEFs) facilitate the exchange of GDP with GTP that leads to G-
protein activation. Small G-proteins are also regulated by post-translational lipid 
modifications that control their subcellular localisation. Most Ras and Rho family 
proteins also contain a C-terminal CAAX box that directs the prenylation of the 
cysteine residue of the CAAX motif by farnesyl or geranyl-geranyl transferases 
that leads to membrane targeting and activation by GEFs (Zhang and Casey, 
 4 
1996). This thesis will concentrate more on the Rho (Ras homologous) family, 





Fig. 1.1. Rho GTPases cycle between active GTP-bound and inactive GDP-
bound states. Guanine nucleotide exchange factors (GEF) mediate Rho GTPase 
(p21) activation by stimulating the exchange of GTPase-bound GDP for GTP. The 
activated p21 is then able to interact with effector proteins like PAK and activate 
them by inducing the needed conformation changes. In contrast, GTPase 
activating proteins (GAP) enhances the intrinsic ability of p21 to hydrolyze GTP 
to GDP, leading to p21 inactivation. Guanine nucleotide disassociation inhibitors 
(GDI) sequesters GDP-bound p21, preventing GEF and membrane binding that 
will lead to activation. 
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1.3 The Rho GTPase family 
The Ras homologous (Rho) family consists of 22 mammalian members, 
namely Cdc42, Miro-1 and 2; Rac1, 2 and 3; RhoA, B and C, RhoD; Rnd1, 2, and 
Rnd3/RhoE; RhoG, RhoBTB1 and RhoBTB2; Rif, TC10 and TCL; TTF/RhoH, 
Wrch and Chp (Jaffe and Hall, 2005). In keeping with the great diversity of the 
family, Rho GTPases play critical roles in a plethora of cellular functions like cell 
division and differentiation, cell-cell and cell-matrix interactions, gene 
transcription, as well as regulation of endocytosis and exocytosis (Ridley, 2001a; 
Etienne-Manneville and Hall, 2002; Jaffe and Hall, 2005). Despite the initial 
hopes of researchers that the Rho proteins would become another nexus of 
oncogenic signaling following its serendipitous discovery in the humble sea slug 
Aplysia (Madaule and Axel, 1985), Rho GTPases quickly became prominent 
regulators of actin cytoskeletal dynamics. 
Early microinjection experiments demonstrated that RhoA stimulates actin 
stress fiber formation and focal adhesion assembly (Paterson et al., 1990; Ridley 
and Hall, 1992). It was then discovered that Rac1 promotes membrane ruffling 
and lamellipodium extension while Cdc42 induces actin microspikes and 
filopodial formation (Ridley et al., 1992; Nobes and Hall, 1995; Kozma et al., 
1996). Such seemingly distinct functional modalities suggest that each of the 
GTPases coordinate discrete and well-defined downstream signaling pathways 
that regulate both the synthesis as well as the organization of actin filaments in the 
cell. For example, both Cdc42 and Rac1 modulate actin polymerization through 
the heptameric actin nucleator Arp2/3 via the Wiskott-Aldrich syndrome protein 
(WASP) family proteins N-WASP (Millard et al., 2004) and the WAVE complex 
(Eden et al., 2002; Innocenti et al., 2005) respectively. Similar to the Ras proteins, 
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mutation of the conserved Gly12 or the equivalent residue (Gly12 Cdc42 and Rac, 
Gly14 in Rho) to valine abrogated the intrinsic GTPase function and resulted in 
constitutively active Rho GTPases (Garrett et al., 1989). Furthermore, the 
mutation of Gln61 to leucine was also found to impede GTP hydrolysis in Rho 
proteins. Such mutants are now widely used in the field to assay for effects of Rho 
protein activation, notwithstanding the caveats with regards to the non-cycling 
nature of the mutant GTPases. 
There is however significant crosstalk between the various Rho protein 
signaling cascades, as recent data has shown that multiple divergent pathways 
may regulate similar higher-order cellular structures. For example, Cdc42-
deficient fibroblastoid cells demonstrated impaired filopodium formation, cell 
polarization and directed migration, only upon further expression of dominant 
negative Cdc42, indicating that other Rho GTPases with common GEFs, are also 
involved in the establishment and maintenance of cell polarity during directed 
migration (Czuchra et al., 2005). Studies depleting Arp2/3 components in 
different cell lines also produced conflicting data in terms of whether the Arp2/3 
complex is needed for filopodial extension (Steffen et al., 2006; Korobova and 
Svitkina, 2008). Furthermore, while it is well established that Rac1 is needed for 
cell migration downstream of lamellipodial extension (Nobes and Hall, 1999; 
Knight et al., 2000), there have been studies that suggest that there are occasions 
when Rac signaling can be bypassed. For example, active Rab5 was found to 
induce lamellipodium extension independently of Rac in fibroblasts (Spaargaren 
and Bos 1999), while Rac inhibition did not eliminate membrane ruffling or cell 
spreading in immature dendritic cells (West et al., 2000) and colon carcinoma 
cells plated on laminin (O’Connor et al., 2000). Evidently there is still much more 
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to learn about the regulation of cytoskeletal dynamics involving the Rho GTPases, 
given the multitude of Rho proteins and the significant crosstalk between the 
various upstream regulators and downstream effectors. 
 
1.4 Downstream effectors of the Rho GTPases 
More recently, the research focus has began to shift towards the functions 
of downstream effectors of Rho GTPases with the discovery of proteins like the 
p21-activated kinases (PAKs) (Manser et al., 1994), Rho kinase (ROK) (Leung et 
al., 1996) and Myotonic Dystrophy kinase-related Cdc42 binding kinase (MRCK) 
(Leung et al., 1998) (Fig 1.2). For example, the Cdc42/Rac1-activated PAKs are 
potent regulators of cytoskeletal dynamics, cell motility, neurogenesis, 
angiogenesis and cancer metastasis (Bokoch, 2003). 
Activated PAK1 was shown to localize to the leading edge of motile cells, 
where it inhibits myosin light chain kinase (MLCK) activity via phosphorylation, 
leading to the selective suppression of contractile forces in the lamellipodium 
(Sanders et al., 1999). This results in reduced stress fiber and focal adhesion 
formation at the leading edge, promoting directional cell migration. Crucially, 
PAK1 can also activate LIM-kinase (LIMK) via phosphorylation of its activation 
loop, leading to a 10-fold increase in phosphorylation of cofilin/ADF that leads to 
a reduction in its F-actin depolymerization and severing (Edwards et al., 1999). 
The same critical threonine residue within the LIMK activation loop can also be 
phosphorylated by MRCK (Sumi et al., 2001) and by ROK (Maekawa et al., 
1999), indicating that modulation of cofilin activity may be a critical part of Rho 






Fig. 1.2. Role of Rho associated kinases in the regulation of cytoskeletal 
dynamics. ROK, PAK and MRCK act downstream of activated Rho proteins to 
activate LIM domain kinase (LIMK), which inhibits cofilin via phosphorylation 
and stabilizes actin filaments. Furthermore, ROK stimulates myosin contractility 
by phosphorylating and inhibiting protein phosphatase-1 (PP1), a myosin 
phosphotase, leading to enhanced regulatory MLC activation. Conversely, PAK 
inhibits myosin light chain kinase (MLCK), which activates myosin contractility.  
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Regulation of myosin activity is another node of crosstalk between 
pathways modulated by downstream Rho GTPase effector proteins. The reversible 
phosphorylation of Ser19 residue on the regulatory light chain (RLC) is critical to 
the regulation of the intrinsic ATPase activity of non-muscle myosin II (NMII) 
molecules and both ROK (Amano et al., 1996) and MRCK (Wilkinson et al., 
2005) are among the handful of kinases that phosphorylate Ser19 of the RLC to 
relieve the head-tail autoinhibitory conformation (Vicente-Manzanares et al., 
2009). ROK can also modulate myosin activity by phosphorylating the MYPT1 
regulatory subunit of the trimeric protein phosphatase I complex, leading to 
inhibition of the complex and enhanced NMII activity (Kimura et al., 1996). 
MRCK has also been shown to form a tripartite complex with LRAP35a and 
MYO18A that localizes to lamellar actomyosin filaments, where it modulates 
actomyosin retrograde flow and cell protrusion in conjunction with MYO2A (Tan 
et al., 2008). 
Beyond the serine/threonine kinases described above, Rho GTPase 
effectors also include a tyrosine kinase – activated Cdc42-associated kinase 
(ACK1) (Teo et al., 2001). ACK1 is intimately linked to receptor tyrosine kinase 
signaling networks (van der Horst EH et al., 2005; Chan et al., 2009), highlighting 
the importance of protein phosphorylation in regulating Rho GTPase signaling. 
 
1.5 Src homology domain adaptor proteins 
Given the significant role of protein phosphorylation in Rho GTPase 
signaling, it is unsurprising that src homology (SH) domain adaptors are critical 
interacting partners of downstream effector proteins. Such adaptor molecules 
consists entirely of SH domains with no known catalytic motifs, and include Crk 
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(reviewed by Feller, 2001), Grap (Feng et al., 1996), Grb2 (Lowenstein et al., 
1992), Grb10 (reviewed by Morrione, 2000), Src-like Adaptor Protein (SLAP) 
(Pandey et al., 1995) and NCK. The SH domains are highly conserved domains 
named after their initial discovery as regions of homology between the Src 
tyrosine kinase and other distantly related kinases (Sadowski et al., 1986).  
NCK consists of three consecutive src-homology 3 (SH3) domains in the 
N-terminus and one src-homology 2 (SH2) domain in the C-terminus. The SH2 
and SH3 domains are protein-protein interaction modules found in a wide range of 
proteins that perform a great diversity of functions in the cell. Beyond their 
nomenclature however, both domains do not share any structural or functional 
similarity. The SH2 domain consists of approximately 100 amino acid residues 
that form a large !-sheet flanked by 2 "-helices (Sicheri et al., 1997) and enables 
specific binding to phosphorylated tyrosine residues (Matsuda et al., 1990; Moran 
et al., 1990). The SH3 domain encompasses around 50 amino acids, and adopts a 
!-barrel structure made up of 5-6 !-strands tightly packed together as 2 anti-
parallel ! sheets (Terasawa et al., 1994; Yu et al., 1994). Classically, SH3 
domains were thought to bind proline-rich sequences containing a PxxP motif 
(Ren et al., 1993), although more recent data have shown that many SH3 domains 
can bind specifically to peptides lacking the PxxP consensus sequence (Ghose et 
al., 2001; Kami et al., 2002). 
The domain architecture of the SH domain adaptors leads to the obvious 
hypothesis that they couple extracellular signals from tyrosine phosphorylation of 
receptor molecules via SH2 domains with downstream effectors through SH3 
domains. One prominent example of such a mechanism is the Ras signaling 
pathway (Lowenstein et al., 1992). The Grb2 adaptor couples extracellular 
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signaling in the form phosphotyrosine residues in activated epidermal growth 
factor (EGF) receptors via its SH2 domain, to the Ras guanine nucleotide 
exchange factor  (GEF) SOS with its SH3 domain, leading to the activation of the 
mitogenic Ras/MAP kinase pathway. Unsurprisingly, signaling mediated by NCK 
proteins also follows a similar mechanism of action (Verma et al., 2006; Ruusala 
et al., 2008). 
 
1.6 NCK adaptor proteins 
NCK is a two-member family of adaptor proteins that contain homologs in 
the chimpanzee, dog, cow, mouse, rat, frog, fruit fly and mosquito. NCK was first 
discovered during the screening of a human melanoma cDNA library, apparently 
due to its cross reactivity towards the monoclonal antibody probe against the 
melanoma-associated membrane protein MUC18 (Lehmann et al., 1990). A 
partial sequence of a mouse NCK homologue with below 70% sequence identity 
named Grb4, was subsequently isolated with a modified CORT (cloning of 
receptor targets) methodology using tyrosine-phosphorylated EGF receptor as a 
probe (Margolis et al., 1992). A subsequent study identified Grb4 as a NCK" 
(NCK1) homolog – thereafter renamed as NCK! (NCK2) – that shares 68% 
amino acid identity, while the orthologous human and mouse genes show 96% 
identity to each other (Chen et al., 1998) (Fig 1.3). Northern blot analysis also 
demonstrated that NCK was ubiquitously expressed across most tissues, including 
the brain, heart, kidney, liver, lung, pancreas, placenta, skeletal muscle, spleen, 
and testis. A simple western blot screen of lysates from commonly used cell lines 
also demonstrates the ubiquitous expression of NCK proteins (Fig 1.4). 
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Structural studies have shown that although the individual SH3 domains 
adopt a canonical !-barrel conformation, containing five antiparallel strands 
separated by three loop regions and one 310-helical turn amongst SH3 domains, 
they exhibit distinctive dynamic properties and differential ligand preferences (Liu 
et al., 2006b; Hake et al., 2008; Santiveri et al., 2009). In particular, the N-
terminal SH3 domain (SH3-1) of NCK1 was found to preferentially bind the non-
canonical PxxPxxDY motif through the canonical SH3 binding pocket with 
similar orientation as class II ligands (Santiveri et al., 2009). It was also found that 
that the NCK SH2 domain had less than 40% sequence identity with other known 
SH2 domains (Campbell and Jackson, 2003), while the C-terminal tail of NCK2-
SH2 adopts a unique short anti-parallel !-sheet conformation that controls the 
structure and solubility of the domain (Ran and Song, 2005). Also of interest is 
the fact that even though the SH2 domains of both NCK isoforms are around 80% 
identical (Fig 1.3; Frese et al., 2006), the existing literature is replete with data 
that suggests that they interact with distinct targets (Nishimura et al., 1993; Chen 
et al., 2000; Cowan and Henkemeyer, 2003).  
However, an elegant study using sequentially mutated, high affinity 
phosphopeptides established that the optimal target sequences for NCK1 and 
NCK2 are largely identical, both containing a core pY(D/E)xV consensus motif 
(Frese et al., 2006). The authors then suggested that the observed binding 
differences could result from sterical modulation by the SH3 domains and the 
much more divergent inter-domain linker sequences connecting individual 
domains, as well as unique post-translational modifications of the SH2 domain. 





Fig. 1.3. NCK homologous and orthologous alignments. (a) ClustalW 
alignment of human NCK1 and NCK2 peptide sequences (encoded by separate 
genes on chromosomes 3 and 3 respectively) reveal a 68% sequence identity, with 
most of the conserved residues found within the SH3 (indicated by the blue lines) 
and SH2 domains (red lines). (b) Alignment of NCK1 sequences from human, 
mouse, Xenopus laevi and Drosophila melanogaster reveal a high-degree of 




Fig. 1.4. Western blot screen of endogenous protein expression in common 
cell lines. A panel of common cell lines were lyzed and separated in 10% SDS-
PAGE gels before being transferred onto PVDF membranes and blotted with the 
corresponding antibodies. 40ug of total protein was loaded in each lane.  
 
 
1.6.1 NCK interacting partners 
NCK adaptors’ molecular architecture makes them suitable candidates for 
conducting extracellular signals through receptor tyrosine kinases (RTKs) to 
downstream effector molecules containing SH3-binding motifs. Indeed, NCK was 
found to interact with cell surface receptors like EGF and PDGF receptors via its 
SH2 domain, leading to phosphorylation of tyrosine and serine residues in NCK 
and oncogenic transformation (Li et al., 1992; Meisenhelder and Hunter, 1992). 
Yeast two-hybrid studies also found that NCK interacts with VEGF receptors in 
endothelial cells and EphB1 receptors in neuronal cells (Igarashi et al., 1998; 
Stein et al., 1998), while the latter study also showed that NCK is required for 
ligand mediated activation of c-Jun kinase and cell attachment to fibronectin. 
Ligand activation of EphB1 and EphB2 receptors also led to the formation of a 
complex between NCK, NCK-interacting kinase (NIK) and p62dok (a member of 
the insulin receptor substrate-1 family of proteins) (Becker et al., 2000). NCK 
most probably couples NIK via SH3-binding to the tyrosine-phosphorylated 
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p62dok, which can then drive the plasma membrane localisation of NCK and 
downstream partners like NIK via its phospholipid-binding PH domain. 
The literature indicates that NCK SH3 domains bind to a great multitude 
of proteins (Buday et al., 2002), including the only tyrosine kinase known to 
interact with Cdc42 – ACK1 (Teo et al., 2001) – and several members of the two 
mammalian homologous families of the yeast Ste20 serine/threonine kinases – 
namely the germinal center kinase (GCK) and p21-activated kinase (PAK) 
families. Intriguingly, NCK SH3 domains have also been implicated in 
constitutive binding of membrane bound receptors like EGF receptors and DCC 
(deleted in colorectal cancer), independent of ligand activation (Li et al., 2002b; 
Hake et al., 2008). The GCK family consists of an N-terminal kinase domain and 
a regulatory region in the C-terminus and can be further subdivided into two broad 
groups based on their structural and functional properties. Group I GCKs include 
GCK, and NCK-binding proteins like hematopoietic progenitor kinase-1 (HPK1), 
NIK, and Traf2-interacting kinase and NIK (TNIK), and selectively activate the 
JNK signaling pathways. Group II GCKs include proteins like the kinase 
responsive to stress (Krs) and lymphocyte-oriented kinase (LOK), however they 
are still poorly characterised and do not activate any of the known MAP kinase 
pathways (reviewed by Kyriakis, 1999). 
PAKs are involved in many critical biological processes, including cell 
migration (Sells et al., 1999), microtubule and actin cytoskeleton reorganization 
(Wittmann et al., 2003), focal adhesions turnover (Manser et al., 1997; Chan et al., 
2008), and cell cycle progression (Faure et al., 1999). The PAK family is also 
subdivided into the Group 1 conventional (PAK1, 2 and 3) and Group 2 
unconventional (PAK4, 5 and 6) PAKs. The N-terminal region contains three 
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well-conserved proline-rich motifs, with the first selectively binding the middle 
SH3 domain (SH3-2) of NCK (Bokoch et al., 1996; Galisteo et al., 1996; Zhao et 
al., 2000a), the second interacts with Grb2 (Puto et al., 2003), and the third binds 
the Rho GEF PIX (Manser et al., 1998; Obermeier et al., 1998). All PAK 
members also contain well-conserved Rho GTPase-binding Cdc42/Rac-interactive 
binding/p21-binding domains (CRIB/PBD) in the N-terminus and C-terminal 
kinase domains. The unconventional PAKs differ from their conventional PAK 
brethren by not binding the Rac GEF !PIX despite the presence of several 
proline-rich motifs and do not get activated by Rho GTPase-binding (Bokoch, 
2003). In accordance with PAK1 convention, the CRIB domain is defined by the 
75-90 amino acid residues, while the more inclusive PBD lies between residues 67 
to 113. Adjacent to the PBD is the kinase inhibitory domain (KID) (residues 83-
149), which physically occludes access to the catalytic binding pocket in trans and 
leads to the formation of an inhibitory dimeric conformation with the aid of a 
dimerisation segment 81-87 (Lei et al., 2000). The regulatory mechanisms of the 
non-conventional PAKs are however not as well studied, and the presence of the 
KID has not been formally recognized. The conventional PAKs are activated upon 
translocation to membranes, whereby binding of prenylated-Rac1 or Cdc42 results 
in the disassociation of the KID and the transition to an “open” and active 
conformation, leading to cytoskeletal reorganization as indicated by enhanced 
lamellipodial protrusion and increased motility (Hing et al., 1999; Sells al el., 
1999).  
 
1.6.2 Modulation of the actin cytoskeleton 
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Actin polymerization is the critical driving force behind many cellular 
morphogenic processes and is highly regulated by extracellular signals. For 
example during wound healing, PDGF-bb is one of the critical growth factors that 
regulate processes like fibroblastic proliferation and migration, chemotaxis of 
neutrophil and macrophage to the wound area, new tissue formation and wound 
closure (Barrientos et al., 2008). Some early studies indicated that PDGF-bb-
induced membrane ruffling and lamellipodial formation in Swiss 3T3 fibroblasts 
were mediated by phosphatidylinositol 3-kinase (PI3K) mediated Rac-activation 
(Ridley and Hall, 1992; Nobes et al., 1995). 
NCK1 was found to be needed for the formation of PDGF-b stimulation 
induced membrane ruffles and stress fiber disassembly (Rivera et al., 2006; 
Ruusala et al., 2008). Interestingly, NCK was shown to regulate downstream PAK 
activity to modulate axon guidance (Hing et al., 1999). Constitutively active Rac1 
and Cdc42 mutants were found to colocalise with PAK1 at focal complexes, while 
overexpression of constitutively active PAK1 also resulted in the dramatic losses 
of focal adhesions and stress fibers as seen with activated Cdc42 and Rac1 
(Manser et al., 1997). PAK1 also induced large, polarized lamellipodia and 
increased motility in NIH3T3 cells that cannot be inhibited by expression of 
dominant-negative Rac1 (Sells et al., 1999). Hence, NCK is intimately linked to 
PAK activity downstream of Cdc42/Rac1 signaling networks that impinge on 
actin cytoskeletal dynamics. 
 NCK can also exert a more direct effect by regulating the activity of an 
important actin nucleator – the actin-related protein-2/3 (Arp2/3) complex. The 
intact complex was first isolated from Acanthamoeba due to its interaction with 
profilin (Machesky et al., 1994), and data soon emerged that demonstrated the 
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ability of the Arp2/3 complex to bind to the sides and pointed ends of actin 
filaments in order to mediate actin nucleation in vitro (Mullins et al., 1998; 
Amann et al., 2001). A key upstream regulator of Arp2/3-mediated actin 
nucleation is the WASP family of proteins, which includes WASP, N-WASP and 
the three SCAR/WAVE isoforms (Yarar et al. 1999; Rohatgi et al. 1999; 
Machesky et al. 1999 respectively). Both WASP and N-WASP contain several 
modular domains, including an N-terminal EVH1 (Ena/VASP homology) domain, 
a basic region that binds phosphatidylinositol-(4,5)-bisphosphate (PIP2), a CRIB-
like domain that binds Cdc42, a WH2 motif that interacts with monomeric G-
actin, a proline-rich motif that binds to SH3 domain-containing proteins and a C-
terminal acidic (A) motif that binds to Arp2/3 (Goley and Welch, 2006). The 
WAVE proteins however do not contain the CRIB domain and hence are not 
activated by Cdc42.  
The exact mechanism of WAVE complex activation however, is highly 
contentious. It was first shown that WAVE proteins exist as an inactive 
pentameric complex with PIR121 (p53-inducible mRNA), NAP125 (NCK-
associated protein), ABI (Abl-interactor), and HSPC300 (haematopoietic stem-
cell progenitor) in the bovine brain (Eden et al., 2002). Activation occurs via Rac-
GTP and NCK induced dissociation of the complex, leading to actin nucleation 
mediated by the active WAVE1–HSPC300 subcomplex. Another study however 
discovered that recombinant WAVE complexes were constitutively active and 
Rac merely serves to localize the complex to the leading edge (Innocenti et al., 
2004). More recent data further suggests that the WAVE complex is natively 
autoinhibited and require coincident signals from Rac-GTP and acidic 
phospholipids to induce allosteric changes that lead to activation of the complex 
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without dissociation (Ismail et al., 2009; Lebensohn and Kirschner, 2009). N-
WASP mediates cortical actin rearrangement in a PIP2 dependent manner 
downstream of activated EGF receptors (Miki et al., 1995), indicating that N-
WASP exists in an autoinhibitory conformation that is relieved by interactions in 
the N-terminus. Indeed, antibody induced clustering of membrane-targeted NCK 
SH3 domains was shown to be sufficient to recruit N-WASP and induce the 
formation of actin comets in living cells (Rivera et al., 2004), while NCK and PIP2 
were found to synergistically activate actin polymerization through the N-WASP-
Arp2/3 pathway (Rohatgi et al., 2001; Rivera et al., 2009). Curiously, while 
individual NCK SH3 domains only bind N-WASP weakly; and the middle and C-
terminal SH3 (SH3-3) domains mediate strong binding in isolation; all three SH3 
domains are needed for strong binding and full activation of the actin nucleating 
activity of N-WASP (Rohatgi et al., 2001). This suggests that multiple 
interactions with NCK SH3 domains are needed to relieve the autoinhibitory 
conformation of N-WASP for full activation. 
Such studies provide further support to the hypothesis that the NCK 
adaptors represent an important link between tyrosine phosphorylation and 
downstream modulators of cytoskeletal dynamics. One study found that the 
vaccinia viral membrane protein A36R activates Src, leading to phosphorylation 
of A36R tyrosine-112 residue and the recruitment of the NCK-WASP-Arp2/3 
complex, via the SH2 domain of NCK, to drive actin polymerization and viral 
motility (Frischknecht et al., 1999). Likewise, clustering of NCK by a 
phosphopeptide from Tir, an enteropathogenic E. coli effector protein, triggered 
actin tail formation in Xenopus egg extracts (Gruenheid et al., 2001; Campellone 
et al., 2004). In activated T lymphocytes, NCK also mediates the assembly of a 
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phosphotyrosine-dependent protein complex containing WASP, SLP-76 and SLP-
76-associated protein (SLAP), linking signaling from T cell receptors to actin 
cytoskeletal remodeling (Krause et al., 2000). Integrin-linked signaling at focal 
adhesions may exploit a similar mechanism of action. 
 
1.6.3 Regulation of focal adhesions 
Focal adhesions were initially discovered as electron dense plaques found 
at the end of cytoskeletal bundles in cultured fibroblasts (Abercrombie et al., 
1971). They are now well established as macromolecular protein and 
phosphoinositide complexes on the inner leaflet of the plasma membrane that 
enable cellular attachment to the substratum by connecting the actin cytoskeleton 
to the extracellular matrix (ECM) via heterodimeric transmembrane receptor 
proteins known as the integrins (Burridge and Chrzanowska-Wodnicka, 1996). 
Adhesion to the ECM is not only necessary for survival and proliferation of cells, 
but also affects cell morphology and motility as well. To date, protein complexes 
that mediate ECM attachment are known to contain more than 150 distinct 
components (Zaidel-Bar et al., 2007). There is also a growing appreciation of 
functional differences between adhesive structures observed by cell biologists 
with modern microscopic equipment and image analysis software. From the 
punctate focal complexes found at the leading edge of protrusive cells to stress-
fiber-associated focal contacts, which can further 'mature' to form fibronectin-
bound fibrillar adhesions, the adhesion machinery represents another fascinatingly 
complex structure within the cell (Zamir et al., 2001; Zaidel-Bar et al., 2004). 
The formation of adhesion structures is initiated by the clustering of 
integrins by the ECM at protrusive regions of the cell such as the lamellipodia, 
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which induces conformational changes in integrins that lead to the recruitment of 
other focal adhesions components and the eventual formation of focal complexes 
(Burridge and Chrzanowska-Wodnicka, 1996). Rac and Cdc42 mediates the 
formation of punctate adhesions containing a low density of integrins at the 
leading edge known as focal complexes, which then mature into the larger focal 
adhesions that contain higher densities of integrins via the up-regulation of Rho 
activity (Nobes and Hall, 1995; Rottner et al., 1999). NCK has been linked with a 
number of focal adhesions components including p130Cas, FAK, PAK, PINCH 
and GIT (Bokoch et al., 1996; Tu et al., 1998; Goicoechea et al., 2002; Okabe et 
al., 2002; Brown et al., 2005).  Given that NCK has been reported to localize to 
adhesion in HEK293 cells (Goicoechea et al., 2002), it is of interest to understand 
how it might be recruited since this interaction is likely to be a critical regulator of 
local cytoskeletal organization. 
Focal adhesions not only provide mechanical traction for cell motility, 
they can also act as mechanosensors that allow the cell to perceive the 
extracellular environment and modulate cytoskeletal dynamics in response 
accordingly (Beningo et al., 2001; Galbraith et al., 2002; Pasapera et al., 2010). 
Both intrinsic and extrinsic mechanical forces mediate the maturation focal 
contacts into larger focal adhesions through the RhoA-ROK signaling pathway 
(Riveline et al., 2001; Geiger and Bershadsky, 2001). Chemical inhibition of MLC 
phosphorylation and expression of dominant-negative myosin mutants not only 
reduced cell contractility, but also suppressed the formation of focal adhesions 
(Volberg et al., 1994; Wei and Adelstein, 2000). The local application of external 
forces by micropipettes and laser tweezers also led to the enlargement of focal 
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contacts and further recruitment of adhesion components (Choquet et al., 1997; 
Riveline et al., 2001). 
Integrin activation and focal complex formation also requires actin 
cytoskeletal dynamics modulated by functional Rho GTPases (Hotchin and Hall, 
1995, Clark et al., 1998). Actin polymerization at lamellipodia and membrane 
ruffles enhances integrin clustering, and consequently increases formation and 
maturation of focal complexs (Machesky and Hall, 1997). Actin nucleating 
proteins like mDia (Butler et al., 2006) and N-WASP (Sturge et al., 2002) have 
been shown to interact with integrin-containing adhesion complexes, while the 
Arp2/3 complex is recruited to focal complexes by the focal adhesions adaptor 
protein vinculin (DeMali et al., 2002). The adhesion targeting of such proteins 
probably accounts for the enhanced actin polymerization and concomitant focal 
adhesions enlargement observed (Geiger and Bershadsky, 2001). Therefore, 
cytoskeletal filament and adhesion structure turnover are closely linked in the cell, 
with both processes constantly influencing the spatiotemporal dynamics of the 
other. 
The assembly and disassembly of adhesion structures are highly regulated 
processes that exert profound consequences for adhesion-dependent cellular 
functions like cell spreading and motility (Ridley et al., 2003). But there is still 
much to be discovered with regards to how the convergence of multiple signaling 
pathways affects adhesion function. While elevated RhoA activity results in 
enlarged focal contacts, integrin adhesion to fibronectin can also negatively 
regulate RhoA-mediated actomyosin contractility via Arg kinase activation of 
p190RhoGAP (Peacock et al., 2007). Conversely, the Rho-ROCK pathway 
mediated actomyosin contractility is also required for the detachment of integrin 
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clusters at the rear of migrating leukocytes (Alblas et al., 2001; Worthylake et al., 
2001). Tyrosine phosphorylation of focal adhesions components is critical for the 
regulation of adhesion turnover. It has been demonstrated that the recruitment of 
adhesion-associated proteins like vinculin, paxillin and focal adhesions kinase 
(FAK) precedes phosphotyrosine enhancement and focal contact enlargement 
(Kirchner et al., 2003), while FAK and Src family kinase (SFK) activity is 
required for proper integrin activation and adhesion turnover required for efficient 
cell migration (Illic et al., 1995; Li et al., 2002a). Interestingly, it has been shown 
that beyond its kinase activity, FAK may also function partially as a scaffold for 
recruiting SFKs to mediate the tyrosine phosphorylation of adhesion components 
like paxillin (Schaller et al., 1999). FAK localizes to focal contacts in conjunction 
with dynamin, leading to adhesion disassembly as a result of microtubule 
targeting (Ezratty et al., 2005). It has been suggested that peripheral focal 
complexes stabilize the lamellipodium by mediating attachment to the ECM and 
provide the traction needed for cell motility, while the large integrin clusters that 
characterize focal adhesions play a passive anchoring role that is dependent on 
strong adhesion to the substratum. This is consistent with data that indicates that 
focal complexes transmit much stronger propulsive forces than mature focal 
adhesions (Beningo et al., 2001), while large stress fibers and focal adhesions are 
often refractory to cells migration (Cox et al., 2001). It is plausible that such 
functional disparities are resultant from the dynamic macromolecular complexes 
localized at such structures. Hence, a better understanding of the spatiotemporal 
regulation of certain key molecules is critical. 
One of the earliest adhesion components to be recruited into nascent 
adhesion structures is paxillin (Laukaitis et al., 2001; Kirchner et al., 2003), which 
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functions as a critical adaptor protein that coordinates multiple structural and 
signaling molecules that regulate actin cytoskeletal and adhesion dynamics (Fig 
1.5). The N-terminus of paxillin contains five leucine- and aspartate-rich motifs 
(named LD domains) that were originally identified during a search for vinculin 
and FAK binding sites (Brown et al., 1996), as well as a proline-rich region that 
binds Src kinase (Weng et al., 1993). The C-terminus of paxillin contains four 
double-zinc-finger motifs, named as LIM (Lin11, Isl-1, Mec-3) domains, which 
mediate protein-protein interactions. For example, the 2nd and 3rd LIM domains 
are essential for focal adhesions targeting of paxillin (Brown et al., 1996),  
 
 
Fig. 1.5. Domain architecture of paxillin and known interacting partners. The 
The N-terminus contains five LD domains that mediates interactions with multiple 
proteins like vinculin (LD1 and 2), FAK (LD2 and 4), GIT (LD4) as well as a 
proline-rich motif (PR motif) that binds Src kinase. The C-terminus of paxillin 
contains four LIM domains, which mediate interactions with the negative 
regulator of phosphotyrosine signaling PTP-PEST (LIM3 and 4), as well as the 
focal adhesion complex (LIM2 and 3), although the identity of the interacting 
partner remains elusive. Paxillin also contains multiple tyrosine, serine and 
threonine phosphorylation sites targeted by kinases like PAK (S274), FAK (Y31 
and Y118) and ERK (S83).  
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although the identity of the interacting partner remains elusive. The 3rd and 4th 
LIM domains also interact directly with PTP-PEST, which mediates inhibition of 
cell migration through dephosphorylation of focal adhesions components and 
adhesion induced Rac activation (Jamieson et al., 2005). Paxillin also contains 
multiple tyrosine, serine and threonine phosphorylation sites that are targeted by 
kinases like PAK (Nayal et al., 2006), FAK (Thomas et al., 1999) and 
extracellular-signal-regulated kinase (ERK) (Ishibe et al., 2003) in response to 
extracellular matrix (ECM) adhesion and growth factor stimulation (Burridge et 
al., 1992; Ishibe et al., 2003; Ishibe et al., 2004). 
Another particularly interesting component of focal adhesions that are 
known to associate with paxillin are the GIT proteins – GIT1 and GIT2, which 
were identified independently by yeast two-hybrid screens using GRK5 as bait 
(Premont et al., 1998) and immunoprecipitation experiments with the paxillin 
LD4 domain (Turner et al., 1999). Both GIT isoforms are ubiquitously expressed 
in most tissues, with the highest levels observed in the testes and the brain; with 
relatively lower expression levels in the liver and spleen (Premont et al., 1998; 
Premont et al., 2000). Both GIT homologs are also highly conserved across 
species, with multiple alignments of the longest isoforms of the murine and rat 
orthologs demonstrating over 90% peptide sequence identity (Fig 1.6 and 1.7). 
While GIT1 is almost exclusively expressed in its full-length form, GIT2 
undergoes extensive tissue-specific alternative splicing that results in the 
expression of potentially 32 different transcripts (Premont et al., 2000).  
Full-length GIT proteins contain a N-terminal Arf-GAP domain 
characterized by a CxxCX16CxxC zinc-finger-like motif; as well as an invariant 
arginine residue that is conserved in many small GTPase GAP proteins as it is 
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needed for forming hydrogen-bonds to the #-phosphate group of GTP (Scheffzek 
et al., 1998). This GAP domain is followed by three ankyrin (ANK) repeats that 
have been found to mediate endosomal localization (Matafora et al., 2001) and 
modulate the autoinhibitory conformation of GIT (Totaro et al., 2007); a Spa2 
homology domain (SHD) that binds PIX and PLC# (Haendeler et al., 2003); a 
coiled-coil domain (CC) that mediates oligomerization (Premont and Vitale, 2001; 
Paris et al., 2003) and a C-terminal paxillin binding domain (PBD) (Turner et al., 
1999; West et al., 2001). The GIT proteins also contain a synaptic localization 
domain (SLD) located between the SHD and the PBD (Zhang et al., 2003) (Fig 
1.8). The SLD also represents the most divergent region between the two GIT 
proteins and potentially constitutes a major determinant of isoform specific 
functions. 
 Although the functional significance of the GIT1-paxillin interaction has 
not been well studied, exogenous expression of GIT1 in fibroblasts was found to 
stimulate focal complex disassembly and cell migration (Zhao et al., 2000b). 
Furthermore, PAG3 (another closely related member of the GIT family) was 
found to inhibit paxillin recruitment to focal contacts in an ARF-GAP-dependent 
manner (Kondo et al., 2000). NCK was found to associate with paxillin-kinase-
linker (PKL)/GIT2 upon fibronectin attachment induced integrin activation and 
SFK phosphorylation (Brown et al., 2005). It has also been suggested that NCK is 
needed for focal adhesions formation in response to serum-stimulation (Ruusala et 
al., 2008). Although direct evidence of such NCK functions at adhesion structures 
remain elusive, it is plausible that the PAK-PIX-PKL complex may recruit NCK 
to adhesion structures in the cell where it can stimulate actin polymerization 
leading to cell protrusion and motility.  
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Fig. 1.6. Alignment of GIT1 orthologs. ClustalW alignment of GIT1 sequences 
from human (Hu), mouse (Mu), rat (Rat) and Xenopus laevi (Xe) reveal a high-
degree of peptide sequence conservation across species. Most of the sequence 
diversity occurs within the synaptic localization domain (SLD): defined by 




Fig. 1.7. Alignment of GIT2 orthologs. ClustalW Alignment of GIT2 sequences 
from human (Hu), mouse (Mu), rat (Rat) and Xenopus laevi (Xe) reveal a high-
degree of peptide sequence conservation across species. Most of the sequence 
diversity occurs within the synaptic localization domain (SLD): defined by 




Fig. 1.8. Domain architecture of GIT and known interacting partners. GIT 
proteins contain a N-terminal Arf-GAP domain; three ankyrin (ANK) repeats that 
have been found to mediate endosomal localization and modulate the 
autoinhibitory conformation of GIT (denoted by dashed arrow); a Spa2 homology 
domain (SHD) that binds PIX and PLCg; a synaptic localization domain (SLD); a 
coiled-coil domain (CC) that mediates oligomerization and a C-terminal paxillin 
binding domain (PBD).  
 
 
1.6.4 Cell migration 
Cell migration is a highly regulated and complex process that underpins 
developmental morphogenesis; controls inflammation and the immune response; 
contributes to tissue repair; and an important driving force behind 
pathophysiological processes like oncogenesis and metastasis, mental retardation, 
atherosclerosis, and arthritis. Complex signaling pathways mediate the 
spatiotemporal regulation and integration of various keystone migratory 
processes, namely cellular polarization; protrusion and adhesion formation in the 
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lamellipodia; and rear retraction. Rho GTPases, together with associated 
downstream effector proteins like PAK, are critical regulators of many of the 
aforementioned cellular processes needed for effective cell migration (Ridley, 
2001b; Ridley et al., 2003).  
As described above, NCK interacts with the N-terminal proline-rich motif 
of PAK1 via SH3-2 (Bokoch et al., 1996, Zhao et al., 2000a). NCK binding of 
activated EGF and PDGF receptors was also shown to recruit PAK1 to the plasma 
membrane, where its kinase activity gets enhanced (Galisteo et al., 1996). 
Crucially, it was found that a myristoylated version of the SH3-2 of NCK could 
drive membrane localisation and activation of PAK1 in the absence of active Rac 
and Cdc42 (Lu et al., 1997). Conversely, overexpression of the N-terminal 
proline-rich sequence of PAK1 can act in a dominant-negative manner to inhibit 
PAK1 mediated cell migration and led to increased stress fiber and focal 
adhesions formation (Kiosses et al., 1999). Interestingly, NCK and PIX binding to 
PAK are both reversibly regulated by kinase autophosphorylation at sites adjacent 
to the SH3 binding motifs (Zhao et al., 2000a; Manabe et al., 2002). Hence, PAK 
autophosphorylation represents a mechanism to regulate its SH3-interactions and 
facilitate its cycling between cytosolic and focal adhesions complexes. 
The downstream effects of PAK phosphorylation are likely to be regulated 
by SH3-containing binding partners that control its subcellular localization. Under 
resting conditions, PAK demonstrates a uniform cytoplasmic distribution. 
However upon growth factor stimulation, PAK gets redistributed to lamellipodial 
edges and membrane ruffles (Dharmawardhane et al., 1997). Activated PAK also 
demonstrated enhanced localization to the leading edge and focal complexes of 
migrating fibroblasts (Sells et al., 2000). Due to the lack of a focal adhesion-
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targeting domain, PAK localization to the lamellipodia and focal adhesions is 
probably mediated by binding partners like PIX (Manser et al., 1998) and NCK 
(Bokoch et al., 1996; Zhao et al., 2000a). The multidomain, Arf-GAP containing 
GIT proteins are of particular interest, due to their aforementioned ability to 
interact directly with the focal adhesions scaffold protein paxillin through its LD4 
motif (Turner et al., 1999; West et al., 2001).  Hence, GIT proteins may mediate 
the spatiotemporal regulation of PAK activity by targeting PAK to paxillin-
containing adhesions. 
Considering its domain architecture and interacting partners, GIT proteins 
may function as regulators of cytoskeletal dynamics during cell spreading and 
migration. Indeed, it was found that GIT protein complexes translocate from the 
cytoplasm and trailing focal adhesions to focal complexes at the leading edge of 
the cell (Manabe et al., 2002). GIT also undergoes SFK dependent 
phosphorylation during cell spreading and stimulation by agonists such as 
angiotensin II, EGF and thrombin (Bagrodia et al., 1999; Haendeler et al., 2003; 
van Nieuw Amerongen et al., 2004). While tyrosine phosphorylation is needed for 
GIT2 recruitment to focal complexes, GIT1 does not appear to have such a 
requirement (Brown et al., 2005).  
GIT proteins also play a critical role regulating directional cell migration. 
Disruption of the GIT-paxillin interaction led to aberrant cell spreading, 
lamellipodial protrusion and inhibition of directional motility, possibly resultant 
from dysregulated Rac1 activity (Turner et al., 1999; West et al., 2001). It has 
been suggested that PKA-mediated phosphorylation of "4-integrin spatially 
excludes paxillin from the leading edge of migrating cells, while enforced 
targeting of paxillin to "4-integrin at the leading edge inhibited lamellipodial 
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protrusion and cell migration (Goldfinger et al., 2003). It was then postulated that 
paxillin recruits GIT1, leading to a repression of Rac-mediated lamellipodial 
protrusion by locally inactivating Arf6 (Nishiya et al., 2005). However, such 
findings are at odds with studies that suggest that GIT mediates the spatial 
restriction of !PIX and the downstream activation of Rac to sites of cell 
protrusion. Firstly, it was observed that disruption of the synaptic localization of 
GIT1 and !PIX by a dominant-negative mutant (GIT1-SLD) led to increased 
dendritic protrusions and a significant decrease in the number of synapses and 
normal mushroom-shaped spines (Zhang et al., 2003). Critically, constitutively 
active Rac shows a phenotype similar to the GIT1 mutant, whereas dominant-
negative Rac inhibits the dendritic protrusion formation induced by mislocalized 
GIT1. It was also demonstrated that GIT1 mediates the translocation PIX-PAK 
complexes to focal complexes at the leading edge where they induce cell 
protrusion and enhance cell migration (Manabe et al., 2002). It is possible that the 
disparity observed could be due to cell-specific effects. 
Since PAK binds stably to !PIX with its third proline-rich motif (Manser 
et al., 1998; Obermeier et al., 1998), GIT1 can drive the focal adhesions targeting 
of PAK through an indirect interaction with PIX. Indeed, it was shown that 
expression of activated Rac/Cdc42 induced conformational changes in PAK that 
led to PIX binding and association with GIT-PIX oligomers that redistributed 
from the cytoplasm to focal adhesions (Brown et al., 2002). The translocation of 
the PAK-PIX-GIT complex is controlled by the GIT-paxillin interaction as 
deletion of the GIT-PBD or paxillin-LD4 abrogated the observed adhesion 
targeting. GIT1 was also observed to target active PAK to focal complexes at the 
leading edge in a Rac-dependent manner, leading to enhanced protrusion and cell 
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migration (Manabe et al., 2002). This is consistent with data that indicates that 
suggests that the GIT-PBD is normally not available for binding to paxillin and 
that association of PAK with GIT-PIX oligomers is needed for efficient paxillin 
binding and focal adhesions targeting (Zhao et al., 2000b; Matafora et al., 2001; 
Brown et al., 2002; Manabe et al., 2002). Clustering of PAK by GIT-PIX 
oligomers was also found to enhance PAK localization to focal adhesions, leading 
p21-independent autophosphorylation and activation (Loo et al., 2004). Finally it 
was demonstrated that PDGF stimulation induced the association of "PIX with 
PI-3K and NCK, leading to downstream GTP-loading of Cdc42 and Rac and 
PAK1 activation (Yoshii et al., 1999), while genetic ablation of NCK resulted in 
impaired chemotaxis stimulated by PDGF-b (Rivera et al., 2006; Ruusala et al., 
2008). Hence, NCK is intimately linked with Rho GTPase signaling events 
downstream of RTK stimulation and could potentially exert profound effects on 
cell migration by coordinating the activities of focal adhesions localized proteins 
like PAK, PIX and GIT. 
 
1.6.5. Slit-diaphragm development and glomerular function 
Podocytes are cells that wrap around the external wall of glomerular 
capillaries of the Bowman’s capsule by the extension of interdigitating processes 
known as foot projections, the formation of which have been shown to be 
dependent on NCK function downstream of tyrosine phosphorylation (Jones et al., 
2006; Verma et al., 2006). The interdigitation of the foot projections produces 
40nm wide slits that contain porous filters known as slit-diaphragms, which 
comprises of the extracellular domains of transmembrane proteins like nephrin 
and podocin (Ruotsalainen et al., 1999; Miner, 2002). Slit-diaphragm defects that 
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arise from the retraction of the foot processes, known as effacement, lead to 
proteinuria disorders in which plasma proteins aberrantly leak into the urine 
(Tryggvason, 1999).  
Beyond being an essential structural component of slit-diaphragms – loss 
of nephrin has been associated with Finnish nephrotic syndrome (Kestila et al., 
1998) – nephrin contains several conserved, cytoplasmic tyrosine residues that are 
phosphorylated in vivo by the SFK Fyn (Simons et al., 2001; Lahdenpera et al., 
2003; Verma et al., 2003). Two groups have independently identified the major 
SFK phosphorylation sites on the human nephrin cytoplasmic domain and showed 
that three of these sites, Y1176DEV, Y1193DEV, and Y1217DQV, interact with 
NCK (Jones et al., 2006; Verma et al., 2006). It was also observed that deletion of 
NCK in podocytes abrogated foot-process formation, while nephrin receptor 
clustering induced SFK-dependent tyrosine phosphorylation of the cytosolic 
domain leading to association of NCK and N-WASP, as well as downstream actin 
polymerization (Jones et al., 2006). Interestingly, the data also indicates that 
nephrin only interacts with NCK during slit-diaphragm formation and for 
recovery from foot-process effacement, when rapid cytoskeletal reorganization is 
required. It was demonstrated that NCK-binding sites in nephrin undergoes 
transient phosphorylation in developing glomeruli and a protamine sulfate–
induced podocyte injury model, with the phosphorylation attenuated in mature 
glomeruli at rest (Verma et al., 2006). Thus, it is possible that once the 
cytoskeletal reorganization needed for foot-process morphogenesis is completed 
and stabilized, nephrin’s non-phosphorylation dependent connections with actin, 
through other binding partners like CD2AP (Shih et al., 2001) will become more 
important for foot-process maintenance. Such studies provide further evidence of 
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NCK’s ability to connect phosphotyrosine signaling with downstream modulation 
of the actin cytoskeleton that provides the driving force for cellular 
morphogenesis. 
 
1.6.6 Regulation of axon guidance 
The human brain is made up of an immensely intricate network of 
neurons, with around one trillion neurons forming well over a thousand 
connections each (Tessier-Lavigne and Goodman, 1996). Proper function of the 
nervous system depends on developing neurons sending their axons over long 
distances (sometimes over a thousand times the diameter of the cell body) along 
predetermined pathways to connect with their cellular targets. The growing tip of 
developing axons contain a dynamic structure known as the growth cone, which 
acts as a sensory apparatus for guidance signals in the extracellular environment, 
leading to directed axonal growth towards the appropriate innervation target.  
The growth cone consists of an actin-rich peripheral domain and a central 
domain that contains microtubules, mitochondria, and various other organelles. 
Actin cytoskeletal polymerization and reorganization in the peripheral domain 
provides the driving force behind the filopodial and lamellipodial protrusions, 
adhesion formation, and tension generation needed for growth cone advancement 
(reviewed by Letourneau, 1996). Microtubules in the central domain meanwhile 
provide structural support for the rapid vesicular transport of structural and 
signaling components needed at the advancing edge (Tojima et al., 2007). 
Filopodia dynamics performs important sensory functions at the leading edge of 
growth cones. It was demonstrated that the attachment of a single filopodium to 
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the substratum is able to steer the growth cone toward the point of adhesion 
(Letourneau, 1996), while the detachment of a single filopodium has the opposite 
effect on growth cone motility (Wessells, 1978). Growth cones also exhibit a wide 
range of morphologies as they migrate through their respective developmental 
pathways in response to environmental signals, in order to concomitantly 
modulate both morphology and directionality of advancement (Bovolenta and 
Mason, 1987). At crucial navigational waypoints, known as choice points, growth 
cones display highly complex morphologies with extensive lamellipodium and 
multiple filopodia, which is needed for the integration of environmental cues that 
determines further advancement directionality (Llirbat and Godement, 1999).  
Guidance cues may be stationary, in the case of cell surface ligands like 
the ephrins and ECM proteins like laminin, or diffusible factors like NGF and 
secreted proteins like the netrins, slits and class 2 and 3 semaphorins. Guidance 
cues can also be further categorized into short- or long-range cues, and axonal 
attraction or repulsion cues. For example, the ephrins (Wang and Anderson, 1997; 
Marquardt et al., 2005) and transmembrane semaphorins (Suto et al., 2005) 
mediate short-range/contact repulsion, while secreted semaphorins (Matthes et al., 
1995; Messersmith et al., 1995) and netrins are implicated in long-range 
chemorepulsion (Winberg et al., 1998; von Hilchen et al., 2010). Conversely, cell 
adhesion molecules like the cadherins (Luo et al., 2004; Barnes et al., 2010) and 
ECM components like laminin (Garcia-Alonso et al., 1996) mediate short-
range/contact attraction, while netrins (Serafini et al., 1994; Braisted et al., 2000; 
Li et al., 2008) and some semaphorins (de Castro et al., 1999; Wong et al., 1999) 
can also act as chemoattractants for some neurons. It is important to note the 
bifunctionality of guidance cues such as the semaphorins and netrins, as it is one 
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of the factors responsible for the complexity of the developing nervous system 
development. Such bifunctionality also emphasizes the highly context-dependent 
nature of axonal guidance, as different neurons can exhibit diverse responses to 
the same guidance molecules, depending on the differential expression of receptor 
complexes and the cross talk among signaling cascades modulated by adaptor 
proteins like NCK. 
One of the four major families of guidance molecules is the Eph receptors 
and their ephrin ligands. The Eph receptors belong to the largest subfamily of 
RTKs, and are activated by cell membrane-bound ephrin ligands. Emerging data 
increasingly implicate the ephrin and Eph receptors in the control of cell 
migration in the peripheral nervous system and axon guidance at the growth cones 
in the CNS (reviewed by Flanagan and Vanderhaeghen, 1998). The extracellular 
region of Eph receptors contains a N-terminal ephrin-binding domain, a unique 
cysteine-rich motif and two fibronectin type III motifs, which are implicated in the 
oligomerization of Eph receptors (Lackmann et al. 1998, Wimmer-Kleikamp et al. 
2004). The single transmembrane domain precedes the intracellular region, which 
includes the highly conserved juxtamembrane segment, the tyrosine kinase 
domain, the sterile alpha-motif (SAM) and a postsynaptic density protein/disc 
large/zona occludens (PDZ) binding domain (reviewed Himanen and Nikolov, 
2003).  
The ephrins are small, membrane-bound proteins that contain an 
extracellular Eph-receptor binding domain (Himanen et al., 2001). The ephrin-As 
(ephrin-A1 – ephrin-A6) are glycosyl-phosphatidyl (GPI)-anchored, while the 
ephrinBs are transmembrane protein with a cytoplasmic C-terminal PDZ binding 
motif (reviewed by Vearing and Lackmann, 2005). The crystal structure of 
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purified EphB2 and ephrin-B2 interacting domains demonstrated that two binding 
interfaces mediate the assembly of a heterotetrameric complex (Himanen et al. 
2001). However, higher-order oligomerization may be needed in vivo for effective 
signal transduction. Indeed, a mutagenesis screen of EphA3/Ephrin-A5 
interactions revealed a third binding interface that falls outside the structurally 
characterized interaction domains, and is required for Eph phosphorylation, 
recruitment of downstream signaling proteins and mediating cellular responses 
(Smith et al., 2004). Crucially, time-lapse microscopy has shown that Eph mutants 
defective for ephrin-binding are also recruited efficiently to signaling clusters and 
undergoes trans-phosphorylation by ligand-activated wild-type Eph receptors 
(Wimmer-Kleikamp et al., 2004).  
High-affinity binding usually occurs between ligands and receptors of the 
same subtype (ephrin-A activating EphA, ephrin-B activating EphB), although 
there is increasing evidence for a cross-activation between subclasses (Himanen et 
al., 2004). Interestingly, juxtapositioning of Eph- and ephrin-expressing cells 
mediated assembly of Eph signaling clusters also leads to ephrin oligomerization 
and “reverse signaling” through the membrane-bound ephrins (reviewed by 
Cowan and Henkemeyer, 2002). Studies indicate that both A- and B-subclass 
ephrins localize to lipid rafts in the plasmalemmal membrane, where they 
transduce reverse signals to modulate axonal guidance (Knoll et al., 2001; 
Birgbauer et al., 2001) and cell adhesion (Davy et al., 1999; Cowan and 
Henkemeyer, 2001; Huai and Drescher, 2001) through activation of SFKs (Davy 
et al., 1999; Huai and Drescher, 2001; Palmer et al., 2002). 
There is strong genetic evidence indicating that the Drosophila homolog 
of NCK, Dreadlock (Dock), is required for axonal guidance and proper target 
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innervation of developing photoreceptor cells (R cells) (Garrity et al., 1996). It 
was also discovered that Dock physically interacts with the GCK family member 
Misshapen (Msn) in vitro and in R cell growth cones, and disruption of the Dock-
Msn interaction leads to a severe disruption of R cell axon targeting (Su et al., 
2000). Another study by Zipurksy’s group established that Drosophila Pak 
functions downstream of Dock to regulate R cell axon guidance and targeting 
(Hing et al., 1999). Dock and Pak was shown to physically interact via the SH3-2 
domain of Dock and the N-terminal PxxP motif of Pak as well as colocalise to R 
cell axons and growth cones, while their loss-of-function phenotypes were 
indistinguishable. Furthermore, rescue of the Dock mutant phenotype by Pak 
requires its Dock-binding site, CRIB and kinase domains, while a myristoylated 
Pak construct but not the kinase-dead or the non-membrane-bound but 
constitutively active Pak was able to rescue the Dock loss-of-function phenotype. 
This was consistent with the notion membrane recruitment of Pak is essential for 
proper activation (Manser et al., 1997). Finally, Trio was found to interact 
genetically with Rac, Pak, and Dock, while mutations in the Rac GEF Trio result 
in R cell axon projection defects similar to those observed in both Pak and Dock 
mutants (Newsome et al., 2000). Hence, Dock may act as an upstream coordinator 
of extracellular guidance cues through the Trio-Rac-Pak pathway to modulate 
axon guidance and growth cone motility. 
 The data from the Drosophila studies corroborates with data from some 
recent studies involving mouse knockout models. While mice lacking either 
NCK1 or NCK2 are viable, double knockout mutants perished at embryonic day 
9.5. Hence, a line of mice with NCK1 knockout coupled with conditional NCK2 
deletion in the nervous system was developed (Fawcett et al., 2007). The mutant 
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mice displayed a unique hopping gait due to defects in the spinal central pattern 
generator, which showed synchronized firing of bilateral ventral motor neurons. 
The mice also demonstrated aberrant midline crossing of ventral spinal 
interneurons that exhibited multiple guidance defects and defective development 
of the posterior tract of the anterior commissure. Such defects are reminiscent of 
EphA4-null mice that displayed similar hopping gait and major disruptions to 
corticospinal tract projections (Dottori et al., 1998).  
A recent study demonstrated that genetic ablation of the Rac-specific 
GTPase-activating protein (GAP) "2-chimaerin in mice resulted in the same 
distinct phenotypic traits seen in the EphA4 and NCK-deletion mutants 
(Wegmeyer et al., 2007). It was then suggested that growth cone collapse 
downstream of EphA4 receptor stimulation require the Rac-GAP activity of "2-
chimaerin, which can be regulated by interacting NCK adaptors, However, the 
molecular basis of such regulation is still unclear. 
 Chimaerins are the only known GAPs that bind the lipid second messenger 
diacylglycerol (DAG) and phorbol esters (Caloca et al., 1997), as well as 
demonstrate specific GAP activity towards the small GTPase Rac (Caloca et al., 
2003). There are four isoforms in the chimaerin family, namely "1-, "2-, !1 and 
!2-chimaerin, alternatively spliced from the "- and !-chimaerin genes. All 
isoforms contain the DAG/phorbol ester binding C1 domain and the C-terminal 
GAP domain, while the N-terminal SH2 domain is present only in the "2- and !2-
chimaerin (reviewed by Yang and Kazanietz, 2007). Multiple alignments of "2-
chimaerin peptide sequences revealed a high-degree of conservation across 
multiple species, with much of the sequence divergence occurring within the SH2-
C1 domain linker region (Fig 1.9). Alignment of "2- and !2-chimaerin peptide 
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sequences revealed that the two isoforms are 72% identical, with much of the 
sequence divergence found in the extreme N-terminus and the SH2-C1 domain 
linker region (Fig 1.10). "2-chimaerin is involved in various repulsion guidance 
pathways in the nervous system. For example, "2-chimaerin is implicated in 
ephrin-EphA4 forward signaling critical for proper corticospinal projections 
(Iwasato et al., 2007; Shi et al., 2007; Wegemeyer et al., 2007); and in 
Semaphorin 3A (Sema3A) mediated growth-cone collapse (Brown et al., 2004). 
Missense mutations in the coding region of the CHN1 (chimaerin 1) gene that 
enhanced in vitro chimaerin GAP activity were found to be causative of Duane’s 
retraction syndrome, a congenital eye movement disorder characterized by the 
failure of oculomotor axons to innervate their target extraocular muscles (Miyake 
et al., 2008). It is plausible that the NCK-chimaerin interaction downstream of 
EphA4 autophosphorylation is critical to regulating the Rac-GAP activity of "2-





Fig. 1.9. Alignment of a2-chimaerin orthologs. (a) ClustalW alignment of a2-
chimaerin sequences from human (Hs), mouse (Mu) and zebrafish (Zf) reveal a 
high-degree of peptide sequence conservation across species. Most of the 
sequence diversity occurs within the SH2-C1 domain linker region: defined by 
residues 127-200. Identical and similar residues shaded by black and grey boxes 
respectively. (b) SH2-C1 linker region alignment. Potential tyrosine-






Fig. 1.10. Alignment of a2- and b2-chimaerin. (a) ClustalW alignment of a2- 
and b2-chimaerin human peptide sequences reveal a high-degree of sequence 
conservation between the two isoforms. Most of the sequence divergence is found 
within the extreme N-terminus and SH2-C1 domain linker region: defined by 
residues 127-200. Identical and similar residues shaded by black and grey boxes 
respectively. (b) SH2-C1 linker region alignment. Potential tyrosine-
phosphorylation sites are indicated by red arrowheads. 
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Mammalian pXJ40 based vectors, incorporating a CMV promoter, 
Ampicillin resistance gene with N-terminal FLAG, HA, HAmCherry, GFP and 
GST tags were used. pcDNA3.1 plasmid vector with the Flag-tag-encoding 
sequence integrated at the 3! end in frame with the coding sequence for EphA4 
was also used. GFP-tagged NCK1 SH3-2 and SH3-3 domain point mutants 
(W143K and W229K) constructs; FLAG-tagged wild type and kinase dead PAK1 
constructs; GST-tagged PAK1 kinase inhibitory domain (KID), p21-binding 
domain (PBD) and PIX-interacting domain (PID) constructs; various GFP-tagged 
GIT1 constructs; HA-tagged wild type Rac1 and Q61L/40C mutant constructs 
were obtained from stocks from our laboratory. GST-tagged a2-chimaerin N-
terminal tyrosine to phenylalanine (YF) mutants (Y21F, Y143F, Y148F and 
Y157F); FLAG-tagged a2-chimaerin GAP domain and inactive GAP mutants 
(R304G); wild type and kinase-dead Fyn kinase cloned in pCDNA3.1 plasmids 
were kind gifts from Dr. Christine Hall’s laboratory at the Institute of Neurology, 
University College London, United Kingdom. For bacteria expressed recombinant 
proteins, constructs were cloned into the pGEX4T1 vector. Restriction-digest 
analysis and direct sequencing were used to validate all constructs. 
 
2.1.2 Primer sequences 
The following primers were used for cloning (gene-start position-restriction site-
forward/reverse):  
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Chimaerin1-1-Xho-Forward (F): 5' - CCGCTCGAGATGGCCCTGACCCTGTTTGATAC - 3' 
Chimaerin1-1-HndIII-F: 5' - CCCAAGCTTATGGCCCTGACCCTGTTTGATAC - 3' 
Chimaerin1-43-Xho-F: 5' - 
CCGCTCGAGGTTTGGAAATCTTACTTATATCAGCTACAACAGG - 3' 
Chimaerin1-61-Xho-F: 5' - CCGCTCGAGTATCAGCTACAACAGGAAGCC - 3' 
Chimaerin1-133-Xho-F: 5' - CCGCTCGAGTATTATGGAAGAGAGTTTCATGGC - 3' 
Chimaerin1-138-NotI-Reverse(R):  
5' - ATTTGCGGCCGCTCAATAATACTTTGGTCTGTTTTCCACCTCGC - 3' 
Chimaerin1wt-360-Xho-R:  
5' - CCGCTCGAGTCATGCCTTGGTTTCAATATAGAGAGTAATCAAGCC - 3' 
Chimaerin1-379-Xho-F: 5' - CCGCTCGAGGAAACCAAGGCAGCAGAATACATTGC - 3' 
Chimaerin1-387-NotI-R:  
5' - ATTTGCGGCCGCTCACTTGGTTTCAATATAGAGAGTAATCAAGCC - 3' 
Chimaerin1-411-Xho-R: 5' - CCGCTCGAGTCA CATCTTGGCAATGTATTCTGCTGCC - 3' 
Chimaerin1-435-NotI-R:  
5' - ATTTGCGGCCGCTCAGTGCTCATAAATTGGGTTTATCGTCATCTTGG - 3' 
Chimaerin1-495-NotI-R:  
5' - ATTTGCGGCCGCTCATTTCAGGACTGGCATATGTTTTTTGTATGCTGG - 3' 
Chimaerin1-495-Xho-R: 5' - 
CCGCTCGAGTCAAGAGACACATGATGAGAGAGATTCTACAGG - 3' 
Chimaerin1-496-Xho-F: 5' - CCGCTCGAGGAGACACATGATGAGAGAGATTCTACAGG - 3' 
Chimaerin1-600-NotI-R: 5' - ATTTGCGGCCGCTCATGGAATTTGCTCGTTTTCTTTCAGAG - 
3' 
Chimaerin1-780-NotI-R: 5' - ATTTGCGGCCGCTCA 
CTTCAAGTCTGGCTTACAGTCATTTGG - 3' 
Chimaerin1-834-NotI-R: 5' - ATTTGCGGCCGCTCA GGTATGTGCTTTCACGAGCGTCG - 3' 
Chimaerin1-1380-NotI-R:  




5' - CCGCTCGAGTCATTAAAATAAAATGTCTTCGTTTTTGATAAGCAGCTCCACC - 3' 
EphA4-1-Xho-F: 5' - CCGCTCGAGATGGCTGGGATTTTCTATTTCATCC - 3' 
EphA4-2961-NotI-R: 5' - ATTTGCGGCCGCTCAGACAGGAACCATCCTGCC - 3' 
GIT1-1126-Xho-F: 5' - CCGCTCGAG CTGTCTGCACGGAAC - 3' 
GIT1-1126-Kpn-F: 5' - CGGGGTACCCTGTCTGCACGGAAC - 3' 
GIT1-1258-Xho-F: 5' - CCGCTCGAG ATGGACTCCTCAGATCTGTCG - 3' 
GIT1-1258-Kpn-F: 5' - CGGGGTACC ATGGACTCCTCAGATCTGTCG - 3' 
GIT1-1336-Xho-F: 5' – CCGCTCGAGGAGGCCAAAGTGCAGCAG - 3' 
GIT1-1438-Xho-F: 5' - CCGCTCGAG ATGGACTCCTCAGATCTGTCG - 3' 
GIT1-1636-Xho-F: 5' – CCGCTCGAG ACAGAGCTGGAAGATGATGCC - 3' 
GIT1-1680-NotI-R: 5' – ATTTGCGGCCGCTCAAGCAGGGACATGTACTGAATAGAT - 3' 
GIT1-1740-NotI-R: 5' – ATTTGCGGCCGCTCAGGAGGAGGGAGTGAAGGTCAC - 3' 
GIT1-1740-HndIII-R: 5' – CCCAAGCTTTCAGGAGGAGGGAGTGAAGGTCAC - 3' 
GIT1-1812-NotI-R: 5' – ATTTGCGGCCGCTCACTCTGCGCCACTGCCGTG - 3' 
GIT1-1872-NotI-R: 5' – ATTTGCGGCCGCTCAGAATCGCTTCCCTTCAAGTCC - 3' 
GIT1-1936-Xho-F: 5' – CCGCTCGAG CCCGGGCTCCCCAGC - 3' 
GIT1-2314-Not-R: 5' – ATTTGCGGCCGCTCA CTGTTTCTTCTCTCGGGTGGTG - 3' 
NCK1-1-BamHI-F 5' - CGCGGATCCATGGCAGAAGAAGTGGTGGTA - 3' 
NCK1-181-BamHI-F 5' - CGCGGATCCAGTGCTCGGAAAGCATCTATTGTG - 3' 
NCK1-256-BamHI-F: 5' - CGCGGATCCGTGCCAGATTCTGCATCTCCT - 3' 
NCK1-292-BamHI-F: 5' - CGCGGATCCGTTGACCCAGGGGAACGTCTC - 3' 
NCK1-310-BamHI-F: 5' - CGCGGATCCCTCTATGACCTTAACATGCCTGCTTTTGTG - 3' 
NCK1-328-BamHI-F: 5' - CGCGGATCC CCCGCTTATGTGAAATTTAACTACATGGC  - 3' 
NCK1-331-BamHI-F: 5' - CGCGGATCCGCTTATGTGAAATTTAACTACATGGCTGAG  - 3' 
NCK1-343-BamHI-F: 5' - CGCGGATCCTTAACTACATGGCTGAGAGAGAGG - 3' 
NCK1-495-Xho-R: 5' - CCGCTCGAGGTCACCTTCTTCAGTTACATAGTTTG - 3' 
NCK1-505-BamHI-F: 5' - CGCGGATCCGGTGACCATGTGGGTTCTCTG - 3' 
NCK1-528-Xho-R: 5' - CCGCTCGAGTCATGACAGAGAACCCACATGGTCACC - 3' 
NCK1-562-BamHI-F: 5' - CGCGGATCCACTGGGCAAGTGTTGCATGTG - 3' 
NCK1-564-Xho-R: 5' - CCGCTCGAGTCAAGTATTTAGGTTATTGACGACTGC - 3' 
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NCK1-756-Xho-R: 5' - CCGCTCGAGTCAATTCTGCATAACGGTAACATAGTTTTTTGG - 3' 
NCK1-768-Xho-R: 5' - CCGCTCGAGTCAGGTTAATGGATTGTTTTGCATAATGGTAACG - 
3' 
NCK1-1134-Xho-R: 5' - CCGCTCGAGTCATGATAAATGCTTGACAAGATATAA - 3' 
NCK2-1-BamHI-F: 5' - CGC GGATCCATGACAGAAGAAGTTATTGTGATAGCC - 3' 
NCK2-169-BamHI-F: 5' - CGCGGATCCGAGCGGAAGAACAGCCTG - 3' 
NCK2-340-BamHI-F: 5' - CGCGGATCCATCCCGGCCTTCGTCAAGTTCG - 3' 
NCK2-345-Xho-R: 5' - CCGCTCGAGCGGGATGTTGAGGTCGTAGATG - 3' 
NCK2-496-Xho-F: 5' - CCGCTCGAGTTGGAGGAGGTGGACGAG - 3' 
NCK2-603-Xho-R: 5' - CCGCTCGAGCTGGACCACATGCAGCAC - 3' 
NCK2-757-Xho-F: 5' - CCGCTCGAGGTGGTCCTCAGTGACGGG - 3' 
NCK2-768-Xho-R: 5' - CCGCTCGAGTCAACTGAGGACCACCACGTAGTTTTTGGG - 3' 
NCK2-1144-NotI-R: 5' - ATTGCGGCCGCTCACTGCAGGGCCCTGAC - 3' 
NCK2-1144-Xho-R: 5' - CCGCTCGAGTCACTGCAGGGCCCTGACGAG - 3' 
 
The following primers were used for mutagenesis (gene-mutated residue-
sense/anti-sense):  
a2-chimerin C82G Sense: 5' - CAGCTACAACAGGAAGCCGCTCATCCTCGAAGAATTAC - 3' 
a2-chimerin C82G Anti-sense: 5' - GTAATTCTTCGAGGATGAGCGGCTTCCTGTTGTAGCTG 
- 3' 
a2-chimerin C88G Sense: 5' - CAACAGGAAGCCCCTCATGCTCGAAGAATTACCTGTAC - 3' 
a2-chimerin C88G Anti-sense: 5' - 
GTACAGGTAATTCTTCGAGCATGAGGGGCTTCCTGTTG - 3' 
 
2.1.3 siRNA sequences 
Small interfering RNA (siRNA) targeting human GIT1 transcripts (394-
414 nucleotides) were designed using the Whitehead Institute online siRNA 
selection program (Yuan et al., 2004) and synthesised from Invitrogen. Validation 
of knockdown efficacy was performed through western blot analysis and 
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observation of siRNA and GFP plasmid co-transfected cells using 
immunofluorescence (IF) microscopy. 
 
2.1.4 Antibodies 
Mouse M2 anti-FLAG (Sigma-Aldrich) WB 1:1000, IF 1:200; rabbit anti-
GFP (Invitrogen) WB 1:1000, IF 1:200; mouse anti-GIT1 and GIT2 (NIH 
NeuroMab) WB 1:1000, IF 1:100; rabbit anti-GIT1 (La-raised serum) WB 
1:1000, IF 1:100; mouse anti-GST (Sigma-Aldrich) WB 1:1000, IF 1:200; mouse 
anti- HA (Santa Cruz) WB 1:1000, IF 1:200; rabbit anti-mouse IgG/HRP (Dako) 
WB 1:4000; rabbit anti-NCK1 (Epitomics) WB 1:1000, IF 1:100; Rabbit pan-
PAK (Lab-raised serum) WB 1:500, IF 1:100; mouse anti-Paxillin (ECM 
Biosciences) WB 1:1000, IF 1:200; rabbit anti-Paxillin (Epitomics) WB 1:1000, 
IF 1:200; mouse !PIX (Lab-raised serum) WB 1:500, IF 1:100; mouse anti-
phosphotyrosine (clone 4G10, Millipore) WB 1:1000; mouse anti-Rac1 (Upstate) 
WB 1:2000. Rabbit anti-"2-chimaerin (WB 1:1000, IF 1:100) were kind gifts 
from Dr. Christine Hall’s laboratory at the Institute of Neurology, University 
College London, United Kingdom. 
Rabbit anti-mouse IgG/HRP (Dako) WB 1:4000; Goat anti-rabbit 
IgG/HRP (Dako) WB 1:4000; Alexa Fluor® 488 goat anti–mouse IgG 
(Invitrogen) IF 1:100; Alexa Fluor® 546 goat anti–mouse IgG (Invitrogen) IF 
1:100; Alexa Fluor® 488 goat anti–rabbit IgG (Invitrogen) IF 1:100; Alexa 





2.1.5 General reagents and pharmacological agents 
Blebbistatin (Merck), Bradford protein assay reagent (BioRad), ECL™ 
Western Blotting Detection Reagent (Amersham), GF109203X (Tocris 
Bioscience), Far Red Phalloidin (Alexa Fluor 647, Invitrogen), Immobilon 
Western Detection Reagents (Millipore), Laminin (Sigma), Lipofectamine 
(Invitrogen), Lipofectamine 2000 (Invitrogen), L-glutamine (Invitrogen), non-
essential amino acids (Invitrogen), NGF (Sigma), PMA (Calbiochem), Rhodamine 
Phalloidin (Invitrogen), SuperSignal West Pico Chemiluminescent Substrate 
(Peirce). 
 
2.2 General methods of DNA analysis 
2.2.1 Polymerase chain reaction (PCR) 
A standard 100µl PCR reaction mix comprised of 100ng of DNA template, 
0.1µM of a primer pair, dNTPs (250µM each) and 0.5-1.0U of polymerase – Pfu 
(Fermentas) or PfuUltra (Stratagene). The typical PCR settings involved an initial 
denaturation step at 95°C of 2-15 mins (depending on polymerase used), followed 
by 30 cycles of 30s denaturation at 94°C, 30s annealing at 50-66°C (depending on 
length of primer used) and 0.5-4 min extension at 72°C with a final extension at 
72°C for 1-8 min (depending on size of amplicon). PCR products were then 
analysed by agarose gel electrophoresis as described below. 
 
2.2.2 Restriction digest and agarose gel electrophoresis 
1-2 µg of plasmid DNA were digested with 1-2 units of restriction 
endonuclease in the respective buffers supplied by the manufacturers at 
recommended temperatures for around 2 hours. The resultant DNA fragments 
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were then separated by electrophoresis in agarose gels (0.8-1.5%) containing 
ethidium bromide (0.5mg/ml). Electrophoresis was performed in TAE buffer 
(0.4M Tris–acetate, 0.01M EDTA) at a constant voltage of 100V for 40-80min 
before the DNA fragments were detected by UV illumination. 
 
2.2.3 DNA ligation 
Digested plasmid vectors and PCR products of target gene sequences were 
separated as described above, and subsequently extracted from agarose gels using 
the gel purification kits from Qiagen according to manufacturers protocol. 
Ligation reactions were then performed using around 100ng of purified plasmid 
vector and 400-500ng of purified insert fragments with 100U of T4 DNA ligase 
(NEB) in the recommended ATP containing buffer. Reaction mixtures of 20µl 
were incubated at 16°C overnight or at room temperature for 2-4 hours. 10µl of 
the reaction was typically used to transform bacteria by heat shock. 
 
2.2.4 Preparation of competent cells 
E. Coli strains DH5" and BL21DE3 Codon Plus Gold (BL21) were grown 
at 37°C with the appropriate antibiotics. Single colonies grown on LB-agar were 
inoculated into 10ml LB and grown overnight in a shaking 37°C incubator before 
being inoculated into 100ml LB broth for around 2 hours at 37°C to an optical 
density at 600nm (OD600) of around 0.6. Cells were then recovered by 
centrifugation at 4000G for 10 min at 4°C.  
BL21 cells were then resuspended in 160 ml ice-cold TFBI (30mM KAc, 
100mM RbCl, 10mM CaCl2, 15% glycerol and 50mM MnCl2, pH was set to 5.8 
before addition of MnCl2) After a 15 min incubation on ice, cells were recovered 
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by centrifugation and resuspended in 16 ml of TFBII (10mM MOPS, 75mM 
CaCl2, 10mM RbCl and 15% glycerol, pH 6.5). DH5" cells were resuspended in 
15ml of ice-cold 0.1M CaCl2 (filtered) and left on ice for 40 min, cells were 
recovered by centrifugation and resuspended in 4ml ice-cold 0.1M CaCl2 with 
20% (v/v) glycerol (filtered). Cells were then immediately flash-frozen in liquid 
nitrogen and stored at -80°C for up to a year. 
 
2.2.5 Transformation of DNA constructs 
25µl of DH5" competent cells were mixed with either plasmid DNA or 
ligated DNA reactions and left to incubate on ice for 30 min. The cells were then 
heat-shocked at 42°C for 1.5 min followed by a quick chill on ice for 1 min. The 
cells were then were allowed to recover in 1ml of pre-warmed LB media for 30 
min before being streaked onto LB agar plates supplemented with the appropriate 
antibiotic(s) for selection. 
 
2.2.6 Purification of plasmid DNA  
Plasmid DNA was extracted from DH5" bacterial cultures after log-phase 
growth with the QIAprep columns (QIAGEN) according to the manufacturer’s 
protocol. Briefly, the bacterial cells were recovered by centrifugation and the 
pellets were subjected to alkaline lysis before bacterial protein was removed by 
precipitation and centrifugation. This was followed by surface adsorption of DNA 
onto a column-based silica matrix under high salt conditions. After flushing the 
columns of unbound material, the DNA was then recovered by elution under low 




2.3 Methods for protein analysis  
2.3.1 Polyacrylamide Gel Electrophoresis (PAGE)  
 8-12% acrylamide gels were cast using the Mini-PROTEAN system 
(BioRad) and were used for the separation of protein for in-gel analyses via 
Coomassie/Silver stains or prior to transfer onto polyvinylidene difluoride 
(PVDF) membranes for western blotting as described below. Typically, samples 
were mixed with equal volumes of 2X SDS sample buffer (50mM Tris pH 6.8, 
6% SDS, 100mM DTT, 0.1% bromophenol blue and 50% v/v glycerol) and 
heated at 70°C for 5-10 minutes before loading. Electrophoresis was performed in 
buffer containing 25mM Tris pH 8.0, 192mM Glycine and 0.1% w/v SDS, at a 
constant voltage of 160V for about 1-1.5hrs. 
 
2.3.2 Western blotting  
The PAGE gels were pre-equilibrated in transfer buffer before they were 
assembled with the methanol activated PVDF membranes (Millipore), sandwiched 
by 2 stacks of pre-equilibrated filter paper (Whatman). The transfers were 
performed using the Mini Trans-Blot cells (Bio-Rad) at 100V for 2 hours. The 
membranes were then blocked in 5% non-fat milk before incubation with primary 
antibodies for 2 hours, followed by secondary antibodies conjugated with 
horseradish peroxidase (HRP) for 1 hour. Three 10-minute washes in phosphate-
buffered saline (PBS) with 0.1% Triton X-100 was performed after each antibody 
incubation step. Lastly, fluorescent reactions with HRP-linked secondary 
antibodies (Dako) were stimulated with luminol solutions (various manufacturers) 
and detected by double-coated Hyperfilm photographic film (Amersham).  
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For the phosphotyrosine blots, the membranes were blocked with 3% BSA 
in 0.1% Triton-X100/TBS (0.1M TrisHCl pH 7.4, 0.15M NaCl) before probing 
with 4G10 antibody in 1% BSA. The washes were performed with 0.1% Triton-
X100/TBS. 
 
2.3.3 Preparation of bacterial expressed recombinant proteins 
The bacterial expression vector pGEX4T1 was used to transform BL21 by 
heat-shock and were grown in LB and grown under the appropriate antibiotic 
selection to an OD600 of 0.6-1.0 before induction with 1µ# isopropyl !-D-1-
thiogalactopyranoside (IPTG) for 3-5 hours at room temperature. Cells were then 
recovered by centrifugation at 4000 X g, resuspended in lysozyme containing 
lysis buffer on ice and allowed to equilibrate for 10 minutes. The lysate was then 
sonicated at 4oC in 3 X 20s pulses with 10-second intervals. The lysate was then 
centrifuged at 60,000 x g for 30 minutes at 4°C and the clarified supernatant 
passed through the gluthatione-Sepharose columns (0.4ml of resin pre-
equilibrated with the appropriate lysis buffer) to purify the overexpressed proteins. 
After washing the resin twice with 15ml of the lysis buffers, the recombinant 
GST-tagged proteins were then eluted with lysis buffer supplemented with 10mM 
reduced glutathione. All elution buffers also include 10% glycerol to protect the 
proteins from freeze-thaw damage. 
 
2.3.4 Lysis and wash buffer constitutions  
Bacteria cells expressing GST-tagged recombinant proteins were lyzed in 
25mM Tris pH 8.0, 0.1% Triton X-100, 0.5mM MgCl2 with freshly added 
lysozyme (1mg/ml), DTT (5mM), PMSF (5mM) and 1X Complete protease 
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inhibitor (Roche). The respective wash buffers only differed from the lysis buffers 
by the exclusion of the lysozyme and protease inhibitors. 
 
2.4 Cell culture conditions and techniques 
2.4.1 Culture media constitutions 
HeLa cells were grown in minimal essential medium supplemented with 
10% fetal bovine serum (FBS), 10% NaHCO3 and 20mM L-glutamine. COS-7 
and PC-12 cells were maintained in Dulbeccos modified Eagle medium (DMEM) 
containing 4.5g/L glucose supplemented with 10% FBS. B16F1 cells were grown 
in DMEM containing 4.5g/L glucose, supplemented with 10% FBS and 20mM L-
glutamine. All cells were grown at 37°C in an incubator with 5% CO2 and 99% 
humidity and harvested by trypsinization with 0.025% Trypsin/Versene for 
around 1-3min (depending on specific cell line).  
 
2.4.2 Transient transfection 
When preparing samples for western blot analysis, cells were grown in 
60mm tissue culture dishes to around 60-80% confluency. A working range of 2-8 
µg of plasmid DNA (with a mammalian promoter) was used. The DNA was then 
mixed with Lipofectamine 2000 reagent (Invitrogen) in a 1:3 ratio in serum free 
growth media (for the respective cell lines) and left to incubate for 30mins at 
room temperature. The complexed DNA was then added drop wise to the cells in 
fresh complete media. After 4 hours, the cells were washed with PBS and left 
overnight in fresh complete growth media at 37°C. 
For immunofluorescence staining, HeLa cells were grown on 20 X 20mm 
glass coverslips in 35mm tissue culture dishes to about 70% confluency; B16F1 
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cells were grown directly on 35mm tissue culture dishes to about 60% confluency 
before replating laminin-coated coverslips post-transfection. Up to 1.5 µg of 
plasmid DNA was mixed with Lipofectamine 2000 (Invitrogen) in a 1:3 ratio in 
serum free media and left to incubate for 30mins at room temperature. The 
complexed DNA was subsequently added to the cells in complete growth media 
for 2-4 hours. The cells were then washed with PBS and replaced with fresh 
complete media overnight before they are further processed for staining as 
described later. 
 
2.4.3 siRNA transfection  
Cells were grown to around 30% confluency at the time of transfection. 
20pmol of siRNA were incubated with 5ml of Lipofectamine 2000 (Invitrogen) in 
serum free media for 30 minutes. The complexed siRNA were then added to cells 
in complete media grown in 35mm dishes and left at 37°C for durations of 2 hours 
(HeLa cells) to overnight (B16F1 cells). The media was then replaced with fresh 
complete media for 24-48 hours before the cells were harvested. 
 
2.4.4 Immunoprecipitation 
  Cells were harvested and lysed in cell lysis buffer (25mM Tris pH 7.4, 
0.05M NaCl, 0.1M KCL, 0.2mM EGTA, 1% Nonidet P-40, 1.5mM MgCl2 and 
with freshly added 1mM DTT, 0.5mM PMSF, 1mM Na3VO4 and 1X Complete 
protease inhibitor cocktail (Roche). Crude cell lysates were clarified by a short 5s 
sonication, followed by centrifugation at 14,000 rpm for 5min at 4°C. The 
clarified supernatants were then rolled with either M2-FLAG beads (Sigma) or 
glutathione beads (Genscript) for 2 hours at 4°C. The beads were then washed 
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thrice with 0.1% Triton X-100/PBS and the immunoprecipitates eluted with 2X 
SDS running buffer, with heating at 70°C for 5min, for western analysis. 
 
2.4.5 Subcellular fractionation 
60mm plates of confluent cells were treated with 5µM GF109203X (broad 
spectrum PKC inhibitor) for 30min before treatment with 10µM PMA for 1hr 
prior to lysis. The cells were then rinsed with PBS and scraped in 300µl of 
hypertonic lysis buffer (20mM Tris-HCl, pH 7.5, 5mM EGTA, and 1X Complete 
protease inhibitor mixture, Roche). 30µl of the total cell lysates were removed for 
analysis (labeled as the total fraction) after a short 5s sonication. The rest of the 
lysate then underwent ultracentrifugation at 100,000 x g for 30min at 4°C, and the 
supernatant removed as the soluble fraction. Proteins in the pellet were extracted 
by rolling for 1hr in 2X SDS sample buffer (labeled as Pellet fraction). Protein 
concentration was determined in each fraction using the Bradford protein assay 
reagent, and equal amounts of protein from each fraction were subjected to SDS-
PAGE and transferred to PVDF membranes for western blotting. 
 
2.4.6 Nucleocytoplasmic translocation assay 
 HeLa cells grown on 20 x 20mm coverslips were transfected with various 
NCK1 constructs as described previous in 2.4.2. Around 24 hours post-
tranfection, cells were treated with 10nM Leptomycin B (LMB) for an hour, 
which has been shown to inhibit the function of Crm1, which is essential for NES-
dependent nuclear export of proteins in both yeast and mammalian cells (as 
described previously by Kudo et al., 1999). The treated cells were then fixed for 
Immunofluorescence staining as described in the next section. 
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2.4.7 Immunofluorescence staining 
Cells grown on 20 x 20mm coverslips were fixed in 4% 
paraformaldehyde/100% methanol (pre-chilled at -20oC) for 20min and washed 
with PBS for 10min. They were then permeabilised by 0.2% Triton X-100/PBS 
(PBST) for 20min before being blocked for 10min by 10% FBS in 0.1% PBST. 
Cells were then incubated with primary antibody (2.5-10µg/ml) in 0.1% PBST for 
2 hours at 37°C or overnight at 4°C. After washing twice for 10min with 0.1% 
PBST, cells were incubated with the appropriate fluorescent secondary antibody 
in 0.1% PBST and/or Rhodamine/Far Red Phalloidin when needed, at room 
temperature for 1hr before washing twice in 0.1% PBST. When necessary, cells 
were incubated with nuclear markers DAPI/Hoesch33342 for 10 min and briefly 
washed with 0.1% PBST. The coverslips were then dried and mounted on slides 
for analysis on a Zeiss Axioplan upright fluorescence or Olympus Laser Scanning 
confocal microscope. 
For B16F1 experiments, coverslips were coated with 60µl of 20µg/ml 
laminin for 1hr at room temperature before plating on freshly trypsinized cells. 
The cells were then given 1hr to spread on the coverslips before treatment with 
50mM AlF for 15min and subsequent fixation with parafomaldehyde as described 
above. For pre-permeabilization experiments, cells were permeabilized with 0.1% 
PBST supplemented with 0.1% paraformaldehyde for around 5s before fixation 





2.4.8 Time-lapse fluorescence imaging 
Cells harvested by trypsinisation were plated onto 30mm glass bottom 
dishes and imaged with the Olympus Laser Scanning confocal microscope housed 
in an incubator as 37°C, 5% CO2 and 99% humidity. Typically the images were 
acquired using the Olympus FluoViewTM software with 0.2-1.0% laser energy 
excitation, acquisition intervals of between 5-60s and tracked for 10-60min for 
various experiments. For B16F1 experiments, the glass bottom dishes were coated 
with laminin prior to AlF treatment as described above. 
For cell migration assays, B16F1 cells were tracked using the ‘Track 
Object’ function in the Metamorph image analysis software. The migration speeds 
were calculated from the total distance travelled per hour by individual cells as 
measured by the software.  
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Chapter 3 Targeting of NCK to focal adhesions via GIT1 
3.1 Introduction 
In the Drosophila, Pak1 has been reported to lie downstream of the NCK 
homologue (dreadlocks) in a pathway that promotes proper axonal targeting of 
axons into the optic tectum (Hing et al., 1999). NCK1 interacts with the 
PxxPxRxxS motif in the PAK1 N-terminus (Zhao et al., 2000a), while PIX 
interacts through a central non-canonical SH3 binding sequence (Obermeier et al., 
1998). The PIX-GIT complex cycles between adhesion structures and the leading 
edge of the cell (Zhao et al., 2000b; Manabe et al., 2002). Localization of GIT to 
focal adhesions is mediated by an interaction with the adaptor protein paxillin 
(Turner et al., 1999; West et al., 2001), which is blocked by phosphorylation of 
the paxillin LD4 motif (Dong et al., 2009). Paxillin is among the first proteins to 
localize to peripheral focal complexes that form at protrusive regions of the cell 
(Laukaitis et al., 2001), however it is still unclear which protein(s) are responsible 
for the interaction with the LIM domains.  
It seemed possible that since GIT1 contains a high affinity site for the 
NCK SH2 domain (Frese et al., 2006), the PAK-PIX-GIT complex could promote 
NCK localization to focal adhesions. This would be interesting given the 
established role for NCK in actin reorganization via the WAVE complex (Eden et 
al., 2002) and in the context of the Tir protein mediated formation of F-actin 
pedestals via N-WASP (Campellone et al., 2004).  No studies on the mechanism 
and functional consequences of such targeting have been reported. In this chapter 
I describe the robust, direct interaction of NCK1 with GIT1, and establish that 
surprisingly one of the binding sites occurs in a region between the SH3 domains 
of NCK1. A series of cell based experiments also point to a role for GIT1 in 
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enhancing the adhesion localization and cell migration promoting activities of 
NCK1. 
 
3.2 NCK and GIT1 co-localizes at cell adhesions 
Fluorescence microscopy was first used to determine the cellular 
localization of epitope-tagged NCK and GIT in HeLa cells, which contain well 
organized focal adhesions. GFP-tagged NCK1 and GIT1 appeared to be mainly 
cytoplasmic, with weak labeling of paxillin-labeled focal adhesions when 
expressed in HeLa cells individually (Fig 3.1a) or in combination (Fig 3.1b). This 
matched immunofluorescence staining of endogenous NCK1 and GIT1 with 
adhesions in HeLa cells after fixation with paraformaldehyde (Fig 3.1c). These 
data suggested that NCK1 localization was to some extent dependent on the PAK-
PIX-GIT complex. One of the hallmarks of PAK activity in the cell is the 
stimulation of focal adhesion turnover (Obemeier et al., 1998), which is promoted 
by PAK under certain conditions such as osmotic stress (Chan et al., 2008). 
Therefore, I wanted to investigate how PAK activity might regulate NCK 
localization to focal adhesions and thereby promote local changes in actin 
organization.  HeLa cells were transfected with wild type GIT1 in the presence or 
absence of PAK1 kinase-inhibitory domain (KID) coexpression, or a 
GIT1(S419/517A) mutant that prevents PAK1 phosphorylation (Zhao et al., 2005) 
(Fig 3.2). The co-expression of the PAK1 KID enhanced the localization of wild 
type GIT1 to adhesion-like structures in HeLa cells (as reported previously by 
Brown et al., 2002) and also enhanced staining of NCK1 with adhesions. The 
GIT1(S419/517A) mutant enhanced localization of both GIT1 and NCK to focal 









Fig. 3.1. NCK1 co-localizes with GIT at focal adhesions. Transfected cells 
were fixed with paraformaldehyde prior to immunostaining antibodies 
targeting the respective tags/endogenous proteins. (a) GFP-tagged NCK1 and 
GIT1 constructs localize to paxillin-labeled focal adhesions in HeLa cells. (b) 
GFP-tagged NCK1 and FLAG-tagged GIT1 also co-localize to adhesions 
when coexpressed. (c) Endogenous NCK1 and GIT1 were also found to co-














Fig. 3.2. NCK1 localization to adhesion structures is regulated by PAK 
activity. HA-tagged NCK1 coexpressed with GFP-tagged GIT1 constructs in 
HeLa cells in the presence or absence of PAK1 kinase-inhibitory domain (KID) 
c-oexpression. Transfected cells were fixed with paraformaldehyde prior to 
immunostaining antibodies targeting the respective tags. NCK1 co-localization 
with GIT1 at focal adhesions is enhanced by inhibition of PAK activity via c-
oexpression of KID. Expression of a GIT1 mutant that inhibits PAK 
phosphorylation of GIT (S419/517A) also enhanced the localization of both 

























GIT is a key player in the localization of NCK to adhesion structures. Further 
experiments were therefore carried out to establish how NCK1 binds to GIT1 and 
whether PAK1 is required. 
 HeLa cells were transfected with constructs encoding GFP-tagged NCK1 
in which the N-terminal SH3 domain was deleted (NCK1 !SH3-1), or harboring 
point mutations (m) in key residues of the SH3-2 and SH3-3 domains (denoted 
NCK1 SH3[2m] and NCK1 SH3[3m] respectively).   The protein distribution was 
observed with both immunofluorescence microscopy of fixed cells as well as 
time-lapse microscopy of live cells in order to assess adhesion localization. All the 
NCK1 SH3 domain mutants localized to adhesions structures in the fixed HeLa 
cells, albeit with lower intensity (comparing the cytoplasmic to FA ratio) than the 
wild-type protein (Fig 3.3). The various NCK1 SH3 mutants also did not alter the 
F-actin organization as assessed by phalloidin staining. In order to confirm these 
staining patterns were not cell-line specific, NCK1 SH3 domain mutants and the 
SH2 domain truncation mutant (NCK1 !SH2) were expressed in the motile 
B16F1 melanoma cell line. Transfected cells were seeded on laminin-coated 
coverslips and subjected to aluminium fluoride treatment, which induces the 
formation of wide and well-developed lamellipodia (Hahne et al., 2001). 
Consistent with the observations in HeLa cells, all the NCK1 SH3 mutants 
localized to adhesion structures found within the lamella as well as small punctate 
adhesion structures at the leading edge or lamellipodium but not the SH2-deleted 
construct (Fig 3.4). Due to the small size of the adhesion structures observed at 
the leading edge, the B16F1 cells were permeabilized prior to fixation to exclude 
the possibility that such structures are staining artifacts of the cytoplasmic pool of  
Fig. 3.3. NCK1 targeting to focal adhesions does not require functional 
SH3 domains. FLAG-tagged NCK1 SH3 mutants were expressed in HeLa 
cells and observed with immunofluorescence microscopy. Transfected cells 
were fixed with paraformaldehyde prior to immunostaining antibodies 
targeting the respective tags/endogenous proteins. All the mutants were found 
to localize to focal adhesions in HeLa cells at the end of actin stress fibers 
















Fig. 3.4. NCK1 targeting to focal adhesions is mediated by the SH2 domain. 
GFP-tagged NCK1 domain mutants localize to focal adhesions in B16F1 
melanoma cells labeled by endogenous paxillin. Cells were plated on laminin-
coated coverslips and permeabilized with Triton X-100 before fixation with 





















proteins congregating at ruffling edges of the lamellipodia. In contrast to the 
adhesion complex localization of the SH3 domain mutants, removal of the SH2 
domain (NCK1 !SH2) blocked this localization. These results suggest that the 
NCK1 SH2 domain is critical for adhesion targeting.  
Adhesions structures undergo rapid assembly and disassembly during cell 
movement, hence it would be important to examine the dynamics of NCK1 
localization. The observations obtained from fixed HeLa and B16F1 cells were 
supported by time-lapse microscopy of GFP-tagged NCK1-SH3 mutants 
expressed in HeLa cells (Fig 3.5, Movies 1-4). Functional SH3 domains were not 
required for localization of NCK to adhesion structures that assemble and 
disassemble at protruding and retracting regions of the cell respectively during 
migration (indicated by white arrowheads and arrows respectively).  Time-lapse 
microscopy of B16F1 cells indicated that GFP-NCK1 co-localizes with mCherry-
tagged paxillin at adhesion structures including those at the lamellipodium (Fig 
3.6, Movies 5-7), rather than localizing with the whole lamellopodial structure or 
peripheral ruffles. One can also observe that GFP-NCK1 translocate away 
(demonstrated by decreasing GFP signal strength) from adhesion structures in 
quiescent and retracting regions of the cell (indicated by white arrows), to active 
regions of protrusion where NCK1 is concentrated (indicated by arrowheads). 
This suggested that NCK1 could be actively involved in protrusive dynamics at 
the leading edge of the cell. 
The NCK1 SH3 mutants expressed in the HeLa cells also exhibited some 
increased localization to the nucleus (Fig 3.3). It was previously shown that NCK 
constitutively translocates between the cytoplasmic and nuclear compartments, a  
Fig. 3.5. Time-lapse microscopy of NCK1 mutants in HeLa cells. 
Representative montage images of HeLa cells expressing various GFP-tagged 
NCK1 SH3 mutants observed with time-lapse microscopy. Retracting areas of 
the cells are indicated by white arrows, protruding areas are indicated by white 
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Fig. 3.6. Time-lapse microscopy of NCK1 co-localizing with paxillin adhesions 
in B16F1 cells. Representative montage images of B16F1 cells expressing GFP-
tagged wild-type NCK1 with mCherry-tagged paxilllin observed with time-lapse 
microscopy. Retracting areas of the cells are indicated by white arrows, protruding 
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process that is mediated by the protein SOCS7 (Suppressor Of Cytokine 
Signaling-7) (Kremer et al., 2007). I decided to investigate if this was indeed the 
cause of the observed nuclear localization of the NCK1 SH3 mutants. Briefly, 
cells expressing various FLAG-tagged NCK1 SH3 domain mutants were treated 
for 1hr with Leptomycin B (LMB), a specific inhibitor of Crm1-mediated nuclear 
export (Kudo et al., 1999), before fixation and immunofluorescence staining (Fig 
3.7). More than 200 cells were counted from at least five randomly chosen optical 
fields for each coverslip. The results indicate that while all the NCK1 constructs 
exhibited enhanced localization to the nucleus in comparison to non-LMB treated 
cells (data not shown), wild-type NCK1 and the SH3-1 domain truncation mutant 
(delSH3-1) showed predominantly cytoplasmic distributions in the cells. On the 
other hand, inactivating point mutations in the SH3-2 and SH3-3 domains 
(SH3[2m] and SH3[3m]) seem to enhance targeting of NCK1 to the nuclear 
compartment, with the SH3[2m] mutation proving exceptionally potent.  
Fig. 3.7. Nuclear localization of NCK1 SH3 domain mutants. FLAG-tagged 
NCK1 SH3 mutants were expressed in HeLa cells and observed with IF 
microscopy after 1hr of treatment with Leptomycin B (LMB).  
Top panel: representative images of criteria for judging nuclear localization. 
Relative fluorescence signal intensities in the cytoplasmic and nuclear 
compartments were used to determine the predominant localization of the protein. 
Bottom panel: quantification of the predominant cellular distribution of the 
respective NCK1 mutants. (C=N: equally cytoplasmic and nuclear; C<N: more 
nuclear than cytoplasmic; C>N: more cytoplasmic than nuclear) NCK1 SH3[2m] 




















3.3 NCK interaction with GIT1 is not dependent on NCK SH-domains 
 Co-immunoprecipitation experiments were carried out using NCK and 
GIT1 (and mutants) to test if there is a requirement for PAK1 to form a stable 
complex.  The goal was also to map the molecular determinants of this interaction. 
Immunoprecipitation of full-length NCK1 (NCK1-FL) and NCK1 lacking the 
SH2 domain (NCK1 !SH2) with a series of GIT1 truncation mutants 
demonstrated that the NCK1 SH2 domain enhances, but is not necessary for 
binding to the C-terminal half of GIT1 (GIT1c = amino acids 376-770) that 
includes the coiled-coil domain (Fig 3.8). NCK1 displayed stronger interaction 
with GIT1c than full length GIT1, suggesting that the NCK-binding motif lies in 
the GIT1 C-terminus. This is also consistent with the notion that GIT1 exists in an 
autoinhibitory conformation mediated by two distinct interactions: one interaction 
implicating the N-terminal ankyrin repeats and the SHD domain, and a second 
weaker interaction between the Arf-GAP domain and the C-terminal part of GIT1 
after the SHD domain (Totaro et al., 2007). Disrupting the ankyrin repeat-SHD 
domain was shown to release the autoinhibition and increase binding to GIT1 
interacting partners like paxillin.  
I also used GIT1 mutants lacking the Src target sites (GIT1c Y392/554F) 
to remove the requirement for tyrosine phosphorylation (Fig 3.9). The results 
revealed that the NCK1 SH2 domain primarily binds to the phosphorylated 
Tyr392 residue, which is located in what has been referred to as the GIT1 synaptic 
localization domain (SLD) (Zhang et al., 2003) although the basis for this putative 
protein interaction site has not been clarified.  It was clear that the NCK1-SH2 
domain promotes, but is not essential for interaction with GIT1. Strangely, 
inactivating the other known NCK1 domains (!SH3-1 or SH3[2]m  or SH3[3]m)  
Fig. 3.8. NCK1 interacts directly with GIT1. FLAG-tagged GIT1 mutants 
were used to pulldown GFP-tagged NCK1 mutants co-expressed in COS 
cells. The data indicates that while full-length NCK1 binds robustly to GIT1, 
deletion of the SH2 domain (NCK1 !SH2) greatly weakened the interaction 
with the full-length GIT1 protein. Interestingly, the NCK1 !SH2 mutant 
retained strong binding with GIT1 C-terminal mutants. 
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Fig. 3.9. NCK1 interaction with GIT1 is independent of SH domains. 
GFP-tagged NCK1 mutants were co-expressed with FLAG-tagged GIT1 C-
terminal tyrosine phosphorylation site mutants (Y392F and Y554F) in COS7 
cells, and co-IP using M2 Anti-FLAG beads (Sigma). The data indicates that 
while the NCK1 SH2 domain binds robustly to the pTyr392 of GIT1, the 
NCK-GIT interaction is not dependent on any individual SH domain. 
Mutations inactivating the SH3 domains (!SH3-1 and SH3 [2+3m]) did not 




did not affect the interaction with GIT1c.  Hence, the NCK1-GIT1 interaction is 
supported by the SH2 domain but requires sequences outside the SH3 domains 
(Fig 3.9). 
To narrow down the NCK1 region responsible for the SH2-independent 
component of binding, further NCK1 N-terminal truncation mutants were tested in 
pulldowns with the GIT1c (Y392F) mutant as illustrated in Fig 3.10. While a 
NCK1 construct that contains the C-terminal SH3 and SH2 domains (amino acids 
188-377) was incapable of binding GIT1c Y392F, one that includes the linker 
region between the SH3-2 and SH3-3 domains (cf. amino acids 169-377) could 
robustly bind GIT1c (Y392F).  This linker region may possibly form some kind of 
folded structure when presented with the SH3-3 domain.  The minimal region on 
GIT1 that mediates the binding to this NCK1 'linker' region was tested with a 
series of truncation constructs that includes the coiled-coil domain (amino acids 
446-474) which mediates oligomerization of GIT1 (Paris et al., 2003; Premont et 
al., 2004).  Based on this analysis, the binding region is defined by GIT1 amino 
acids 446-580 (Fig 3.11). Interestingly, the peptide sequence that seemed critical 
for NCK1 linker binding (residues 560-580) includes a RxxK motif that has been 
proposed to bind SH3 in a non-canonical fashion (Berry et al., 2002; Harkiolaki et 
al., 2009; Takeuchi et al., 2010).  It is possible that the linker region in NCK1 is 
required to stabilize such non-canonical binding to the flanking SH3-3 domain. 
Fig. 3.10. Mapping the GIT1 interaction motif in NCK1. FLAG-tagged 
GIT1c Y392F was used to pulldown various GFP-tagged NCK1 truncation 
mutants in COS7 cells. The results indicate that the linker region between 
the middle and C-terminal SH3 domains of NCK1 (residues 169-188) 
mediates the non-SH domain interaction with GIT1. 
Fig. 3.11. Mapping the non-SH dependent NCK1 binding region in 
GIT1. FLAG-tagged GIT1 C-terminal truncation mutants was used to 
pulldown GFP-tagged NCK1 mutant containing just the SH3-3 domain and 
the preceding linker region with the SH3-2 domain. The data shows that 
residues 560-580 in the GIT1 synaptic localization domain (SLD) is critical 




3.4 GIT1 drives NCK1 localization to adhesion structures 
Considering the robust nature of the NCK-GIT interaction, I wanted to test 
if the adhesion targeting of NCK proteins (which is affected by PAK inhibition) is 
a direct result of GIT1 recruitment. Previously it was suggested that NCK1 
localization to focal adhesions in fibroblasts required phosphorylation of GIT2 by 
SFKs (Brown et al., 2005). To further investigate this hypothesis, small interfering 
RNA (siRNA) targeting human GIT1 transcripts was tested in HeLa cells. 
Western blot analysis 48hr post-siRNA transfection demonstrated knockdown of 
endogenous GIT1 protein levels to ~20% of control (Fig 3.12a). HeLa cells 
expressing the GIT1 siRNA observed with immunofluorescence revealed loss of 
both GIT1 and NCK1 at focal adhesions (Fig 3.12b). Endogenous GIT1 assessed 
by indirect-immunofluorescence typically exhibit a diffuse 
cytoplasmic/perinuclear distribution with weak localization to cell adhesions. 
After GIT1 siRNA treatment, the remaining immunofluorescence signal was more 
fibrillar in appearance, with little or no localization to adhesions. The remaining 
signal might be non-specific staining from the GIT antibody or represent a 
residual pool of GIT1 protein that have a slower turnover rate than those localized 
at adhesion structures (Fig 3.12a). This point of contention could be resolved by 
using GIT1 -/- fibroblasts.  
To further support the notion that GIT1 drives the focal adhesion 
localization of NCK1, I used the PIX-interacting domain of PAK1 (termed the 
PID, Obermeier et al., 1998) to pulldown the endogenous PIX-GIT complex in 
COS7 cells (Fig 3.13). GST-tagged PID constructs were able to efficiently 
pulldown endogenous PIX-GIT complexes and one can detect a fraction of NCK1   
Fig. 3.12. GIT1 drives NCK1 localization to adhesion structures. (a) Human 
GIT1-specific siRNA produced efficient knockdown of endogenous GIT1 
protein levels in HeLa cells. (b) Endogenous NCK1 and GIT1 co-localization at 
adhesion structures is unaffected by control, scrambled siRNA. GIT1 siRNA 
disrupted normal distribution of GIT1 and adhesion targeting of NCK1. 
Immunofluorescence signal in GIT1 knockdown cells may be resultant from  
non-specific staining by the antibody. Scale bar: 20 µm. 
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Fig. 3.13. Endogenous NCK1 interacts stably with the PAK-PIX-GIT 
complex in vivo. GST-tagged PIX-interacting domain (PID) of PAK1 was 
used as bait to pulldown endogenous proteins from COS7 cells, with GST 
proteins as a negative control. The data indicates that endogenous NCK1 
binds strongly to the PAK-PIX-GIT1 complex in vivo. 
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associated with the complex. Thus PAK1, !PIX, GIT1 and NCK1 are found in 
cellular stable complexes in vivo. The adhesion targeting of the complex was also 
tested using paxillin as 'bait' to pulldown full-length GIT, PAK1 and NCK1 
constructs (Fig 3.14). Contrary to previous reports (Turner et al., 1999) I found no 
evidence that NCK1 binds directly with paxillin, but rather the recruitment of 
NCK1 to adhesions occurs via GIT1 (Fig 3.14, lane 1 vs 4). 
In order to investigate the functional role of NCK at focal adhesions, I 
made a GST-tagged NCK1-SH2 domain construct that by virtue of being dimeric, 
should have higher affinity for NCK binding sites on GIT1, which is also known 
to dimerize  (Kim et al., 2003; Paris et al., 2003; Premont et al., 2004). The data 
from staining of B16F1 melanoma cells suggests NCK1-SH2 domain can block 
recruitment of endogenous NCK to focal complexes (Fig 3.15). The loss of 
adhesion localized NCK had no apparent impact on the gross organization the F-
actin network as assessed by phalloidin-staining (Fig 3.16). Analysis of 
paraformaldehyde-fixed B16F1 cells expressing NCK1-SH2 constructs did not 
yield appreciable effects on the gross morphology of cell adhesion structures 
compared to untransfected control cells (Fig 3.17a). This was not surprising given 
that GIT1 knockdown also failed to alter the gross morphology and size of focal 
adhesions (Fig 3.17b). Hence, this suggests that the GIT-NCK complex likely 
controls the dynamics of adhesions. 
To investigate how adhesion localized NCK might affect cell protrusion 
and migration dynamics, time-lapse microscopy was used to observe B16F1 cells 
expressing various GFP-tagged NCK1 domain mutants (Fig 3.18, and Movies 8-
11). B16F1 melanoma cells are useful because they are polarized and migratory in 
nature, and are widely used to investigate cell migration and actin cytoskeletal  
Fig. 3.14. NCK1 associates with paxillin-bound GIT complexes in vivo. 
COS7 cells expressing FLAG-tagged paxillin in combination with GFP-
tagged GIT1 and NCK1, and HA-tagged PAK1 constructs were used for IP 
experiments, in which anti-FLAG M2-beads (Sigma) were used to pulldown 
paxillin. The data indicates that NCK1 does not interact directly with 
paxillin, and that NCK1 only co-IP in the presence of GIT1. 
Fig. 3.15. NCK1-SH2 can block endogenous NCK adhesion localization 
in a dominant-negative manner. GST-tagged NCK1-SH2 constructs were 
overexpressed in B16F1 cells spreading on laminin-coated coverslips. Cells 
were permeabilized with Triton X-100 prior to fixation with 
paraformaldehyde and immunostaining. Actin filaments were labeled with 
phalloidin-rhodamine. Localization of endogenous NCK1 to adhesion 
structures in the lamellipodia was abrogated by overexpression of the 
NCK1-SH2 domain. Scale bar: 20 µm. 
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Fig. 3.16. Delocalization of NCK1 from adhesion structures does not 
affect focal adhesion morphology and F-actin organization. spreading 
on laminin-coated coverslips. Cells were fixed with paraformaldehyde 
without pre-permeabilization. Actin filaments were labeled with phalloidin-
rhodamine. Blocking adhesion targeting of NCK did not seem to affect size 
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(a) 
Fig. 3.17. Impact of blocking NCK1 adhesion targeting and GIT1 
knockdown on size of focal adhesions. (a) Quantification of focal adhesion 
size in B16F1 cells expressing GST-tagged NCK1-SH2 spreading on 
laminin-coated coverslips. Blocking adhesion targeting of NCK did not have 
a statistically significant impact on the size of adhesions. Representative 
image on the left panel: NCK1-SH2 (blue), paxillin (green). (b) 
Quantification of focal adhesion size in HeLa cells expressing GIT1 siRNA. 
Knockdown of GIT1 did not have a statistically significant impact on the 
size of adhesions. Representative image on the left panel: GIT1 siRNA 
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(b) 
Fig. 3.18. Impact of blocking NCK1 adhesion targeting on cell migration. 
B16F1 cells expressing various GFP-tagged NCK1 domain mutants (GST-
NCK1-SH2 was co-expressed with GFP-Paxillin) spreading on laminin-
coated coverslips were observed using time-lapse confocal microscopy. The 
migratory path and speed of each cell was tracked and quantified using 
Metamorph image analysis software, which were then compared to that of 
untransfected control cells. (a) Representative time-lapse montage of 
spreading B16F1 cells expressing the respective NCK1 mutants.  


























































Fig. 3.18. Impact of blocking NCK1 adhesion targeting on cell migration. 
B16F1 cells expressing various GFP-tagged NCK1 domain mutants (GST-
NCK1 SH2 was co-expressed with GFP-Paxillin) spreading on laminin-coated 
coverslips were observed using time-lapse confocal microscopy for about an 
hour. The migratory path and speed of each cell was tracked and quantified 
using Metamorph image analysis software, which were then compared to that 
of untransfected control cells. (b) Quantification of mean migration speeds of 
cells expressing the various NCK1 constructs. (Student’s T-test, * indicates 






dynamics particularly with respect to lamellipodial structures (Ballestrem et al., 
1998; Hahne et al., 2001; Steffen et al., 2004; Koestler et al., 2009) since they lack 
myosin IIb, which typically lies downstream of ROK (Vicente-Manzanares et al., 
2008).  
Confocal microscopy was used to generate time-lapse images, from which 
the migratory paths and speeds of individual cells were tracked and quantified 
using Metamorph image analysis software, and compared to that of untransfected 
control cells. The data was collated from 6-8 cells from at least two independent 
experiments in which the GFP signal was determined to be similar. Migration 
speeds of B16F1 cells expressing full-length NCK1 was similar to WT cells (87.4 
± 12.3µm n=8) (Movie 8), while the NCK1 SH3[2+3m] mutant (103 ± 11.4µm, 
n=6) (Movie 9) did not have a statistically significant effect. However cells 
expressing the NCK1 SH2-domain truncation mutant (NCK1 delSH2) (52.1 ± 
7.57µm, n=6) (Movie 10), as well as cells expressing the NCK1-SH2 domain 
alone (51.8 ± 10.1µm, n=7) (Movie 11) migrated more slowly (Student’s T-test, p 
< 0.05). These results indicate that NCK1 plays a role in coupling adhesion 
structures with migratory processes in the cell (Stoletov et al., 2001; Bladt et al., 
2003). This data is also consistent with existing literature that demonstrates 
enhanced tyrosine-phosphorylation of the PAK-PIX-GIT complex upon cell 
adhesion and spreading (Bagrodia et al., 1999; Haendeler et al., 2003; Chang et 
al., 2007). 
 
3.5 NCK proteins can potentially oligomerize in vivo 
Many signal transduction pathways involve higher order protein 
complexes that assemble through the oligomerization of individual components. 
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Common examples are the ligand-induced dimerization and trans-activation of 
growth factor receptors (Tzahar and Yarden, 1998; Schlessinger, 2002) and the 
clustering of integrin heterodimers upon binding to ECM ligands like fibronectin 
(Hynes, 1992; Chrzanowska-Wodnicka and Burridge, 1996). PIX and GIT are just 
two components of FA protein complexes that are known to exist as oligomers 
((Kim et al., 2003; Paris et al., 2003; Premont et al., 2004). More importantly, 
oligomerization seems to be critical for localization of the PIX-GIT complex to 
FA since mutations that block the GIT-PIX interaction or disrupt the 
homodimerization of PIX led to the abrogation of the adhesion localization of 
both proteins (Kim et al., 2001; Loo et al., 2004). 
 Hence, it would be of interest to check if NCK had the ability to form 
oligomers that could potentially affect the avidity of its interactions with 
oligomeric partners in the FA. FLAG-tagged NCK1 and the SH2-truncation 
mutant were used to pulldown various HA-tagged NCK1 truncation mutants co-
expressed in COS7 cells (Fig 3.19). NCK1 is capable of homophilic interactions 
through the SH3-1 domain, as deletion of the SH3-2, SH3-3 and SH2 domains did 
not affect binding to full-length NCK1 (lane 1 vs lanes 4, 5 and 6). Further 
experiments with FLAG-tagged NCK1 and GST-tagged NCK1/2 constructs (Fig 
3.20) suggest that NCK1 can form heteromers with NCK2 (lane 2) and that the 
NCK1 SH3-1 domain is obligate for oligomerization (lane 3). However, this 
hypothesis needs to be further tested with pulldown assays using just the NCK1 
SH3-1 domain alone, and a construct containing the NCK1 SH3-1 and SH3-2 
domains to investigate the possible role of the linker region. Upon identifying the 
minimal interacting motif, size exclusion chromatography could also be 
performed to detect native NCK oligomers in cell lysates. 
Fig. 3.19. NCK1 can form oligomers via the N-terminal SH3 domain. 
FLAG-tagged full-length NCK1 and a SH2-truncation mutant were used to 
pulldown various HA-tagged NCK1 mutants co-expressed in COS7 cells. 
The results indicate that NCK1 is capable of forming oligomers through the 
N-terminal SH3 domain (SH3-1). 
Fig. 3.20. NCK1 can form oligomers with NCK2. FLAG-tagged full-
length NCK1 and SH2-truncation mutant was used to pulldown various 
GST-tagged NCK1 mutants and full-length NCK2 co-expressed in COS7 





I have identified GIT1 as a critical regulator of NCK1 cellular localization. 
Although NCK1 primarily interacts with a conserved phosphotyrosine residue 
(Y392) in GIT1 through its SH2 domain, I also describe a novel interaction 
between sequences in the GIT1-SLD and the NCK1 SH3-2/SH3-3 linker region. 
There is strong evidence for the role of GIT1 in the adhesion recruitment of 
NCK1: inhibition of PAK activity enhanced adhesion targeting of both proteins; 
NCK1 interacts stably with endogenous PAK-PIX-GIT complexes in vivo; NCK1 
only co-immunoprecipitates with paxillin in the presence of GIT1; and 
knockdown of GIT1 abrogates adhesion localization of NCK1. The adhesion 
localization of NCK1 can be blocked by a dominant-inhibitory NCK1-SH2 
construct, leading to the inhibition of the migration-promoting activity of 
endogenous NCK. I also demonstrate that NCK proteins can potentially 
oligomerize through the SH3-1 domain, while the NCK1 SH3-2 and SH3-3 
domains regulate the cytoplasmic retention of NCK1. 
 
 
 Chapter 4 Identification and characterization of a direct 
interaction between NCK and the Rac-GAP !2-chimaerin 
4.1 Introduction 
There are four isoforms in the chimaerin family, namely !1-, !2-, "1 and 
"2-chimaerin, alternatively spliced from the two !- and " -chimaerin genes. All 
isoforms contain the diacylglycerol (DAG)/phorbol ester binding C1 domain and 
the C-terminal located GAP domain.  The N-terminal SH2 domain is present only 
in the !2- and "2-chimaerin (Yang and Kazanietz, 2007) and lacks key features of 
typical SH2 domains with respect to the phosphotyrosine-binding site, suggesting 
that it might have acquired new function(s). It is established that !2-chimaerin 
plays a role in axonal repulsion in the nervous system. For example, !2-chimaerin 
is implicated in ephrin/EphA4 'forward signaling' that is critical for proper 
corticospinal projections and function (Iwasato et al., 2007; Shi et al., 2007; 
Wegemeyer et al., 2007), and in Semaphorin 3A (Sema3A) mediated growth-cone 
collapse (Brown et al., 2004). Missense mutations in the coding region of the 
CHN1 (chimaerin 1) gene that enhanced chimaerin GAP activity in vitro were 
found to be causative of Duane’s retraction syndrome, a congenital eye movement 
disorder characterized by the failure of oculomotor axons to innervate their target 
extra-ocular muscles (Miyake et al., 2008).  
Selective inactivation of both NCK isoforms in the murine nervous system 
causes multiple axonal guidance defects that led to aberrant midline crossings of 
corticospinal neurons and a hopping gait in the mutant mice (Fawcett et al., 2007). 
These are reminiscent of the defects observed in knockout animals of guidance 
cue receptor EphA4 (Dottori et al., 1998), and !2-chimaerin (Iwasato et al., 2007; 
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 Wegmeyer et al., 2007). It was found that both !2-chimaerin and NCK associate 
with EphA4, and that this affects the activity of the !2-chimaerin GAP domain 
(Shi et al., 2007; Wegmeyer et al., 2007), although the basis of these interactions 
was not investigated in detail. 
NCK interacts with Eph#2 receptors via its SH2 domain (Miura et al., 
2009) and likewise to Ephrin B3 receptors (Xu and Henkenmeyer, 2009) in a 
phosphotyrosine-dependent manner. While it is not clear whether the NCK SH2 
domain is involved in EphA4 receptor forward signaling, !2-chimaerin has been 
shown to interact with EphA4 (Shi et al., 2007; Wegmeyer et al., 2007). !2-
chimaerin could play a wider role in Sema3A mediated growth cone collapse 
through its interaction with the serine/threonine kinase Cdk5 and its substrate 
collapsin response mediator protein (CRMP2) that bind the GAP and SH2 
domains respectively (Brown et al., 2004). Cdk5 phosphorylation of CRMP2 
Ser522 enables GSK3" phosphorylation of upstream sites essential for growth 
cone collapse (Brown et al., 2004; Uchida et al., 2005). Together with Cdk5, the 
SFK Fyn also participates in Sema3A and EphA4 neuronal signaling networks 
(Sasaki et al., 2002; Morita et al., 2006; Bourgin et al., 2007; Shi et al., 2007).  
Comparative structural and functional analyses of "2-chimaerin (Brown et 
al 2004; Canagarajah et al., 2004; Colon-Gonzalez et al., 2008) and !2-chimaerin 
(Shen et al., 2008) suggest that both proteins are similarly maintained in an 
autoinhibited, closed conformation under resting conditions, with the N-terminus 
capable of sterically occluding access to the C1 and Rac-GAP domains (Fig 4.1). 
It is thus conceivable that engagement of the N-terminal region, which contains a 
number of conserved proline-containing motifs (cf. alignment in Fig 4.1) or the 
SH2 domain may release the chimaerin from this autoinhibitory conformation. 
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 The role of C1 domain engagement by acidic phospholipids (like 
phosphatidylserine) has been suggested to relieve the autoinhibitory conformation 
of chimaerin as (Konig et al., 1985). However, the concentration of the phorbol 
ester analogue PMA required to activate "2-chimaerin, as indicated by membrane 
translocation, is some 100 times higher than for PKC (Canagarajah et al., 2004; 
Colon-Gonzalez et al., 2008).  It has been shown that the ! 2-chimaerin SH2 
domain is essential for EphA4-mediated growth cone collapse (Shi et al., 2007), 
suggesting that this domain plays an key role, perhaps in protein-protein 
interaction. In other signaling pathways, "2-chimaerin has been suggested to 
function downstream of phospholipase C" (PLC")-mediated generation of DAG 
(Wang et al., 2006), which is a common feature of many receptor tyrosine kinase 
pathways including EphA4 (Zhou et al., 2007). I decided to further investigate the 
functional impact of the physical links between chimaerin, EphA4 and NCK, 
since in addition to possibly down-regulating Rac1 activity, NCK have been 
shown to modulate cytoskeletal dynamics (Rohatgi et al., 2001; Eden et al., 2002; 





Fig. 4.1. Crystal structure of !2-chimaerin. Solved by Shen et al., 2008 of 
the Structural Genomics Consortium (SGC), Protein Data Bank (PDB) 
accession number 3CXL. The extreme N-terminal helix of the SH2 domain is 
folded back into the cleft between the C1 and GAP domains resulting in steric 
hindrance of the C1 domain and possibly autoinhibition of the GAP domain. 
Closer examination of the N-terminal peptide sequence revealed a high 
degree of conservation across species and the presence of two proline-
containing motifs (highlighted in yellow in the alignment and structure) that 
could potentially bind SH3 domains. 
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 4.2 The biochemical basis of the NCK-chimaerin interaction 
The observation that two proteins co-localize or affect each other's cellular 
localization provides an indication that they may potentially interact physically. 
Immunofluorescence microscopy was performed on cells expressing FLAG-
tagged constructs to determine the cellular localization of !2-chimaerin. FLAG-
!2-chimaerin co-localized with GFP-NCK1 at peripheral ruffles or lamellipodia in 
HeLa cells (Fig 4.2a). In B16F1 cells spreading on laminin-coated coverslips, !2-
chimaerin and NCK1 co-localized to the leading edge lamellipodia, but not to 
paxillin-labeled focal adhesions under these conditions (Fig 4.2b, top panel), 
presumably because the larger cytoplasmic pool obscures the FA localized 
proteins. These lamellipodial localizations were further investigated in cells that 
were pre-permeabilized with Triton X-100 prior to fixation (Fig 4.2b, bottom 
panels). Interestingly, NCK1 was retained at paxillin-labeled adhesions, while !2-
chimaerin was lost. Thus, while a more stable pool of NCK associated with PAK-
PIX-GIT complexes at peripheral adhesions, chimaerin is localized in a different, 
more labile pool, at the leading edge. The potential role of NCK1 in recruiting 
chimaerin through tyrosine-phosphorylated protein complexes localized at the 
leading edge was therefore considered. 
It was previously shown that NCK interacts with the N-terminus of !2-
chimaerin (Wegmeyer et al., 2007), which does not contain canonical SH3 target 
sequences. Furthermore, the determinants of the interaction were not further 
investigated. In order to assess the basis of NCK1 binding to !2-chimaerin, the 
previously generated NCK1 mutants (see chapter 3) were used to pull-down !2-
chimaerin after co-expression of these proteins in COS7 cells. The results indicate 
that NCK1 requires the SH3-3 domain to interact with !2-chimaerin (Fig 4.3). 
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Fig. 4.2. NCK1 co-localizes with !2-chimaerin at membrane ruffles and 
dynamic leading edge of polarized cells. (a) FLAG-tagged !2-chimaerin 
and GFP-tagged NCK1 co-localize to membrane ruffles in HeLa cells and 
the dynamic leading edge, but not to paxillin-labeled focal adhesions of 
B16F1 melanoma cells spreading on laminin-coated coverslips. Scale bar: 
20 µm.   










Fig. 4.2. NCK1 co-localizes with !2-chimaerin at membrane ruffles and 
dynamic leading edge of polarized cells. (b) Top panels: FLAG-tagged !2-
chimaerin exhibit localization to the leading edge of protrusive regions 
(indicated by white arrowhead), but not retracting edges of the cell (indicated 
by white arrow) and paxillin-labeled focal adhesions in spreading B16F1 
cells. Leading edge localization of !2-chimaerin was abolished by pre-
permeabilization with Triton-X100. Bottom panel: GFP-tagged NCK1 was 
observed to colocalize with paxillin-labeled focal adhesions in pre-
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Fig. 4.3. The C-terminal SH3 domain of NCK1 mediates the interaction 
with !2-chimaerin. GST-tagged NCK1 SH-domain mutants were used to 
pulldown FLAG-tagged !2-chimaerin in COS7 cells using glutathione 
beads. A point mutation inactivating the C-terminal SH3 domain of NCK1 
abrogated the interaction with !2-chimaerin. 
 While trying to map the NCK1 binding motif, the lack of canonical SH3 target 
sequences in the !2-chimaerin N-terminus led me to consider two proline-
containing motifs N-terminal to the SH2 domain (Fig 4.1). A number of !2-
chimaerin N-terminal truncation constructs were then transfected with NCK1: 
deletion of the first 38 amino acids of chimaerin (!2-chimaerin $38), completely 
abolished the binding between the two (Fig 4.4, lane 2). However, I discovered 
that neither this region N-terminal to the SH2 domain alone (N-terminal 46 
residues), nor inclusion of the SH2 domain of chimaerin (N-terminal 129 
residues) was sufficient to efficiently bind NCK1 (Fig 4.4, lanes 3 and 5).  
Further efforts were therefore made to define the minimal region of 
chimaerin required for interaction. Of the two 'proline-containing motifs' present 
at the N-terminus of chimaerin, only the second was needed for NCK1 binding as 
deletion of the first 14 residues appeared if anything to enhance NCK1 binding 
(Fig 4.5, lane 3). Curiously, !2-chimaerin mutants targeting proline residues in the 
second 'proline-containing motif' (P28/30A) still exhibited the same level of 
binding as wild type chimaerin, indicating an unusual SH3 interaction (Fig 4.5, 
lanes 5 and 6). Further experiments revealed that the N-terminal 145 residues of 
chimaerin binds NCK1 strongly (Fig 4.6), suggesting that the SH2-C1 domain 
linker region of chimaerin participates in NCK1 binding. Hence, I looked in detail 
at the residues in the 'linker' sequence beyond the SH2 domain. However, this 
linker region alone (cf. residues 127-200) did not facilitate binding between 
NCK1 and chimaerin (Fig 4.7). Thus, I have demonstrated that these two regions, 
which lie outside the usual SH2 and C1 domains of chimaerin, acting in concert 
contribute critically to the NCK1 interaction. Alignment of !2-chimaerin 
sequences from human, murine and zebrafish also demonstrated that these 
101
 "linker" regions are conserved across species and contains a putative NCK1 SH2 
domain binding site with the pY(D/E)xV consensus motif, which will be 
discussed in the next section (Fig 4.7, bottom panel).  
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Fig. 4.4. The extreme N-terminus of !2-chimaerin is necessary but not 
sufficient for NCK1 binding. GST-tagged !2-chimaerin truncation 
mutants were used to pulldown full-length NCK1 in COS7 cells. Deletion 
of the first 38 amino acids (containing the two proline-rich motifs – see Fig 
4.1) of chimaerin abolished the interaction with NCK1. However, the N-
terminal region of chimaerin, including the SH2 domain, was not sufficient 







Fig. 4.5. NCK-chimaerin interaction requires the second proline-
containing motif in the !2-chimaerin N-terminus. GST-tagged NCK1 
mutants were used to pulldown FLAG-tagged !2-chimaerin N-terminal 
mutants in COS7 cells. Deletion of the first proline-containing motif (!2-
chimaerin "14) and point mutations targeting individual proline residues in 















































Fig. 4.6. NCK-chimaerin interaction requires the SH2-C1 domain 
linker sequence. GST-tagged N-terminal !2-chimaerin mutants were used 
to pulldown FLAG-tagged full-length NCK1 in COS7 cells. The data 
indicates that the first 145 residues of chimaerin, which includes the N-
terminal SH2 domain and part of the SH2-C1 domain linker sequence, 
























Fig. 4.7. The SH2-C1 domain linker region of chimaerin is necessary but 
not sufficient for NCK1 binding. GST-tagged N-terminal !2-chimaerin 
mutants were used to pulldown FLAG-tagged full-length NCK1 in COS7 cells. 
The data indicates that the SH2-C1 domain linker region (residues 127-200) is 
necessary but not sufficient for NCK1 binding (top panel). Sequence 
alignments indicate that the linker region is highly conserved between humans, 
mice and zebrafish (bottom panel).  
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 4.3 NCK1 and !2-chimaerin interactions with potential upstream regulators 
The EphA4 receptors demonstrate a high degree of conservation between 
species, with 98-82% sequence identity comparing human, mouse, zebrafish and 
frog orthologs (Fig 4.8). The various EphA receptor isoforms show significant 
sequence divergence in the transmembrane region (cf. murine EphA4 residues 
548-570), while the tyrosine kinase domain (residues 621-878) and 
autophosphorylation sites in the juxtamembrane region (residues 571-620) 
exhibited a higher degree of conservation (Fig 4.9). Critically, while chimaerin 
has been shown to bind to the phosphorylated juxtamembrane region of EphA4 
receptors via its SH2 domain (Beg et al., 2007; Wegmeyer et al., 2007), both 
studies had to use purified recombinant !2-chimaerin fragments to demonstrate 
the interaction in vitro. It has also been shown that either membrane-bound or Fc-
clustered ligands can bind and activate EphA4 receptors (Flanagan and 
Vanderhaegen, 1998).  
I carried out a number of experiments in COS7 cells expressing EphA4 
receptors in combination with both chimaerin and NCK1 constructs. These cells 
were also treated with recombinant EphrinA1-Fc pre-clustered using anti-human 
IgG antibodies. Under these conditions, phosphorylation levels of exogenously 
expressed EphA4 receptors were not significantly enhanced beyond basal levels 
by EphrinA1-Fc treatment (comparing the 120 kDa autophosphorylation signal, 
Fig 4.10), unlike previous reports (Flanagan and Vanderhaegen, 1998; Shi et al., 
2007). Interestingly under these conditions, wild type EphA4 and a kinase-
inactive mutant (EphA4-KD) bound NCK1 and !2-chimaerin to the same extent, 
while NCK1-$SH2 still bound EphA4 albeit with less affinity than control (Fig 
4.10). The data also indicates that the NCK1 SH2 rather than the SH3-3 domain 
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Fig. 4.8. Alignment of EphA4 orthologs. ClustalW alignment of EphA4 
sequences from human (Hs), mouse (Mu), Xenopus laevi (Xe) and rat (Rat) 
reveal a high-degree of peptide sequence conservation across species. 
Identical and similar residues shaded by black and grey boxes respectively. 
Fig. 4.9. Alignment of EphA receptor isoforms. ClustalW alignment of EphA1 – 
A4 sequences reveal significant sequence divergence in the transmembrane region 
(residues 548-570), while the tyrosine kinase domain (residues 621-878) and 
autophosphorylation sites in the juxtamembrane region (residues 571-620) exhibited 
a higher degree of conservation. Identical and similar residues shaded by black and 
grey boxes respectively. 
Fig. 4.10. NCK and chimaerin interaction with EphA4 receptors. FLAG-
tagged EphA4 receptors expressed in COS7 cells was used to pulldown 
GST-tagged !2-chimaerin and various NCK1 mutants with M2 FLAG-
binding beads. Relative binding intensities were quantified as indicated by 
anti-GST blots. The data indicates that the NCK1-SH2, but not the C-
terminal SH3 domain, modulates phosphotyrosine-independent interactions 























  modulates the chimaerin-EphA4 interaction, as the NCK1-$SH2 mutant and !2-
chimaerin exhibited concurrent weakened binding to EphA4 (Fig 4.10, lane 2 vs 
3). Therefore, while its possible that NCK1 and !2-chimaerin can both 
individually interact with EphA4 via phosphotyrosine-independent mechanisms, 
the NCK1 SH2 domain is required for efficient EphA4 binding, probably through 
allosteric modulation of NCK1. I also noted that the EphA4 mediated interactions 
were extremely weak (comparing input protein levels with pulldown efficiency) 
relative to the NCK-chimaerin or NCK-GIT1 interaction (Fig 4.11). These 
experiments indicate complex interplay between EphA4, NCK and chimaerin; 
more work is needed to unravel these details, keeping in mind that proper 
localization and function of the receptor tyrosine kinase likely requires cell lines 
that express lower levels of EphA4. 
It seemed possible that the PAK-PIX-GIT complex (rather than the 
isolated proteins) is an upstream regulator of !2-chimaerin, via the adaptor NCK1.  
I investigated the ability of these proteins to form complexes when over-expressed 
in COS7 cells (Fig 4.12). The results indicate that !2-chimaerin can interact with 
NCK1 while bound to the PAK-PIX-GIT complex. Interestingly, PAK1 (with 
GIT1 or "PIX) enhanced NCK1 association with chimaerin (Fig 4.12, lanes 3-6). 
This effect was not dependent on PAK1 activity, as a kinase-dead mutant of 
PAK1 (PAK1-KD) was observed to have an equivalent effect on chimaerin 
binding (Fig 4.13, lanes 4 and 6). These observations suggest that PAK1 may 
perform certain kinase-independent adaptor functions at focal adhesion complexes 
to modulate NCK activity. 
 NCK1 and !2-chimaerin both co-localize to the leading edge of spreading 
B16F1 cells (Fig 4.2). Endogenous NCK1 and components of the PAK-PIX-GIT  
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Fig. 4.11. EphA4 receptors bind NCK1 weakly. FLAG-tagged EphA4 
mutants, wild-type !2-chimaerin and GIT1c were used to pulldown GST-
tagged NCK1 in COS7 cell lysates using M2 FLAG-binding beads (Sigma). 
The results indicate that NCK1 binding to EphA4 (as indicated by band 
intensity of anti-GST blots) is almost an order of magnitude weaker than 








Fig. 4.12. !2-chimaerin can interact with the PAK-PIX-GIT-NCK 
complex. GST-tagged NCK1 was used to pull-down FLAG-tagged !2-
chimaerin and various components of the PAK-PIX-GIT complex 
expressed in COS7 cells using glutathione beads. Co-expression of PAK1 










Fig. 4.13. PAK can enhance the NCK-chimaerin interaction in a kinase-
independent manner. GST-tagged NCK1 mediated pulldown of !2-
chimaerin with FLAG-tagged components of the PAK-PIX-GIT complex. 
Co-expression of PAK1 in the presence of GIT1 or bPIX enhances NCK1 
binding with chimaerin, in a kinase-independent manner. 
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 complex show similar co-localization to focal complexes at the leading edge of 
the cells (Fig 4.14). In contrast, time-lapse microscopy of B16F1 cells expressing 
mCherry-tagged !2-chimaerin showed a small fraction of !2-chimaerin localized 
to actively protruding regions, but not to adhesion structures in the lamellipodia 
(Fig 4.15, Movie 12). Thus, while the PAK-PIX-GIT-NCK complex does not 
recruit significant amounts of !2-chimaerin to this site, the proteins may be 
playing a cooperative role in the regulation of cytoskeletal organization in the 
lamellipodial region, which exhibits the most dynamic pool of F-actin (Ballestrem 
et al., 1998; Le Clainche and Carlier, 2008). 
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Fig. 4.14. Endogenous NCK1 co-localizes with components of the 
PAK-PIX-GIT complex at the dynamic leading edge of polarized cells. 
FLAG-tagged PAK1, !PIX and GIT1 co-localize with GFP-tagged NCK1 
at the dynamic leading edge of B16F1 melanoma cells spreading on 













Fig. 4.15. !2-chimaerin localizes to the leading edge of protruding regions 
in the cell. mCherry-tagged !2-chimaerin expressed in B16F1 cells spreading 
on laminin-coated coverslips. Representative montage of time-lapse 
microscopy images shown. 
Time: 0min 2.5min 5min 7.5min 10min 
 4.4 Functional impact of the NCK-chimaerin interaction 
The hyperactivating mutations that cause Duane’s retraction syndrome 
(Miyake et al., 2008) underline the need for tight regulation of chimaerin Rac-
GAP activity under physiological conditions. In order to assess how the NCK-
chimaerin interaction might influence the Rac-GAP activity of chimaerin, 
recombinant GST-tagged p21-binding domain (PBD) of PAK1 (residues 67-150) 
was used in a Rac.GTP pulldown assay performed with lysates from COS7 cells 
expressing !2-chimaerin, NCK and HA-Rac1 (Fig 4.16). As proof of concept, the 
recombinant PAK1-PBD domain was able to pulldown exogenously expressed 
wild-type Rac1, but not a constitutively active Rac1 mutant defective for PBD-
binding (Rac Q61L/40C). Exogenous NCK1 appeared to increase the levels of 
Rac.GTP and, contrary to expectation, !2-chimaerin had the same effect. More 
curiously, expression of the 'unregulated' !2-chimaerin Rac-GAP domain did not 
decrease apparent Rac.GTP levels (Fig 4.16, lane 8).  
Such results suggested that either the GAP activity of !2-chimaerin was 
not functional under these conditions, contrary to previous studies (Caloca et al., 
2003; Brown et al., 2004; Shi et al., 2007), or that the pull-down assay conditions 
did not accurately assay Rac.GTP levels. The existing literature suggested that 
exogenous expression of !1-, "1- and "2-chimaerin without additional stimulation 
would reduce Rac1.GTP levels in a manner detectable by the PBD-binding assay 
(Caloca et al., 2003), while coexpression of !2-chimaerin and EphA4 led to a 
synergistic reduction in Rac.GTP pulled down by PAK-PBD (Shi et al., 2007). 
PMA treatment of cells stably expressing !2-chimaerin also led to further 
reduction in Rac1.GTP pulled down by PAK-PBD (Brown et al., 2004). Further 
attempts to pulldown endogenous Rac.GTP from COS7 and B16F1 cells proved  
118
Fig. 4.16. Impact of NCK-chimaerin interaction on Rac activity. 
Bacterially expressed recombinant p21 binding domain (PBD) of PAK1 
(residues 67-150) was used to pulldown HA-tagged Rac1 mutants 
coexpressed with NCK1 and various chimaerin mutants in COS7 cells. A 
constitutively active (CA) Rac mutant defective for CRIB-binding (Rac 
Q61L/40C) was used as a negative control for non-specific binding. The data 
indicates that under the established assay conditions, NCK1 and chimaerin 
interaction did not significantly affect Rac1 activity. 
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 unsuccessful, even though exogenously expressed HA-Rac1 was efficiently 
recovered using PBD-domains from either PAK1 or PAK3. Therefore I had to 
conclude that the PBD pulldown assay was not working well in my hands and 
thus attempted to establish alternative assays for measuring Rac.GTP levels by 
assaying its activity in vivo. 
 Neurite extension provides an alternate method of scoring Rac1 activity as 
previously reported (cf. Luo L., 2000). Briefly, pheochromocytoma cells (PC12) 
expressing various NCK1 and !2-chimaerin constructs were plated on laminin-
coated coverslips and treated with NGF for 48-hours before fixation and observed 
with immunofluorescence microscopy (Fig 4.17). Cells having neurites longer 
than two cell body lengths were scored positively. Approximately 200 cells per 
coverslip were scored from randomly chosen fields and the results are the average 
of 3 independent experiments. Overexpression of NCK1 and !2-chimaerin led to a 
significant increase (Student’s T-test, p < 0.05) in the efficiency of neurite 
extension (Fig 4.17), rather than a decrease as expected. These results indicate that 
!2-chimaerin is tightly regulated , and more inputs are required to activate its 
GAP activity in vivo. This is consistent with studies that suggest that chimaerin 
exists in autoinhibitory conformation under basal conditions (Canagarajah et al., 
2004; Shen et al., 2008) as well as observations showing that overexpression of 
chimaerin actually promotes neuritogenesis in N1E-115 neuroblastoma cells (Hall 
et al., 2001). 
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Fig. 4.17. Impact of NCK-chimaerin interaction on neurite extension. 
PC12 cells overexpressing various NCK1 and a2-chimaerin were plated on 
laminin-coated coverslips and treated with NGF for 48-hours. Cells were 
observed with IF microscopy post-fixation and scored for having neurites 
longer than two cell body lengths. More than 200 cells per coverslip were 
scored from randomly chosen optical fields and the results are the average of 
3 independent experiments. The data indicates that under the established 
assay conditions, NCK1, GIT1 and chimaerin enhanced neuritogenesis, and 
that a2-chimaerin’s GAP activity is quiescent. Scale bar: 20 µm. (Student’s T-


































* * * * * 
  Multiple tyrosine residues in !2-chimaerin have been suggested to be 
phosphorylation targets in vivo: the N-terminal Y70, Y143 and Y148 residues 
were postulated to be EphA4 targets (Shi et al., 2007), while "2-chimaerin Y21 
(equivalent of Y11 in !2-chimaerin) and Y153 (equivalent of Y143 in !2-
chimaerin) (Siliceo and Merida, 2009) are putative Src-family kinase targets (Kai 
et al., 2007). SFKs are important downstream effectors of EphA4-mediated 
repulsion of retinal axons (Knöll and Uwe Drescher, 2004). In particular, Fyn has 
been detected in Sema3A and EphA4 signaling complexes in neurons (Sasaki et 
al., 2002; Morita et al., 2006; Bourgin et al., 2007; Shi et al 2007). Fyn is likely to 
impact the NCK-chimaerin signaling complex by phosphorylating either one or 
both of these proteins.  
In order to identify which tyrosine(s) are targets, a series of tyrosine to 
phenylalanine (YF) mutations were generated, targeting residues in the N-
terminus of !2-chimaerin that is involved in NCK1 binding (Y21F, Y143F, 
Y148F and Y157F). FLAG-tagged !2-chimaerin was tested against GST- NCK1 
or NCK1 $SH2 in the presence of Fyn, which is constitutively active when over-
expressed. All the mutants interact with NCK1 with similar affinity as wild-type 
chimaerin, and only exhibited minimal phosphorylation in the presence of Fyn 
coexpression without PMA treatment (Fig 4.18). Interestingly, Fyn was also 
observed to co-immunoprecipitate with all the chimaerin tyrosine mutants, while 
NCK1 #SH2 binds all the chimaerin mutants with lower affinity than full length 
NCK1, suggesting that the SH2 domain may allosterically regulate binding to !2-
chimaerin. Secondly, EphA4 receptors with C-terminal FLAG-tags were co-
expressed with GST-tagged !2-chimaerin YF mutants and Fyn kinase in COS7 
cells for IP experiments (Fig 4.19). The !2-chimaerin YF 
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Fig 4.18. !2-chimaerin N-terminal tyrosine mutants interaction with 
NCK1. FLAG-tagged !2-chimaerin mutants were co-expressed with GST-
tagged NCK1 mutants in COS7 cells for IP experiments. The data indicates 
that all the tyrosine mutants (Y21F, Y143F and Y148F) interact with NCK1 
with similar affinity as wild-type chimaerin, and only exhibited minimal 
phosphorylation in the presence of Fyn co-expression without PMA 
treatment. Interestingly, deletion of the NCK1-SH2 domain (NCK1 "SH2) 
slightly reduced the binding affinity to all the chimaerin mutants, suggesting 
that the SH2 domain may be involved in binding chimaerin. 
Fig 4.19. !2-chimaerin N-terminal tyrosine mutants interaction with 
EphA4 receptors. FLAG-tagged EphA4 receptors were used to pull-down 
GST-tagged !2-chimaerin mutants and Fyn kinase co-expressed in COS7 
cells using M2 FLAG-binding beads. The results indicate that !2-chimaerin 
tyrosine mutants exhibit slightly weaker interaction with EphA4, which is 






 mutants exhibited slightly weaker interaction with EphA4 as compared to wild 
type chimaerin, with co-expression of Fyn kinase having little impact on binding 
as well as chimaerin phosphorylation.  
The acidic phospholipid/phorbol ester (PMA) binding of the C1 domain 
has been reported to induce membrane translocation of "2-chimaerin (Caloca et 
al., 1997) and activation of ! 2-chimaerin (Colon-Gonzalez et al., 2008). 
Therefore, I tested chimaerin translocation with respect to the effects of NCK1, 
Fyn and EphA4 (with or without PMA treatment) as illustrated in (Fig 4.20a). 
Indeed, PMA treatment induced both membrane translocation and enhanced 
tyrosine phosphorylation of !2-chimaerin without exogenous Fyn. These effects 
were potentiated by co-expression of NCK1 and Fyn. Interestingly, tyrosine-
phosphorylated NCK1 was retained in the soluble, cytosolic fraction (lane 5 and 
10). The same membrane translocation protocol was applied to COS7 cells 
expressing the various chimaerin N-terminal YF mutants in order to assess their 
ability to respond to PMA treatment (Fig 4.20b). It was shown that in comparison 
to wild type !2-chimaerin, the Y143F and Y148F mutants are predominantly 
membrane localized. To assess which tyrosine residue were primarily modified, 
the chimaerin YF mutants were tested with wild type or kinase-inactive Fyn (KD 
= K229M): cells were treated with PMA in the presence of the broad-spectrum 
PKC inhibitor GF 109203X to eliminate the effects of PKC activation (Fig 4.21). 
Both NCK1 binding and PMA treatment were found to enhance Fyn-mediated 
phosphorylation of chimaerin, which was blocked by the Y143F mutation (lane 
3), and Fyn-KD expression (lanes 5-8). Therefore, the results indicate that 
engagement of the C1 domain is indeed critical to the membrane localization of  
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Fig 4.20. Membrane translocation of !2-chimaerin and NCK1 with PMA 
treatment. (a) Cells expressing chimaerin with various combinations of 
NCK1, Fyn and EphA4 – with  or without PMA treatment – were lysed and 
subjected to subcellular fractionation as described in Chapter 2. The data 
indicates that that phorbol ester binding can induce membrane translocation 
and tyrosine phosphorylation of !2-chimaerin that may be potentiated by 




Fig 4.20. Membrane translocation of !2-chimaerin in the presence of 
PMA treatment. (b) Cells expressing various FLAG-tagged chimaerin YF 
mutants were treated with PMA before being lysed and subjected to 
subcellular fractionation as described in Chapter 2. The data indicates that 
that phorbol ester binding can induce membrane translocation of !2-
chimaerin and that the Y143F and Y148F mutants are predominantly 
membrane localized. 
Fig 4.21. Fyn kinase phosphorylates Tyr-143 of !2-chimaerin in the 
presence of PMA treatment. Cells expressing NCK1 with various chimaerin  
YF mutants of with wild-type Fyn kinase or its kinase-dead mutant, were 
treated with PMA before the phosphorylation status of chimaerin were 
analysed using anti-4G10 blots. The data indicates that Fyn kinase 




































































 !2-chimaerin and may combine with NCK binding to enhance Fyn-mediated 
phosphorylation leading to activation of the chimaerin GAP domain.  
I tested this hypothesis using a cell spreading assay based on the B16F1 
melanoma cells. The inhibition of cell spreading would be indicative of the 
depression of Rac activity by chimaerin, as it has been previously shown that cell 
spreading was phenotypically linked to Rac activity (Wells et al., 2004; McCarty 
et al., 2005; Nodari et al., 2007). Briefly, chimaerin was expressed along with 
NCK1 and Fyn in B16F1 cells. These cells were then allowed to spread on 
laminin-coated coverslips for 30 minutes before paraformaldehyde fixation. 
Approximately 150 cells were counted from at least five randomly chosen fields 
for each treatment condition. The data were collated from at least two independent 
experiments. Under these conditions, activation of !2-chimaerin required NCK1 
binding, PMA treatment as well as Fyn phosphorylation (Fig 4.22). Inspection of 
the data revealed that ~ 80% of control cells spread but NCK1, !2-chimaerin and 
Fyn co-expression (with PMA treatment) reduced cell spreading to ~25% of cells. 
Expression of the NCK1-binding deficient chimaerin mutant (#1-38aa), the !2-
chimaerin-binding deficient NCK1 mutant (NCK1 SH3[3m]) or Fyn-KD  by 
contrast did not demonstrate such strong inhibition of this cell spreading (Fig 
4.23). As a negative control in this assay, I expressed the !2-chimaerin GAP-




Fig. 4.22. NCK1, Fyn and PMA binding synergistically activates !2-
chimaerin GAP activity in vivo. B16F1 cells expressing various 
combinations wild-type NCK1, !2-chimaerin (!2-wt) and Fyn kinase were 
allowed to spread for 30 minutes in the presence of PMA treatment on 
laminin-coated coverslips before fixation. (a) Representative images of cells 
spreading under the various treatment conditions. Cells demonstrating 
defective spreading are indicated by blue circles. Scale bar: 20 µm. 
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Fig. 4.22. NCK1, Fyn and PMA binding synergistically activates !2-
chimaerin GAP activity in vivo. B16F1 cells expressing various 
combinations NCK1, !2-chimaerin (!2-wt) and Fyn, with or without PMA 
treatment, were allowed to spread for 30 minutes on laminin-coated 
coverslips before fixation. (b) Quantification of cells that spread normally on 
the laminin-coated coverslips. More than 150 cells were counted from at least 
five individual, randomly chosen optical fields per coverslip.  
Fig. 4.23. NCK1-chimaerin interaction and Fyn kinase activity are 
needed for effective activation of !2-chimaerin GAP activity in vivo. 
B16F1 cells expressing various combinations NCK1, !2-chimaerin and Fyn 
mutants were allowed to spread for 30 minutes in the presence of PMA 
treament on laminin-coated coverslips before fixation. NCK1-SH3[3m] is 
chimaerin-binding defective; !2-"38 is a NCK-binding defective mutant; 
Fyn-KD is a kinase-dead mutant (K229M) and !2-R304G is a chimaerin 
mutant with an inactive GAP domain. (a) Representative images of cells 
spreading under the various treatment conditions. Cells demonstrating 

















Fig. 4.23. NCK1, Fyn and PMA binding synergistically activates !2-
chimaerin GAP activity in vivo. B16F1 cells expressing various 
combinations NCK1, !2-chimaerin and Fyn mutants were allowed to spread 
for 30 minutes in the presence of PMA treament on laminin-coated coverslips 
before fixation. NCK1-SH3[3m] is chimaerin-binding defective; !2-"38 is a 
NCK-binding defective mutant; Fyn-KD is a kinase-dead mutant (K229M) 
and !2-R304G is a chimaerin mutant with an inactive GAP domain.  (b) 
Quantification of cells that spread normally on the laminin-coated coverslips. 
More than 150 cells were counted from at least 5 individual, randomly 
chosen optical fields per coverslip.  
 Therefore, I conclude that !2-chimaerin is a RacGAP that is auto-inhibited 
through a variety of mechanisms, as suggested by the compact crystal structure of 
the full-length protein (Shen et al., 2008). Further mutagenesis of the interface 
between these auto-inhibitory modules and the GAP domain, and recombinant 
assays are required to address these issues. The physiological membrane 
recruitment of chimaerin via the C1 domain may occur through interactions with 
DAG, which may further enhance the co-localization with adhesion-targeted 
NCK, as GIT1 also interacts with and activates PLC" (Jones and Katan, 2007). 
 
4.5 Summary 
In this chapter, I have demonstrated NCK1’s role in regulating the GAP 
activity of !2-chimaerin. The NCK1 SH3-3 domain mediates an unconventional 
interaction with two regions in !2-chimaerin: N-terminal sequences preceding the 
SH2 domain as well as part of the SH2-C1 domain ‘linker’ region. The NCK1 
SH2 domain modulates phosphotyrosine-independent binding of both NCK1 and 
!2-chimaerin to EphA4 receptors, although more work is needed to work out the 
exact mechanism. !2-chimaerin also associates with NCK1 bound to the PAK-
PIX-GIT complex, with PAK enhancing the binding in a kinase-independent 
manner, probably through the allosteric modulation of GIT1. NCK1 binding in 
conjunction with phorbol ester engagement of the C1 domain, was also found to 
induce tyrosine-phosphorylation of the Y143 residue by Fyn, leading to the 
synergistic activation of !2-chimaerin’s Rac-GAP activity in vivo as measured by 





Chapter 5 Discussion  
5.1 NCK at focal adhesions 
5.1.1 Adhesion localization of NCK1 does not require functional SH3 
domains 
NCK has been linked with a number of FA components including 
p130Cas, FAK, PAK, PINCH and GIT (Bokoch et al., 1996; Tu et al., 1998; 
Goicoechea et al., 2002; Okabe et al., 2002; Brown et al., 2005).  Given that NCK 
has been reported to localize to adhesion structures in HEK293 cells (Goicoechea 
et al., 2002), it is of interest to understand how it might be recruited since this 
interaction is likely to be a critical regulator of local cytoskeletal organization, 
based on the well established role of NCK proteins in promoting F-actin assembly 
(reviewed by Buday et al., 2002) via  N-WASP (Frischknecht et al., 1999; 
Rohatgi et al., 2001; Campellone et al., 2004; Rivera et al., 2004; Jones et al., 
2006; Rivera et al., 2009) and WAVE (Eden et al., 2002). Previous data from 
Christopher Turner's laboratory suggested that the GIT family member PKL forms 
stable complexes with NCK in vivo (Turner et al., 1999; Brown et al., 2005), 
while an epitope scanning strategy that identified the optimal phosphopeptide 
binding sequence for NCK-SH2 domains also predicted that ACK1 and GIT1 are 
likely NCK-SH2 targets in the human proteome (Frese et al., 2006). Hence, I 
decided to focus my efforts on how the PAK-PIX-GIT complex might be involved 
in recruiting NCK to adhesion structures, since initial observations suggested that 
NCK localization was sensitive to the expression of the conventional PAK kinase 
inhibitory domain (KID – residues 83-149), as illustrated in Fig. 3.2.  
Exogenously expressed NCK1 in both non-motile and motile cells (HeLa 
and B16F1 melanoma cells respectively) showed that a small fraction of NCK1 is 
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associated with adhesion structures as labeled by paxillin (Fig 3.1; Fig 3.3; Fig 
3.4). Similar observations in COS7 and U2OS cells expressing GFP-tagged NCK1 
constructs (data not shown) suggested this to be a universal phenomenon. By 
screening for the best antibodies against endogenous NCK1 and GIT1 proteins I 
could also easily detect these proteins in HeLa cell adhesions (Fig 3.1c). Thus, the 
presence of N-terminal tags does not appear to affect the localization of these 
proteins.  In contrast, GFP-PAK1 does not localize well to adhesions compared to 
FLAG-PAK1, suggesting there might be a problem with the size of the tag (data 
not shown). 
PAK signaling has been shown to enhance FA turnover in a number of 
contexts (Manser et al., 1997; Kiosses et al., 1999; Chan et al., 2008) although the 
mechanism for this process is not well established. PAK1 is observed 
phenotypically to antagonize the RhoA-ROK pathway with respect to stress fiber 
formation, possibly through local inhibition of Rho activation (Alberts et al., 
2005). PAK1 has been shown to phosphorylate GIT at Ser517 (Zhao et al., 2005) 
while PKA phosphorylates Ser419 (Ng unpublished observations), thus a GIT1 
mutant resistant to phosphorylation by these two kinases GIT1(S419/517A) was 
used to investigate further how the enhanced association of GIT1 with adhesions 
might affect the localization of NCK. These experiments indicated that the ability 
of PAK1 KID to enhance NCK1 association with adhesions is likely a 
consequence of GIT1 stabilization at adhesions, and not as a result of PAK1 
acting on other components (Fig 3.2). This is important because PAK-mediated 
phosphorylation of NCK1 was previously reported (Bokoch et al., 1996), although 
the function of this modification has never been established  
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The FA targeting of NCK1 does not require any of the three SH3 domains 
(Fig 3.3) but rather occurs through GIT1 interactions with the NCK1-SH2 domain 
and an unusual interaction with the linker sequence between the NCK1 SH3-2 and 
SH3-3 domains (Fig 3.10). Similar data using B16F1 cells demonstrated that the 
FA localization of NCK1 with various SH3-domain inactivating mutations was 
unaffected (Fig 3.4). Therefore, this allows us to probe the functional role of 
NCK1’s FA recruitment by testing which of the SH3 domains appear to promote 
motility (Fig 3.18). Time-lapse microscopy of living HeLa cells also allowed us to 
assess which NCK1 SH3-domain mediates dynamic associations with 
assembling/disassembling adhesion structures in vivo (Fig 3.5, Movies 1-4). It is 
also interesting to note that interaction with PAK (cf. NCK1 SH3[2m]) does not 
appear to play a major role in NCK1 recruitment (Fig 3.3 and 3.4). This is 
somewhat contrary to expectations, as previous data suggested that NCK was 
recruited to paxillin-targeted complexes by PAK (Turner et al., 1999).  
The general organization of the actin cytoskeleton is unaffected by the 
expression of NCK1 and the various SH3-domain mutants (Fig 3.3). This was not 
unexpected considering the plethora of agents that promote F-actin assembly 
including key players such as N-WASP (Rohatgi et al., 2001; Rivera et al., 2009), 
the WAVE complex (Ismail et al., 2009; Lebensohn and Kirschner, 2009) and 
multiple formins (reviewed by Chesarone et al., 2010; Schonichen and Geyer, 
2010). However, it seems plausible that NCK could affect local actin nucleation 
activity, which might be the primary function of its localization to adhesion 
structures. Time-lapse imaging of the migratory B16F1 cells co-expressing GFP-
NCK1 and mCherry-paxillin allowed for the simultaneous tracking of NCK1 
localization and adhesion dynamics (Fig 3.6, Movies 5-7). It is significant that 
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NCK1 was observed to asymmetrically localize in the cell with paxillin-labeled 
adhesions at the leading edge being preferentially labeled by NCK1. One gets the 
impression that NCK1 dynamically 'translocates' from adhesions in more 
quiescent parts of the cell towards punctate focal complexes found at the actively 
protruding parts of the cell, and is preferentially lost from disassembling 
adhesions at the rear of the cell. 
 
5.1.2 The SH3-2 and SH3-3 domains are involved in NCK1 dynamics 
 The NCK1 SH3[2m] and SH3[3m] mutants were observed to be enriched 
in the nucleus relative to NCK1-WT by IF staining (Fig 3.3 and Fig 3.7). NCK1 is 
known to translocate between the cytoplasmic and nuclear compartments, even 
though it lacks an obvious nuclear localization signal (Kremer et al., 2007). LMB 
treatment of HeLa cells expressing various FLAG-tagged NCK1 constructs 
indicated an enrichment of the nuclear localization of these constructs. Thus, 
functional SH3-2 and SH3-3 domains of NCK1 are required to retain the adaptor 
in the cytoplasm. Candidate proteins involved in this process include PAK1 
(Bockoch et al., 1996; Zhao et al., 2000a), N-WASP (Rohatgi et al., 2001), and 
membrane receptors like DCC and EGF receptors (Li et al., 2002b; Hake et al., 
2008).  These interacting partners could potentially block association with nuclear 
import proteins like SOCS7 (Kremer et al., 2007).  
One line of evidence that supports this hypothesis is the observation that 
while NCK can associate with the predominantly nuclear protein SAM68, the 
tyrosine-phosphorylated NCK1 is cytoplasmic (Lawe et al., 1997). This matched 
my own observations that tyrosine-phosphorylated NCK1 was indeed retained in 
the cytoplasm (cf. lower panels of Fig 4.20a). The role of post-translational 
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modifications of NCK1, which undergoes serine and tyrosine phosphorylation by 
PAK, PKC, SFKs, PDGF and EGF receptors (Meisenhelder and Hunter, 1992; 
Park and Rhee, 1992; Bokoch et al., 1996) has not been explored. Considering the 
dynamic nature of NCK interactions, it is unlikely to be simply physically 
sequestered in the cytoplasm, thus phosphorylation is likely to play a critical role 
in regulating its nucleocytoplasmic distribution. Given the potential role for 
NCK1 in the nucleus (Kremer et al., 2007; Lettau et al., 2010), its nuclear 
retention could reveal unappreciated roles for this versatile adaptor protein. 
 
5.1.3 The biochemical mechanism underlying the NCK-GIT interaction 
Co-immunoprecipitation indicated that while NCK1 binds robustly to 
GIT1, deletion of the SH2 domain (NCK1 !SH2) greatly weakened this 
interaction (Fig 3.8). However, NCK1 !SH2 could still bind well to the GIT1 C-
terminus construct (GIT1c), which probably represent an 'open' state of the GIT1 
structure (Totaro et al., 2007). The NCK1-GIT2 interaction is dependent on 
phosphorylation of Tyr392 (Fig 3.9), which has been shown to occur downstream 
of cell adhesion and Src activation (Brown et al., 2005). Truncation of the GIT1 
N-terminus enhanced such NCK1 binding most likely because the regions 
involved in non-SH2 binding (cf. residues 446-580) are occluded by interactions 
between the GIT1 Arf-GAP domain/ankyrin repeats and the C-terminus of the 
protein, which promotes some degree of autoinhibition that have at least been 
demonstrated for the paxillin binding domain (Totaro et al., 2007).  
NCK1 is also capable of phosphotyrosine-independent interactions with 
GIT1 independent of functional SH3 domains (Fig 3.9). This is the first report of 
NCK1 interactions lying outside the recognized domains, and reinforces the idea 
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that NCK1 and GIT1 are important physiological partners. Residues 169-252 of 
NCK1 constitute the minimal binding region with the GIT1c Y392F mutant (Fig 
3.10), with the linker region (residues 169-187) N-terminal to the SH3-3 domain. 
This linker region could possibly be folded up against the SH3-3 domain. The 
minimal region in GIT1 required for this non-SH2 domain dependent binding of 
GIT1 (446-580) as illustrated in Fig 3.11. This novel mode of interaction between 
NCK1 and GIT1 would be expected to contribute to their binding, and could 
indicate that engagement of the SH2 domain to Tyr-392 would lead to an 'opening 
up' of the GIT1 C-terminal region. The sequence identity between NCK homologs 
is lower in the inter-domain linker regions, as one would expect for such 
structurally labile, 'unfolded’ regions. Interestingly, a recent NMR study that 
uncovered putative NCK autoinhibition via interaction between the SH3-2 domain 
and a non-canonical (K/R)x(K/R)RxxS sequence in the linker that lies between 
the SH3-1 and SH3-2 domains of NCK2 (Takeuchi et al., 2010). A conserved 
serine residue predicted as a p90-RSK and/or protein kinase C (PKC) 
phosphorylation site in the target linker sequence could function as a switch to 
regulate the binding efficiency of binding partners of the NCK2 SH3-2 domain. 
The observed interaction between the NCK1 SH3-2/SH3-3 domain linker 
and GIT1 is consistent with other data showing that SH2 domains often work in 
tandem with additional binding modalities to provide specificity and enhanced 
binding affinity (Panchamoorthy et al., 1994; Woodside et al., 2002). For 
example, it was demonstrated that occupancy of the Fyn kinase SH3 domain with 
a proline-rich peptide enhanced phosphotyrosine binding to the linked SH2 
domain, while phosphotyrosine-engagement of the SH2 domain also enhanced 
binding of certain cognate SH3-domain ligands (Panchamoorthy et al., 1994). My 
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experiments studying the NCK1-"2-chimaerin interaction (mediated by the NCK1 
SH3-3 domain and possibly involving other regions) also provide further support 
for the physiological relevance of multi-modal contacts for mediating stable 
interactions.  One way to assess the possible impact of such multiple interaction 
sites is to compare the binding affinity of NCK targets with single interaction sites 
such as PAK1, with those that interact via multiple sites like GIT1. These could 
be tested using biophysical assays like surface plasmon resonance (Fisher and 
Fivash, 1994). Sequence comparison across vertebrates of the SH3-2/SH3-3 
domain linker region shows that a number of residues are conserved (Fig 1.3). 
Rather than extensive mutagenesis of all the conserved residues, it might be more 
productive to pursue an NMR strategy as demonstrated above (Takeuchi et al., 
2010) to pinpoint the exact residues in the linker region that engages GIT1 (cf. 
within residues 115-187).  
 
5.1.4 GIT1 controls NCK1 localization to adhesion structures 
siRNA targeting GIT1 in HeLa cells resulted in endogenous protein levels 
dropping to ~20% of controls (Fig 3.12a). IF analysis of transfected cells showed 
that GIT1 knockdown reduced or abolished the FA localization of NCK1 (Fig 
3.12 b). Although it has been reported that GIT2 is expressed in HeLa cells (Frank 
et al., 2006), I was unable to reproduce the data although the GIT2 antibodies 
employed (two different commercially available monoclonal antibodies were 
used) do detect GIT2 when over-expressed (my unpublished observations).  This 
could be the result of the pleiotropic effects of long-term in vitro cell culture 
(Tuschl and Mueller, 2006; Nagai et al., 2010). In fact, HeLa cells under clonal 
selection exhibits variable expression of the cytoskeletal protein ArgBP2, which 
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profoundly stabilizes stress fibers and affects cell migration, depending on the 
culture conditions (Praju Vikas, personnal communication). In summary, the 
HeLa cell line used in my experiments express little to no endogenous GIT2 
proteins.   
A recent report of PKL/GIT2 knockdown in MEFs also highlighted the 
role played by GIT2 in mediating cell polarization and directional migration 
downstream of PDGF stimulation (Yu et al., 2009), which is reminiscent of GIT1 
function as detailed in the existing literature (Zhao et al., 2000b; Manabe et al., 
2002; Nishiya et al., 2005; Nayal et al., 2006). Although the two GIT are 
differentially regulated by SFK phosphorylation (Brown et al., 2005), both form 
stable complexes with PAK1, !PIX and NCK1 in vivo and hence may perform 
related functions at FA. The use of GIT1 -/- fibroblasts would help to resolve 
GIT2-specfic functions in the cell through the study of functional impairments 
when GIT2 is knocked down in the absence of GIT1. However the viability of 
GIT1 -/- mice (Menon et al., 2010) suggests significant functional redundancy 
between the two gene products. Therefore I propose that both GIT1 and GIT2 
recruit NCK1 to adhesions: evidence for endogenous NCK1-GIT1 protein 
complexes comes from the ability of the PIX-interacting domain of PAK1 to 
efficiently recover the entire complex (Fig 3.13), while paxillin was only effective 
in the co-immunoprecipitation of NCK1 with GIT1 coexpression (Fig 3.14). Thus, 
the existence of a dynamic complex involving PAK1, !PIX, GIT1 and NCK1 in 
vivo is well supported by experimental data.  
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5.1.5 NCK1 localization to adhesion structures stimulates cell motility 
Genetic ablation strategies have been used to study NCK function, either 
through studies involving animals or by the generation of relevant MEFs (Bladt et 
al., 2003; Campellone et al., 2004; Rivera et al., 2006; Fawcett et al., 2007; 
Ruusala et al., 2008). These results are consistent with data from siRNA-mediated 
knockdown of endogenous NCK (Miura et al., 2009; Abella et al., 2010). Because 
of the significant residual pool of endogenous protein in almost all siRNA 
experiments, and the compensation between NCK1 and NCK2 (Bladt et al., 2003) 
I chose to investigate the role of NCK by expressing a dominant-inhibitory form 
of NCK1, in which the wild type SH2 domain is used to out-compete the 
endogenous NCK1/2. The NCK1-SH2 domain was effective in blocking adhesion 
localization of endogenous NCK proteins in B16F1 cells (Fig 3.15). Indeed, 
overexpression of both NCK1-SH2 or the NCK1 mutant lacking the SH2 domain 
(NCK1 !SH2) significantly inhibited cell motility in B16F1 cells stimulated with 
AlF (Fig 3.18). Under these conditions, I conclude that this defect does not arise 
from the defective RTK-NCK interactions (Stoletov et al., 2004) because the 
stimulus for migration arises from the activation of heterotrimeric G-proteins 
(Cotton and Claing, 2009). 
The involvement of the NCK1-SH2 domain in mediating cell migration is 
consistent with tyrosine-phosphorylation of the PAK-PIX-GIT complex 
downstream of integrin-dependent adhesion and cell spreading (Bagrodia et al., 
1999; Haendeler et al., 2003; Chang et al., 2007). It has been reported that 
formation of dorsal ruffles induced by N-WASP involves recruitment of NCK by 
tyrosine-phosphorylated RTKs at the plasma membrane (Rivera et al., 2006; 
Ruusala et al., 2008; Abella et al., 2010). Other data implicating NCK in actin 
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dynamics includes its role in generating actin-rich foot processes in glomerular 
podocytes via SFK-phosphorylated nephrin receptors (Verma et al., 2006; 
Blasutig et al., 2008).  The proposed role of NCK1 in modulating actin dynamics 
is consistent with what is known about its role in pathogen-induced cytoskeletal 
reorganization (Frischknecht et al., 1999). An essential role of NCK was also 
noted for the formation of F-actin pedestals by enteropathogenic Escherichia coli 
(EPEC) via tyrosine-phosphorylated bacterial Tir transmembrane receptors, which 
contain the pYDxV NCK-SH2 binding motif (Gruenheid et al., 2001; Campellone 
et al., 2004). FAs are also known to drive actin polymerization (Butler et al., 
2006, Hotulainen and Lappalainen, 2006) through the local recruitment of actin 
nucleators (Sturge et al., 2002; DeMali et al., 2002). 
 The fact that the NCK1 SH3[2+3m] mutant did not result in significant 
inhibition of cell migration speed, suggests that the SH3-1 domain plays a key 
role in this function. This would be consistent with the role of the NCK SH3-1 
domain in recruiting the WAVE complex via Nap1 (Kitamura et al., 1996).  The 
WAVE2 complex is required for the generation of lamellipodial protrusion in 
B16F1 cells (Steffen et al., 2004). In vitro actin polymerization assays indicate 
that NCK1 is as effective as Rac1 in activating the WAVE1 complex (Eden et al., 
2002). One might envisage that NCK1 and Rac1 may act in concert in vivo to 
recruit and activate WAVE proteins at sites of active actin polymerization at the 
leading edge of cells (Pilpel and Segal, 2005).  
The induction of broad lamellipodia and highly polarized cellular 
morphologies in B16F1 cells treated with AlF probably reflects activation of the 
Cdc42-polarity complex (Hahne et al., 2001). This is somewhat surprising given 
the indiscriminate nature of the G-protein activation mediated by AlF (
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phosphate analog), which activates practically all proteins that bind phosphates or 
nucleoside-polyphosphates (reviewed by Strunecka et al., 2002). As one might 
expect, it was shown that AlF treatment increases levels of Rac.GTP in the cell 
(Steffen et al., 2004), which could potentially lead to activation of N-WASP 
(Benesch et al., 2002; Tomasevic et al., 2007) via coincident signals from Rac1, 
NCK and PIP2 binding. This could also give rise to enhanced endocytosis of 
membrane-bound proteins due to the well-established role of N-WASP activity in 
vesicular trafficking (Qualmann and Kelly, 2000; Kessels and Qualmann, 2002; 
Innocenti et al., 2005). This is of interest because focal adhesion turnover is linked 
to clathrin-mediated endocytosis (Vassilieva et al., 2008; Hines et al., 2010) and 
GIT1 is clearly involved in Arf-mediated membrane trafficking of G-proteins (de 
Curtis, 2001; Gavina et al., 2010). Hence, there is considerable crosstalk between 
NCK and GIT mediated signaling pathways, emphasizing the physiological 
significance of the NCK-GIT interaction. 
My results derived from blocking the adhesion localization of NCK1 is 
consistent with data from NCK double-knockout MEFs, which can form 
lamellipodia but exhibit sparser actin filament networks just beyond the leading 
edge (Bladt et al., 2003). Both lamellipodia formation and cellular polarization 
appear normal in my experiments (Fig 3.18, Movies 8-11), but nonetheless 
expression of dominant-inhibitory NCK1 mutants led to a significant reduction in 
migration speeds . Future experiments would require the generation of stable cell 
lines expressing the NCK-SH2 construct in order to investigate the role of 
adhesion targeted NCK in directional migration, which could be measured in 
transwell migration assays or wound-healing assays. Since my experiments have 
shown that the NCK1 SH3-1 domain is critical for NCK function in vivo, the 
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observation that it might be involved in the formation of NCK oligomers (see next 
section) is not unexpected.` 
 
5.1.6 Do NCK proteins oligomerize in vivo? 
Using expression of differentially tagged NCK proteins in cells, I could 
demonstrate homodimerization of NCK1 proteins and heterodimerization of 
NCK1 and NCK2 proteins (Fig 3.19 and 3.20), which requires the N-terminal 
region including the SH3-1 domain and the SH3-1/SH3-2 ‘linker’ region (residues 
1-114). One possibility is that SH3-1 domain undergoes a homodimeric 
interaction in trans with the ‘linker’ region, in a similar manner as the 
autoinhibitory conformation of PAK1 (Lei et al., 2000).  A recent paper also 
identified an "autoinhibitory" conformation for NCK2, mediated by an interaction 
between a non-canonical, yet conserved (K/R)x(K/R)RxxS sequence in the SH3-1 
/SH3-2 domain linker, and the second SH3-2 (Takeuchi et al., 2010). However, 
the authors also pointed out that the substitution of the Thr84 residue in the NCK2 
target sequence with the corresponding Pro residue (equivalent residue in NCK1) 
abrogated the binding to the SH3-2 domain of NCK2. Therefore, further 
investigation is needed to investigate the validity of such an interaction in NCK1 
although the NCK1 SH3-2 domain was not found to be required for dimerization. 
I will formally test this model by further pulldown assays using the minimal 
binding region to co-immunoprecipitate full-length NCK, as well as investigate 
the ability of purified recombinant NCK proteins to form native oligomers under 
various salt conditions by size exclusion chromatography. 
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5.1.7 How do GIT1 and NCK function at focal adhesions? 
In chapter 3 of this thesis, I proposed the existence of a PAK-PIX-GIT-
NCK complex in vivo, which functions to recruit NCK1 to adhesions (Fig 5.1). 
While GIT1 dynamics at this site is affected by PKA and PAK phosphorylation, 
the regulation of focal adhesion turnover by PAK1 (Manser et al., 1997; Kiosses 
et al., 1999; Brown et al., 2002; Chan et al., 2008) likely involves multiple targets 
other than GIT1 itself. NCK1 association with GIT1 is primarily modulated by 
SFK phosphorylation, although an interaction between GIT1 and the NCK1 SH3-
2/SH3-3 linker was also observed. As discussed above, the functional implications 
of such multi-modal interactions could be further assessed via biophysical assays. 
The tyrosine phosphorylation of the GIT protein complex that likely occurs upon 
recruitment of adhesions (Bagrodia et al., 1999), therefore serves to both recruit 
SH2-domain adaptors like NCK1 as well as activate FA components like !PIX 
(Chang et al., 2007) and PLC" (Haendeler et al., 2003) leading to the downstream 
activation of multiple proteins including chimaerin (see next section). Since there 
are no good pharmacological inhibitors of PLC, it is difficult to study the role of 
these two pathways downstream of GIT1.  
Fig. 5.1. Working model of the role of GIT1 in NCK1 signaling at focal 
adhesions. NCK1 recruitment to adhesion structures is controlled by the PAK-
PIX-GIT complex in vivo, and is regulated in tandem with GIT1 by PAK 
phosphorylation, which has been shown to mediate focal adhesion turnover 
(see red box). The biochemical association of NCK1 with GIT1 seems to be 
predominantly regulated by Src family kinase phosphorylation through the 
NCK1 SH2 domain. GIT1 recruitment of NCK1 to adhesion structures 
mediates pro-migratory processes at the leading edge, probably through 
activation of actin nucleators like N-WASP and/or the WAVE complex (green 
box). The NCK1 SH3-2 domain also mediates cytoplasmic retention of the 
protein as it cycles through the cytosolic and nuclear compartments of the cell 
(black box).  
Retracting rear Leading edge 
focal complex 




5.2 NCK1 and !2-chimaerin 
5.2.1 The cellular localization of !2-chimaerin 
In HeLa and B16F1 cells, exogenous "2-chimaerin is primarily cytosolic, 
although a small fraction of the protein seems to localize to protrusive regions of 
the lamellipodia (Fig 4.2). This was recapitulated in time-lapse microscopy of live 
B16F1 cells (Fig 4.15, Movie 12), and resembles localization of endogenous 
PAK1, !PIX, GIT1 and NCK in focal complexes at leading edge of B16F1 cells 
(Fig 4.14). However, chimaerin is not adhesion associated (cf. bottom panel of Fig 
4.2). Chimaerins do undergo membrane translocation upon DAG/phorbol ester 
binding (Caloca et al., 1997; Brown et al., 2004), bringing the two proteins into 
permissive proximity and plausibly allowing dynamic interactions with adhesion-
localized NCK1. 
 
5.2.2 NCK1 mediates an unusual interaction with the !2-chimaerin N-
terminus, primarily through the SH3-3 domain 
Deletion of the first 38 amino acids of "2-chimaerin (Fig 4.4) and an 
inactivating mutation of the NCK1 SH3-3 domain both eliminated binding (Fig 
4.3). This N-terminal region preceding the SH2 domain is involved in the 
autoinhibited conformation of "2-chimaerin (Colon-Gonzalez et al., 2008) 
suggesting NCK binding could mediate transition to an activation state. In #2-
chimaerin, the N-terminal proline (P) residues 21 and 22 (the equivalent of P13 
and P14 in "2-chimaerin) physically contact the GAP domain (Caraganajah et al., 
2004). Although deletion of both proline-containing motifs (cf. "2-chimaerin !38) 
prevented NCK1 binding (Fig 4.4), deletion of the first proline-containing motif 
("2-chimaerin !14) and mutation of both proline residues in the second (P28 and 
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P30) did not negatively affect NCK1 binding (Fig 4.5). Finally, the SH2-C1 
domain linker region of "2-chimaerin is needed, but not sufficient for robust 
NCK1 binding (Fig 4.6 and 4.7).  
In summary, strong binding of NCK1 to "2-chimaerin requires 
involvement of an unconventional SH3 interaction with the region N-terminal to 
the SH2 domain and the SH2-C1 domain linker region. This indicates that the 
previous model that implicates the "2-chimaerin-SH2 domain was overly 
simplistic (Wegmeyer et al., 2007). It is significant that the interactions detailed 
here occur in the absence of phorbol ester engagement of the chimaerin C1 
domain, suggesting there is no need for additional conformational changes for 
NCK1 to bind "2-chimaerin. Interestingly, truncation of the C-terminal NCK1 
SH2 domain inhibited "2-chimaerin binding in the presence of Fyn kinase co-
expression, suggesting that the NCK1 SH3-3 domain interaction with "2-
chimaerin may be regulated by tyrosine phosphorylation of one or both proteins 
(Fig 4.18). This is consistent with my previous observations of the multi-modal 
interaction between NCK1 and GIT1 (see chapter 3) and previously published 
data that demonstrates that ligand occupancy of adjacent domains can 
allosterically modulate binding affinities of other domains in the same protein 
(Panchamoorthy et al., 1994; Woodside et al., 2002).  
 
5.2.3 NCK1 and !2-chimaerin interactions with potential upstream 
regulators 
"2-chimaerin has been reported to bind to EphA4 receptor in an SH2-
dependent, or SH2-independent manner (Iwasato et al., 2007; Wegemeyer et al., 
2007; Beg et al., 2007; Shi et al., 2007). Both NCK1 and "2-chimaerin are both 
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capable of binding EphA4 receptors individually (Fig 4.11 and 4.19 respectively), 
but the NCK1-SH2 domain rather than the SH3-3 domain affects the chimaerin 
interaction with EphA4 (Fig 4.10). NCK1 and "2-chimaerin bound wild-type 
EphA4 similarly to a kinase-dead version (Fig 4.10): this suggests that NCK1 and 
"2-chimaerin can interact with EphA4 without prior tyrosine 
(auto)phosphorylation. This EphA4-NCK1 interaction is much weaker compared 
to the other interactions I have described in this thesis (Fig 4.11). Other 
investigators also reported poor interaction between EphA4 receptors and #-
chimaerins (Wegmeyer et al., 2007). Both interactions with the kinase domain of 
EphA4 (Wegmeyer et al., 2007) and phosphotyrosine-dependent interactions with 
the juxtamembrane tyrosines (Beg et al., 2007) are known. This low level of 
binding that I observed could correspond to the constitutive, phosphotyrosine-
independent interaction of non-stimulated EphA4 receptors. Similarly, the NCK-
chimaerin interaction is unaffected by EphA4 activity (Fig 4.10). One possible 
working model involves an initial constitutive interaction with non-activated 
EphA4, and a subsequent interaction augmented by EphA4 kinase activity. There 
is experimental evidence of bimodal effects downstream of EphA4 interactions 
with NCK1 and chimaerin, which indirectly supports my proposed model. Studies 
have shown that Rac undergoes a biphasic mode of regulation post-EphA4 
stimulation, with the initial down-regulation of Rac activity being rapidly reversed 
(Wahl et al., 2000; Jurney et al., 2002). Clearly more work is needed to unravel 
the signaling intricacies of the tripartite EphA4-NCK-chimaerin interaction. Such 
experiments need to interrogate cell lines that express EphA4 at physiological 
levels. 
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The PAK-PIX-GIT-NCK1 complex localizes preferentially to peripheral 
focal complexes (Chapter 5.1) but the mechanism underlying this is obscure at 
this stage. To assess the possible association of this complex with "2-chimaerin, I 
expressed the PAK-PIX-GIT complex in various combinations with "2-chimaerin 
in COS7 cells. Although very little "2-chimaerin was observed at adhesions in the 
lamellipodia (Figs 4.2, 4.14, 4.15 and Movie 12), NCK1 could still interact with 
"2-chimaerin while associating with the PAK-PIX-GIT complex. PAK1 also 
potentially enhances the NCK1-chimaerin interaction, although the exact 
mechanism remains unclear (Fig 4.12 and 4.13). This is consistent with a previous 
study that suggested that PAK1 binding induces a conformational change in GIT1 
that enhances paxillin binding (Totaro et al., 2007), possibly through the exposure 
of cryptic binding sites in the C-terminus. PAK could also potentially induce 
allosteric changes in NCK1 by binding to the SH3-2 domain, but it seems more 
likely that the effects of PAK-mediated phosphorylation of !PIX at Ser340 
(Rennefahrt et al., 2007) and GIT1 phosphorylation at Ser517 (Zhao et al., 2005) 
are responsible for the observed effects on the dynamics of the complex.   
 
5.2.4 Does NCK regulate !2-chimaerin activity? 
Recombinant PAK1-PBD is commonly used to assess cellular Rac.GTP 
levels. In cells expressing epitope-tagged Rac, NCK1 and "2-chimaerin appeared 
to increase Rac.GTP levels while the "2-chimaerin GAP domain alone did not 
decrease Rac.GTP levels (Fig 4.16). Despite previous reports that "2-chimaerin 
activity can be measured by this assay (Caloca et al., 2003; Brown et al., 2004; 
Shi et al., 2007), I could not replicate such results using a number of different 
strategies.  As I discussed in Chapter 4, it is unclear why this PAK1-PBD assay I 
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performed apparently failed to measure endogenous Rac.GTP levels, but this 
needs follow up with additional positive and negative controls.  
 As an alternate method of scoring Rac activity in vivo, a neurite extension 
assay was performed using the neuronal-like PC12 cells (Luo L., 2000). I 
discovered that overexpression of "2-chimaerin alone, or in combination with 
NCK1, did not effectively abolish  neurite extension, a process highly sensitive to 
Rac1.GTP levels (Fig 4.17). It is known that "2-chimaerin can promote 
neuritogenesis independent of its GAP activity (Hall et al., 2001), which may 
positively offset its inhibitory impact on Rac.GTP levels in cells. Full-length "1-
chimaerin was also found to stimulate lamellipodial and filopodial protrusions in 
N1E-115 cells downstream of Rac1/Cdc42, in a GAP-independent manner 
(Kozma et al., 1996). Such results provide further support for the notion that 
chimaerin GAP activity is highly regulated in the cell. 
 
5.2.5 NCK, Fyn and phorbol ester binding may be required to activate !2-
chimaerin 
Structural analyses of #2- and #2-chimaerin crystal structures suggest that 
under 'resting conditions', the DAG/phorbol ester binding C1 domain of both 
proteins makes extensive hydrophobic interactions with four other regions of the 
molecule: the N-terminal 30 residues, the SH2 domain, the SH2-C1 domain linker 
sequence, and the Rac-GAP domain (Canagarajah et al., 2004, Shen et al., 2008). 
In this structure, the #2-chimaerin Pro21 and Pro22 residues (Pro13 and Pro14 "2-
chimaerin) make direct contact with the structurally rigid Rac binding cleft of the 
GAP domain, occluding access by the p21 substrate. To activate the GAP domain 
would require reorganizing these extensive intramolecular interactions, which is 
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energetically unfavorable unless the 'active' conformation is stabilized by 
compensatory interactions. Access to the lipid-binding pocket of the C1 domain is 
also restricted, with ~40% of the C1 domain surface and most of the putative 
phospholipid-binding site effectively occluded in this resting conformation 
(Canagarajah et al., 2004).  
This explains previous findings that intact #2-chimaerin are much less 
responsive to phorbol ester treatment than other proteins with less sterically 
occluded C1 domains. The ED50 of PMA needed for inducing membrane 
translocation of "2-chimaerin (estimated to be > 1µM) (Colon-Gonzalez et al., 
2008), and !2-chimaerin (~1.2µM) is ~100 times that of PKC" (~10nM) and the 
#1-chimaerin splice variant that lacks the N-terminal SH2 domain (~20nM) 
(Canagarajah et al., 2004). Similarly, recombinant "1-chimaerin, which also does 
not contain the N-terminal SH2 domain, exhibited identical binding affinities as 
PKC" (low nanomolar range) for the phorbol ester [3H]PDBu (phorbol 12,13-
dibutyrate) (Areces et al., 1994). It is notable that PKCs contain two C1 domains 
that promote efficient membrane translocation (Szallasi et al., 1996; 
Ananthanarayanan et al., 2003). This is consistent with the notion that the N-
terminal NCK1-binding sequences of "2- and #2-chimaerin proteins are critical 
for regulating access to the C1 domain, which is postulated to mediate association 
of chimaerin-GAP domains with membrane-bound Rac to regulate the strength 
and duration of Rac activation. Therefore, I would propose that NCK1-binding is 
one of the inputs required for activation of the GAP domain in addition to C1 
domain binding by DAG/acidic phospholipids (Caloca et al., 1997; Caloca et al., 
2001).
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Phosphorylation is likely to be critical to unlocking the autoinhibitory 
conformation of chimaerin. Multiple tyrosine residues in N-terminus like Y70, 
Y143 and Y148 (Shi et al., 2007), as well as residues Y202 and Y303 in the C1 
domain of "2-chimaerin (Wegmeyer et al., 2007) are known targets of EphA4. It 
has been suggested that #2-chimaerin GAP activity is down-regulated by Src-
family kinase phosphorylation of Y21 (Y11 in "2-chimaerin) (Kai et al., 2007) or 
Y153 (Y143 in "2-chimaerin) (Siliceo and Merida, 2009). Fyn is implicated in 
EphA4 signaling (Bourgin et al., 2007; Shi et al 2007), and the regulation of 
several neuronal RhoGAPs (Wolf et al., 2001; Taniguchi et al., 2003; Liu et al., 
2006a). Hence I decided to investigate the role of Fyn phosphorylation in the 
regulation of "2-chimaerin interactions and activity. Several N-terminal "2-
chimaerin YF mutants were generated targeting tyrosine residues within the newly 
identified Nck1 binding region; all the YF mutants bind to NCK1 and EphA4 
receptors with similar affinity as the wild-type protein (Fig 4.18 and 4.19), 
suggesting that these interactions are not phosphotyrosine-dependent. 
Furthermore, Fyn coexpression did not significantly affect "2-chimaerin binding 
or the extent of phosphorylation. This suggests that interactions with NCK1 and 
EphA4 are not directly involved in regulating access to "2-chimaerin sites 
phosphorylated by Fyn, although the presence of multiple phosphorylation targets 
in the chimaerin N-terminus suggests this could be a platform for regulating other 
protein-protein interactions (Kai et al., 2007; Shi et al., 2007; Wegmeyer et al., 
2007; Siliceo and Merida, 2009). 
PMA treatment induces the simultaneous membrane translocation and 
enhanced tyrosine phosphorylation of NCK1 and "2-chimaerin mediated by Fyn 
kinase (Fig 4.20a). This was consistent with data from other published studies that 
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suggested that phorbol ester treatment drives the membrane targeting of 
chimaerins (Caloca et al., 1997; Caloca et al., 20001; Colon-Gonzalez et al., 
2008). The Tyr143 residue of "2-chimaerin, which was previously shown to be a 
SFK target in !2-chimaerin (Siliceo and Merida, 2009), was then established as 
the Fyn phosphorylation target in the presence of PMA treatment (Fig 4.21). This 
is also similar to observations in podocytes that demonstrated that Fyn 
phosphorylation of nephrin-mediated NCK recruitment and actin polymerization 
(Blasutig et al., 2008), indicating that Fyn targets are physiological ligands for 
NCK-SH2 domains. Interestingly, the NCK1 $SH2 mutant binds all the chimaerin 
YF mutants with lower avidity than full-length NCK1 in the presence of Fyn co-
expression (Fig 4.18), suggesting that Fyn phosphorylation may modulate NCK-
SH2 domain binding of "2-chimaerin through a similar mechanism as the NCK-
nephrin interaction.  
My data suggests that NCK1 binding and C1 domain engagement (by 
DAG/phorbol ester binding) relieves the autoinhibitory conformation, thereby 
promoting Fyn kinase phosphorylation and full activation of "2-chimaerin GAP 
activity. It is well established in the literature that Rac1 activity is intimately 
linked with lamellipodial protrusion and integrin-dependent cell spreading (Wells 
et al., 2004; McCarty et al., 2005; Kai et al., 2007; Nodari et al., 2007). The 
hypothesis that the Rac-GAP of chimaerin requires multiple coincident signals for 
fully activation was then tested with a B16F1 cell spreading assay. The data 
suggests that NCK1 and DAG/phorbol ester binding, combined with Fyn kinase 
phosphorylation synergistically activates "2-chimaerin GAP activity (Fig 4.22). 
Significantly, full activation of the GAP domain was prevented by the lack of 
PMA stimulation, inhibition of Fyn kinase phosphorylation via the expression of 
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the KD mutant, and disruption of the NCK1-chimaerin interaction through 
expression of the "2-chimaerin $38 or NCK1 SH3[3m] mutants (Fig 4.23). 
However, the N-terminal truncation ($38) is also likely to perturb the general 
conformation of "2-chimaerin. As "2-Chimaerin(Y143F) was as effective as wild-
type "2-chimaerin in the inhibition of cell spreading, Fyn phosphorylation does 
not seem to be needed for GAP activation. On the other hand, "2-
chimaerin(Y21F) exhibited attenuated GAP activity (Fig 4.21), although this 
effect could also be due to local structural perturbation of the chimaerin N-
terminus. It is however unclear why the Y143F mutation reduces the solubility of 
"2-chimaerin (Fig 4.20b).  
"2-chimaerin Y143, Y148 and Y157 residues are found in the SH2-C1 
domain linker region, but Y143 and Y148 are buried in the C1 domain interface. 
"2-Chimaerin Y143 in particular, forms hydrophobic interactions with residues of 
the DAG-binding cleft in the C1 domain (Caraganajah et al 2004). This explains 
why Fyn could not phosphorylate Y143 efficiently in the absence of PMA binding 
(Fig 4.18). It is therefore possible that even the conservative Y!F mutations alter 
the native conformation of "2-Chimaerin. Indeed, both Y143F and Y148F 
residues mutants were predominantly localized in the membrane compartment of 
the cell (Fig 4.20b). An additional complication is that Fyn phosphorylation of "2-
chimaerin Y143F could allow further phosphorylation of cryptic residues (like 
Y21) by Fyn and/or EphA4.  Indeed, an analysis of EphA4 receptor tyrosine 
kinase substrate specificity using peptide-array-based kinase assays identified the 
consensus sequence pY-(D/E)-(D/E)-(I/L/P) (Warner et al., 2008), and 
demonstrated that the Y21 residue in the N-terminus, as well as the Y143 and 
Y202 residues in the SH2-C1 domain linker of "2-chimaerin are efficiently 
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phosphorylated by EphA4 in vitro. Thus EphA4 and Fyn kinase may cooperate to 
open up the autoinhibitory conformation of "2-chimaerin. However, the 
functional relevance of these sites needs to be addressed in a model vertebrate 
system such as the developing zebrafish (Sager et al., 2010), whose rapid rate of 
development and high fecundity, combined with exceptional optical clarity of the 
developing embryo, facilitates long-term microscopic interrogation of 
developmental processes. Interestingly, PKC-mediated phosphorylation of Ser169 
(not conserved in "2-chimaerin) is suggested to inhibit membrane targeting of #2-
chimaerin (Griner et al., 2010) perhaps as a negative-feedback loop downstream 
of DAG/phorbol ester signaling. Therefore, although the N-terminal sections of "- 
and #-chimaerins are highly conserved (Fig 1.10) and contain multiple 
phosphorylation sites that appear to participate in the regulation of their GAP 
activities, there may be significant divergence in their regulatory mechanisms. 
While tyrosine phosphorylation has been shown to be involved in the up-
regulation of "2-chimaerin GAP activity (Shi et al., 2007; Wegmeyer et al., 2007 
and Fig 4.23), phosphorylation of #2-chimaerin has been suggested to inactivate 
GAP activity (Kai et al., 2007; Siliceo and Merida, 2009). 
Taken together, my results indicate that the interaction of NCK1 with 
inactive "2-chimaerin contributes to relaxation of its intramolecular inhibitory 
structure, allowing for C1 domain engagement by DAG/phorbol esters and 
redistribution to cellular membranes, where Fyn kinase phosphorylation leads to 





5.2.6 The role of NCK in the regulation of !2-chimaerin GAP activity 
NCK1 appears to be able to bind chimaerin with significant avidity, and 
play a role in regulating their GAP activity. The NCK1 SH3-3 domain mediates 
an unconventional interaction with two regions in #2-chimaerin: N-terminal 
sequences preceding the SH2 domain as well as part of the SH2-C1 domain 
‘linker’ region. The NCK1-SH2 domain modulates phosphotyrosine-independent 
binding of both NCK1 and #2-chimaerin to EphA4 receptors, although more work 
is needed to work out the exact mechanism. Although biochemically some #2-
chimaerin bind NCK1 associated with the PAK-PIX-GIT complex, there is no 
evidence of co-localization at cell adhesions. NCK1 binding and phorbol ester 
engagement of the C1 domain induced tyrosine-phosphorylation of the #2-
chimaerin Y143 residue by Fyn, resulting in a phenotype consistent with 
enhanced chimaerin Rac-GAP activity. 
Other studies suggest that DAG is a physiological ligand for the chimaerin 
C1 domain. For example, EGF treatment induced the membrane translocation and 
sustained association of #2-chimaerin with Rac1 in a PLC"-dependent manner 
(Wang et al., 2006). G-protein coupled receptors (GPCR) that activate PLC# and 
stimulate DAG generation can promote membrane translocation of #2-chimaerin 
(Siliceo et al., 2006). The muscarinic acetylcholine receptor 1 can recruit "1-
chimaerin to the plasma membrane in cultured hippocampal neurons (Buttery et 
al., 2006). Interestingly, PLC" is associated with and regulated by GIT1 (Jones 
and Katan, 2007) and EphA4 (Zhou et al., 2007). These combined signals could 
mediate the transition to the ‘open’ conformation of chimaerin required for GAP 
activation (Caloca et al., 1997; Caloca et al., 2001; Colon-Gonzalez et al., 2008). 
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In conclusion, the results presented in this thesis suggest that NCK1 binding 
and membrane recruitment of "2-chimaerin by DAG promotes tyrosine 
phosphorylation mediated by EphA4 and/or Fyn kinases to provide a 
combinatorial stimulus leading to activation of the "2-chimaerin GAP domain and 
the localized down-regulation of Rac1 activity (Fig 5.2).  
Fig 5.2. Working model of NCK1 function in the regulation of !2-
chimaerin activity. NCK1 binding to the N-terminus of !2-chimaerin, in 
combination with phosphorylation by Fyn and DAG engagement of the C1 
domain relieves the autoinhibition of GAP domain (See “Closed” 
conformation), leading to reduction of Rac,GTP levels and inhibition of cell 
spreading. Physiological sources of DAG synthesis include RTK, G-protein 
coupled receptor (GPCR) and GIT1-mediated PLC activation. (a) NCK1 
recruitment to adhesion structures by the PAK-PIX-GIT complex enhances 
the NCK1-chimaerin interaction, possibly by targeting NCK1 to the same 
cellular compartment as membrane-bound chimaerin. (b) NCK1 and 
chimaerin are recruited to activated EphA4 receptors via both 
phosphotyrosine-dependent and independent mechanisms. NCK1-SH2 
domain was shown to positively modulate NCK-chimaerin binding to 
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